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This project aims to develop the first isothiourea-catalyzed acylative kinetic resolution (KR) 
of biaryl diols. To place this work in context, a brief introduction to chirality and its 
importance, an overview of methods for isolating enantiopure compounds, as well as an 
introduction to, and theories behind, KR is given in the Chapter 1. This chapter finishes by 
summarising previous publications concerning the KR of biaryl compounds and the use of 
isothiourea catalysts. Chapter 2 details the optimization of the model KR of (±)-BINOL, which 
includes screenings 3 isothiourea catalysts, 10 bench-stable solvents, 21 anhydrides as acyl 
donors, 3 catalyst loadings and 4 different temperatures to deliver optimal selectivity. The 
optimized conditions for the KR of BINOL was found to be: BTM (1 mol%); 2,2-diphenylacetic 
pivalic anhydride (0.55 equiv.); room temperature for 18 hours, giving high selectivity (S = 55) 
at 50% conversion while minimizing the formation of an unwanted diacylated side-product. 
The scope and limitation of this procedure were evaluated in Chapter 3, which details the 
synthesis and attempted KR of 13 biaryl compounds aimed to test the generality of the 
procedure established in Chapter 2 (Scheme 1). It was found that the selectivity of the KR is 
sensitive to the steric bulk and/or electronic property of the substituents on the biaryl rings. 
While 6/6’- and 7,7’- substitution on BINOL are well-tolerated, as well as the 4/4’, 5/5’ and 
6/6’-substitution on 2,2’-biphenol, substrates bearing 3/3’-substitution could not be 
tolerated by this procedure. The successful KR of N-Boc-NOBIN and unsuccessful KR of 
mono-O-protected BINOL derivatives, suggests that two H-bond donors are required within 
the substrate to have good selectivity and reactivity in acylative KR. A proposed catalytic 
cycle, as well as a simple stereochemical model that can be used to rationalise the observed 
sense of asymmetric induction, is discussed in Chapter 4. 
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Chapter 1: Introduction 
 
1.1 Chirality 
The term chiral, coming from the Greek word χειρ which means hand, is used to describe a 
geometric property of the asymmetric nature of a given object.1 In chemistry, a chiral 
structure can exist in two distinct configurations, where one is a non-superimposable mirror-
image of the other. Opposite configurations of a chiral molecule are referred to as the two 
enantiomers. A chiral molecule does not have any plane of symmetry or inversion centre. 
Other than optical rotation dispersion, and unless in a chiral environment, a pair of 
enantiomers possess identical chemical and physical properties. Chiral molecules are 
optically active and a pair of enantiomers can rotate plane-polarised light with the same 
degree of rotation in opposite directions, one being dextrorotatory ((+)-rotation) and the 
other being levorotatory ((-)-rotation).1 Ever since Louis Pasteur separated the two 
enantiomers of the sodium ammonium salt of tartaric acid in 1848,2 chirality has become a 
very interesting and important topic among chemistry researchers. 
 
The many different types of chirality can be subclassified depending on the spatial 
arrangements of the atoms within a molecule (Figure 1).3 The most common type is point 
chirality (Figure 1a), where a stereogenic centre is present in the molecule. This is most 
commonly observed for a tetrahedral carbon atom that bears four different substituents as 
observed in amino acids such as serine (Figure 1a). Another common classification is that of 
axial chirality, where two non-superimposable configurations, referred to as atropisomers of 
one another, are present due to the restricted rotation about a bond in the molecule. This 
type of chirality is commonly found in biaryl compounds (as exemplified by BINOL (Figure 
1b)) and allenes. Planar chirality is present when two non-coplanar rings cannot rotate easily 
about the chemical bonds connecting them, and the plane of symmetry is lost by adding 
substituents to the rings. This type of chirality is commonly found in monosubstituted 
paracyclophanes (Figure 1c). Helical chirality results from helicity itself and commonly 
presents in DNA and proteins (as exemplified by hexahelicene (Figure 1d)). The absolute 








Figure 1. Examples of different types of chirality 
 
Our biosphere is a chiral world, with many natural organic molecules associated with life are 
often found to be chiral. Moreover, homochirality is a fascinating feature developed over 
the evolution of life on earth.5 All the basic chiral building blocks are almost exclusively one 
of the possible stereoisomers. For example, only D-ribose and 2-deoxy-D-ribose are found to 
be monomer units of RNA and DNA polymers respectively, while D-glucose is found as the 
exclusive monomer of glycogen, cellulose and starch. Similarly, natural building blocks for 
proteins are mostly found as L-amino acids, which makes proteins inherently chiral. 
Consequently, protein receptors can target one structurally specific molecule, and hence can 
bind specifically to a single enantiomer to generate responses. 
 
The chirality of proteins therefore has great biological significance. For example, odour 
perception is closely linked to chirality.6 The olfactory protein receptors in the nasal cavity 
are each highly specialised in differentiating structures and configurations.7 Because of the 
specificity of these interactions and their corresponding signal responses, enantiomers can 
have different scents. For example, (R)-carvone has a minty smell while (S)-carvone smells of 
caraway,8 (R)-limonene smells of oranges while (S)-limonene smells of lemon  (Figure 2). 
 




Likewise, chirality also plays a vital role in drug design. The incorporation of stereogenic 
centres gives molecules higher structural complexity and may lead to the desired physical 
properties or biological selectivities.9 Again, based on the interactions between chiral 
molecules and chiral protein receptors, a pair of enantiomers could trigger different 
biological effects. While one enantiomer triggers a beneficial effect, the other could be 
differently beneficial, inactive or even harmful.10 For example, the two enantiomers of 
Methorphan (Figure 3) have different beneficial effects. Dextromethorphan 2a is an over-
the-counter cough suppressant whilst levomethorphan 2b is a potent opioid analgesic.11 L-
DOPA 3a helps to replenish the brain’s supply of dopamine, hence used to treat Parkinson’s 
disease,12 while D-DOPA 3b is inactive. (S)-Naproxen 4a is known to have beneficial anti-
inflammatory effects while (R)-Naproxen 4b causes liver poisoning.13 
 
 
Figure 3. Enantiomers of methorphan (2a, 2b), DOPA (3a, 3b) and Naproxen (4a,4b) 
 
1.1.1 Biaryl compounds  
Overview: This thesis is concerned with studies towards the enantioselective acylative KR of 
biaryl diols using Lewis base catalysis. As such, the remainder of this introduction chapter 
will aim to place this work in context by summarising the inherent chirality of biaryl diols, 
their utility in synthesis and catalysis, as well as methods for their preparation. 
  
Chiral biaryls are found in many bioactive structures and natural products. For example, 
gossypol 5a (yellow pigment; antimalarial) and isokotanin A 5b (Figure 4) both contain a 
chiral biaryl motif. Similarly, the structure of vancomycin 5c (a potent antibiotic),14 contains a 






Figure 4. Gossypol 5a, isokotanin A 5b and vancomycin 5c 
 
In chiral biaryl structures, the stereogenicity is a consequence of restricted rotation about 
the C(sp2)-C(sp2) single bond separating the biaryl units. The high energy barrier of rotation 
is usually a result of the steric effects of the 2/2’ and 6/6’ substitutions, which puts the biaryl 
structure into an orthogonal orientation (Figure 5). Theoretically, if enough energy is 
provided, the two atropisomers can interconvert by rotating about the C(sp2)-C(sp2) single 
bond that connects the two aryl groups. Isolation of the two atropisomers is possible only if 
a high enough energy barrier can be provided by the restricted rotation about that single 
bond.16 Analytical separation is only possible if the interconversion of the two enantiomers 
has a half-life of 1000 s or longer.17  
 
 
Figure 5. Non-superimposable mirror images of chiral biaryl 
 
Based on their structural features, biaryl compounds can also be used as auxiliaries, ligands 
or catalysts in asymmetric synthesis to direct the generation of new chiral elements.18 Many 
biaryl compounds have been employed for such purposes. Representative examples include, 
but are not limited to, [1,1'-binaphthalene]-2,2'-diol (BINOL) 6, 2,2'-bis(diphenylphosphanyl)-
1,1'-binaphthalene (BINAP) 7, 2'-amino-[1,1'-binaphthalen]-2-ol (NOBIN) 8, 3,3'-diphenyl-




yl)isoquinoline (QUINAP) 10 (Figure 6). The ready modification of the BINOL19 and BINAP20 
skeletons has ensured that these are the most widely used. As a representative example, in 
1979, Noyori showed that BINOL is a highly competent chiral ligand for the reduction of 
ketones using LiAlH4, giving the alcohol products in up to 99% ee.21 He subsequently used 
BINAP as a chiral ligand in metal-catalysed asymmetric hydrogenation reactions and allylic 
hydrogen shift reactions.22,23 Noyori was co-awarded the Nobel Prize in Chemistry in 2001 
for his work with BINAP-derived highly selective chiral catalysts.24 The wide use of chiral 
biaryl compounds in reactions such as Diels-Alder reactions, ene reactions, carbonyl 
reductions, Michael addition reactions, metal-catalysed allylic allylations and more25 is 
demanding more efficient methods with lower costs for the synthesis and/or isolation of 
enantiomerically pure forms of biaryl compounds. 
 
Figure 6. Structures of BINOL 6, BINAP 7, NOBIN 8, VAPOL 9 and QUINAP 10 
 
1.2 Methods for obtaining enantioenriched compounds 
The traditional methods for obtaining enantioenriched compounds can be classified into 
three general types: chiral pool, which starts from naturally-occurring chiral compounds; 
enantioselective synthesis, which starts from prochiral compounds and encompasses chiral 
auxiliary and chiral catalytic methods; and resolution, which starts from racemates (Figure 7). 
 
 




The chiral pool: Syntheses employing the chiral pool approach choose a suitable chiral 
starting material from a collection of cheap and readily available natural products, such as 
amino acids, sugars or metabolites from plants and microorganisms. The stereogenic 
centre(s) within the starting material will be maintained or used to relay stereochemical 
information throughout the whole process. Although this method usually has fairly low cost, 
it is heavily limited by the number, structure, and quantity of naturally-occurring chiral 
structures. Despite these limitations, this method is employed in the synthesis of an 
antiinfluenza drug Olsetamivir (Tamiflu®), starting from shikimic acid - originally found as a 
metabolite of Chinese star anise (Figure 8).26 This drug was widely used and stocked in 2005 
during the H5N1 Avian influenza ‘Bird flu’ epidemic in Southeast Asia. Due to the lack of 
availability of naturally-occurring biaryl compounds, the chiral pool strategy is not commonly 
employed in the synthesis of enantioenriched biaryls.  
 
Figure 8. Structures of Shikimic acid and Olsetamivir 
 
Asymmetric Synthesis: Asymmetric synthesis, or stereoselective synthesis, creates new 
stereogenic elements with control of configuration from a prochiral starting material 
through the use of either chiral auxiliaries or chiral catalysis. The chiral auxiliary approach 
requires a functional group that can be covalently bound to a given (usually achiral) starting 
material. Chiral auxiliaries can direct the stereochemical course of subsequent reactions on 
the substrate, selectively generating a preferred product diastereoisomer. However, the 
auxiliary needs to be incorporated into a synthesis in a stoichiometric manner, and removed 
at the end of the synthesis in order to obtain the target compound, which inherently 
increases the cost of the process and generates more waste unless the auxiliary can be 
readily recycled. As a representative example of this approach, in 1983, Yamamoto and co-
workers reported an asymmetric synthesis of D-limonene, where (R)-BINOL (R)-6 was utilised 
as a chiral auxiliary for the first time.27 (R)-BINOL (R)-6 was attached through monosilylation 
and alkylation, and D-limonene was isolated in moderate yield and moderate enantiopurity 
after a cyclisation mediated by organoaluminium reagent 8 (Scheme 2). (S)-BINOL (S)-6 has 






Scheme 2. (R)-BINOL (R)-6 as chiral auxiliary in the asymmetric synthesis of D-limonene 
 
Enantioselective catalysis, in contrast, uses only a substoichiometric amount of a chiral 
catalyst to direct the formation of the new stereogenic centre or element. The catalysts used 
in such processes can usually be classified as being based upon enzymes (biocatalysis), metal 
complexes (metal catalysis) or organic structures (organocatalysis). While using non-
stoichiometric quantities of a chiral catalyst can help reduce the costs of a given process, 
syntheses are however limited by the availability, stability, recyclability and specificity of the 
catalysts. A number of enantioselective metal catalysed synthetic routes have been 
developed for obtaining enantioenriched biaryl compounds.29 For example, Buchwald and 
co-workers reported one of the earliest cases to isolate enantioenriched biaryl compounds 
using an enantioselective Suzuki-Miyaura coupling reaction (Scheme 3).30 A number of biaryl 
phosphonates 12 were successfully isolated in high yields and high enantiopurity using a Pd 
catalyst with an (S)-KenPhos ligand 11. 
 
Scheme 3. Synthesis of biaryl phosphonates through Suzuki-Miyaura coupling reactions  
 
Resolution: The resolution strategy can be subdivided into three groups: chiral 
chromatography, classical resolution and kinetic resolution (KR). Chiral chromatography uses 
columns with a chiral stationary phase, with the separation of the enantiomers achieved 
based on the differences in the affinity between the enantiomers and the chiral stationary 
phase. This results in different retention times for each enantiomer. The high cost of chiral 





Classical resolution uses a stoichiometric amount of a chiral enantiopure reagent to convert 
a racemic mixture into a mixture of two diastereoisomers. Separation then relies on the 
different physical properties of the diastereoisomers, such as solubility and melting/boiling 
points.31 Jacques and co-workers were the first to report the chemical resolution of BINOL 
(±)-6 through the cyclic binaphthyl phosphoric acids 13. The racemic acid 13 reacts with 
cinchonine salt to give two diastereomeric salts, which were then separated and hydrolysed 
back to enantioenriched acids (R)/(S)-13. Enantioenriched BINOL (R)/(S)-6 were isolated 
after treating the enantioenriched acids (R)/(S)-13 with LiAlH4 (Scheme 4).32  
 
Scheme 4. Chemical resolution of BINOL (±)-6 by Jacques and co-workers 
 
In contrast, KR separates a racemate based on the different reaction rates between the two 
enantiomers and a chiral enantiopure reagent or catalyst-derived species, ideally 
transforming only one enantiomer, resulting in easier separation of the mixture. More 
details on KR will be discussed in the next section. 
 
The choice of the most suitable methodology for obtaining a given enantioenriched 
compound should be made specific to the case. A collection of factors should be taken into 
account in order to find the best methodology, such as the efficiency and the costs of the 
process; the costs, availability, stability and toxicity of the reagents; the reaction conditions 
and even the expertise of the chemists involved.  Although asymmetric synthesis is arguably 
the most popular method for obtaining enantioenriched compounds in academia, resolution 
remains an area of interest in research from an industrial and academic point of view. This 
project focuses on KR of biaryl compounds in order to contribute to the collection of 






1.2.1 Kinetic resolution 
The first reported KR was enzyme-catalysed and was performed by Pasteur in 1858.34 He 
reported that by performing fermentation on an aqueous solution of racemic ammonium 
tartrate using Penicillium glaucum mould, the unreacted starting material was optically 
active. This indicated that the two enantiomers of ammonium tartrate were consumed with 
different rates by the mould. 
 
A successful KR relies on the difference in the rate constants (k) for the reaction of each 
enantiomer of a racemate with an enantiopure catalyst or reagent. A KR can only happen 
when the rate constants are different, i.e. kR ≠ kS. In the ideal scenario, the rates would be so 
different (kR >> kS) that one of the enantiomers (SMR) is completely transformed into the 
product (PR) while the other enantiomer (SMS) shows no reactivity, thus providing a mixture 
of 50% SMS and 50% PR at the end of the reaction. However, in reality, both enantiomers 
usually show some reactivity and the reaction therefore provides scalemic product and 
recovered SM. In this case, a compromise on either the enantiomeric purity or yield of the 
recovered SM would have to be made (Figure 9). 
 
 
Figure 9. A general scheme of a KR process 
 
The enantiomeric purity of a chiral structure is usually assessed by measurement of its 
enantiomeric composition or ratio (er) which can be readily converted into an enantiomeric 
excess (ee), which indicates the excess of one enantiomer over the other (Figure 10. 
Equation A). In a KR process, the relative rate constants for the reaction of a pair of 
enantiomers with the same chiral catalyst or reagent can be assessed using the selectivity 
factor, S, which is related to the difference between the activation energies (ΔΔGǂ) of the 
two diastereomeric transition states (TS) (Figure 10. Equation B). It is assumed that S is 
applicable in the cases where the resolution is pseudo-first-order in respect to the substrate. 
A larger energy gap of ΔΔGǂ results in a larger difference in the rate constants for the 
reaction of the two enantiomers, hence a bigger S factor, and a more efficient KR. A 






Figure 10. Equations for ee and S factor 
 
 
Figure 11. A schematic free energy diagram for KR 
 
Equations that enable the experimental determination of the S factor using enantiomeric 
excess (ee) and conversion (c) were first developed by Kagan35 and are shown below (Figure 
11). A representative KR plot showing the ee of substrate and product throughout a reaction 
with S = 10 is also shown below (Figure 12). It can be seen that as the reaction proceeds, the 
ee of the remaining substrate increases as one enantiomer is being selectively transformed. 
The product, however, starts with a high ee that gradually decreases throughout the 
reaction. As shown in the plot, enantiopure product can be obtained at low conversion, and 
can only be isolated in high enantiopurity upon full conversion of the reaction if a very big S 
factor is present. In contrast enantiopure recovered substrates are usually obtained at c > 
50%. It is therefore easier to obtain highly enantioenriched recovered substrate than 





Figure 12. Equations relating S, ee and c; plot of ee v.s. c throughout a reaction (S = 10) 
 
The KR plot below shows the relationship between ee and c for the recovered substrate for 
resolutions with different S values (Figure 13). It can be seen that the bigger the S value, the 
steeper the curve. The trend in the curves indicates that with bigger S values, it is easier to 
obtain recovered substrate in high ee at lower conversion. For example, with S = 10, the ee 
of the substrate reaches 90% at around 60% conversion, i.e. 40% maximum yield; while the 
same level of enantiopurity can be reached at around 50% conversion with S = 20. A KR is 
generally considered synthetically useful only if it has S > 10. 
    
Figure 13. ee against conversion plot with different S factors for recovered substrate 
 
The inherent disadvantage of KR is that the maximum yield of either enantiomer is only 50%. 
This can be overcome by using dynamic kinetic resolution (DKR), where the starting material 
is concurrently racemised under the reaction conditions. Ideally, one single enantiomer 
could be isolated with high yield and enantiopurity upon completion of the reaction. This 
technique is not employed in this project. 
 
Just like asymmetric syntheses employing chiral catalysis, KR can be achieved through using 
biocatalysis, metal catalysis or organocatalysis. Although enzymatic KR has been widely 
investigated to show high levels of selectivity, the substrate scope is usually limited by the 
availability and specificity of the enzymes used. Alternative non-enzymatic KR processes, 
especially organocatalytic routes, are still challenging and are attracting more attention in 




1.3 Organocatalytic kinetic resolution of biaryl compounds 
Although rapid progress in KR has been made in recent years, the KR of biaryl compounds 
still remains challenging. The first example of enzymatic KR of biaryls was reported by 
Ikekawa and co-workers in 1985, employing microbial asymmetric hydrolysis of diesters of 
BINOL 6.36 Further biocatalysed KR of biaryl compounds was later reported by Myano37, 38, 
Ayogi39, 40, 41 and Seki42, 43 with moderate to high selectivity. Metal catalysed KR of biaryl 
compounds has also been reported by Tsuji (Palladium)44 and Schlosser (Titanium, 
Sharpless–Katsuki epoxidation)45 with good selectivities. To date, however, there are only 7 
publications regarding organocatalytic KR of biaryl compounds. 
 
The first organocatalytic KR of biaryl compounds was reported by Spivey in 2011.46 The 
acylative KR of two NOBIN derivatives was attempted using 11 different pyridine-derived 
chiral catalysts (1 mol%). Although suitable conditions were found for obtaining good 
conversions, only one substrate (±)-14 was successfully resolved through N-acylation 
catalysed by (-)-16, albeit with a low S factor of 4. The absolute configuration of neither the 
recovered starting material 14 nor the product 15 was determined (Scheme 5).  
 
 
Scheme 5. The first organocatalytic KR case of biaryl compounds by Spivey 
 
In 2013, a very interesting case of a chiral phosphoric acid (R)-20 catalysed 
desymmetrisation/KR sequence of biaryl substrates (±)-17 through bromination was 
reported by Akiyama and co-workers.47 It was found that the desymmetrised 
monobrominated product (±)-18 can undergo a second bromination through a KR under the 
optimal reaction condition, giving enhanced overall selectivity with a slight sacrifice on the 
yield. A collection of substrates (±)-18 was tested in the KR to give S factor up to 97.3 with 
high enantiopurity of (R)-18. The methoxymethyl group at the 6’-position of the bottom aryl 
ring (as drawn) was found to be essential for obtaining good selectivity and reactivity 
through control experiments. It was also shown that both electron-donating and electron-





Scheme 6. Enantioselective desymmetrisation/KR sequence by Akiyama 
 
Maruoka and co-workers reported a phase-transfer-catalysed KR of N-sulfonyl anilines (±)-21 
through N-allylation in the same year (Scheme 7).48 They proposed that direct interaction 
between deprotonated chiral biaryl amino compound (±)-21 and the phase-transfer catalyst 
(S,S)-23 would result in efficient chiral recognition through the formation of an ion pair. The 
procedure showed good tolerance to various substituents on the biaryl backbone, giving 
good reactivity (combined yield up to 98%) and high selectivity (S factor up to 43). It was also 
shown that the N-sulfonyl protecting groups on the enantioenriched starting material and 
product could be easily removed using trimethylsilyl chloride, magnesium powder and 
Ti(OiPr)4 generated in-situ from titanium(IV) isopropoxide.  
 
Scheme 7. KR of biaryl compounds by phase-transfer-catalysed N-allylation 
 
In 2014, Tan and co-workers reported a very efficient chiral phosphoric acid catalysed 
enantioselective KR of BINAM derivatives, using aryl aldehydes and Hantzsch ester as a 
hydride source.49 Variations of both the phosphoric acid catalyst and Hantzsch ester were 




the amines of BINAM was required to provide an effective energy barrier to rotation, 
rendering the biaryl structure chiral. A collection of protecting groups were tested and well 
tolerated to give good reactivity (yield up to 99%) and good to excellent selectivity (S= 7-
340). Further studies showed that very poor selectivity was observed by replacing Hantzsch 
ester with NaBH4, suggesting that the KR was not controlled by the imine formation, but by 
the cooperation of phosphoric acid catalyst and Hantzsch ester in the transfer 
hydrogenation (Scheme 8). 
 
Scheme 8. Brønsted acid catalysed KR of BINAM derivatives 
 
Sibi and co-workers reported a case of chiral DMAP 30 catalysed acylative KR of biaryl 
compounds later in the same year.50 A low temperature of −50 °C was required for optimal 
selectivity, requiring a high catalyst loading (15 mol%), addition of base and long reaction 
time was required for good conversion. A collection of mono-protected BINOL derivatives 
and an N-methylated NOBIN derivative were resolved, giving moderate to high selectivity (S 
= 11-51) (Scheme 9).  
 
 






A stereochemical model was proposed by Sibi to explain the enantioselectivity observed 
(Figure 14). The fluxional naphthylmethyl group of the catalyst is proposed to adopt a 
conformation anti- to the adjacent tert-butyl group in order to minimise steric repulsion. 
This naphthylmethyl unit effectively blocks the “bottom” face of the pyridine core as drawn, 
with the biaryl substrate forced to approach from the opposite “top” face. The interactions 
that lead to selectivity between the two isomers of the biaryl and the catalyst 30 are shown 
below. A proposed π-π/π-cation interaction between the pyridine and ring A was suggested 
to stabilise the complex. In order to minimise the steric repulsion between the catalyst 30 
and ring B, the OR group was oriented toward the catalyst rather than the ring B, resulting in 
a more stable transition state TS-31 for the S isomer than the R isomer (TS-32). 
 
 
Figure 14. Proposed DMAP-biaryl interaction model by Sibi 
 
An NHC-catalysed acylative KR of biaryl compounds was also reported by Zhao and co-
workers51 at the same time as Sibi. The S factor was found to be sensitive to the substituents 
on the aldehyde used. A very broad range of substrates were tolerated by this procedure, 
including binaphthyl and biphenyl diols as well as NOBIN derivatives, giving very good 
selectivity (S = 15-116) with good yields at a high catalyst loading of 10 mol%. It was shown 
that the procedure can be performed well at gram-scale with S > 25. Further tests on 
monomethylated BINOL and di-N-methylated NOBIN lead to very low selectivity (S < 2) and 
reduced reactivity. It was suggested that the good selectivity of the system might be related 





Scheme 10. NHC catalysed acylative KR of biaryl compounds by Zhao 
 
The first case of KR of axially chiral heteroaromatics was reported in 2016 by Zhou and co-
workers.52 Chiral phosphoric acid (R)-39 and Hantzsch ester 36 were employed for the 
enantioselective transfer hydrogenation of axially chiral 8- or 5- substituted quinolines (±)-
37/(±)-40. A wide collection of substrates was tested and excellent selectivities were 
observed (S = 13-209). It was shown that 8-substituted quinolines generally gave better 
selectivities than 5-substituted quinolines, with the selectivity very sensitive to the 
substitution on the aromatic moiety without nitrogen (Scheme 11). A few examples of the 
products were shown to be thermally stable at 80 °C.  
 
Scheme 11. KR of heteroaromatics reported by Zhou 
 
1.4 Isothioureas in kinetic resolution of alcohols 
Acylation is probably the most often used technique for the KR of alcohols and amines since 
Wegler reported the first KR using organocatalysis in 1932.53 Other than the families of 
DMAPs and NHCs, which have been used in the KR of biaryl compounds, isothioureas are 
another family of Lewis base catalysts often used in acylation reactions and for the acylative 




The family of isothioureas developed from the structure of amidine 2,3-dihydroimidazo-[1,2-
α]pyridine (DHIP) 42 introduced by Birman and co-workers as enantioselective acyl transfer 
catalysts.57 Modification of the structure to incorporate an adjacent sulphur atom led to the 
use of the commercially available isothiourea tetramisole (TM) 43 by Birman in 2006 for the 
KR of aryl alkyl secondary alcohols, with a modified benzannulated version, 
benzotetramisole (BTM) (R)-44, showed increased selectivity.58 Around the same time, 
Okamoto and Kobayashi developed a related catalyst 3,4-dihydro-2H-pyrimido[2,1-
b]benzothiazole (DHPB) 45, which contains a 6-membered ring. DHPB 45 was shown to be 
more efficient as an acyl transfer catalyst relative to the amidine and isothiourea catalysts 
studied by Birman, which contained 5-membered rings.59 Building upon the structure of 
DHPB 45, a family of isothiourea catalysts soon emerged. Birman developed (S)-HBTM 46 in 
2008, which gave S factors up to 122 for the resolution of aryl-cycloalkanols.60 In 2009, 
Birman developed further modified isothiourea catalyst HBTM 2.0 (2S,3R)-47,61 while at the 
same time, independent work by Smith developed the catalyst HyperBTM (2S,3R)-48,62 both 
finding that substitution in the 3-position gave improved selectivities and allowed lower 
catalyst loadings to be used in catalytic applications (Figure 15). 
 
Figure 15. Structures of different isothiourea catalysts 
 
Isothiourea catalysis has been a research focus within the Smith group for close to a decade. 
HyperBTM 48 was first reported for the enantioselective Steglich reaction, and first used in 
the KR in 2011, in which aryl alkyl alcohols could be resolved with excellent selectivity with 
S > 100 at very low catalyst loadings (< 1 mol%).56  
 




The proposed transition state is shown below (Figure 16). N-acylation of the isothiourea by 
the anhydride gives an N-acyl ammonium ion, with the adjacent phenyl group forced to 
adopt a pseudoaxial conformation to avoid 1,2-interactions. This effectively blocks the 
bottom face of the acylated catalyst and directs the approach of the alcohol from the top 
face as drawn. The conformation of the acylated catalyst is locked by the non-bonding O-S 
interaction (nO to σ*C-S).63 The good selectivity is proposed to be due to the π-cation 
interactions between the aromatic moieties of the (R)-isomer of the alcohol and the 
positively charged isothiouronium, which further stabilises the transition state.  
 
 
Figure 16. Proposed TS for isothiourea catalysis 
 
Over the years, different isothioureas have been used to resolve a wide range of secondary 
alcohols, including aryl-alkyl alcohols, alkenyl-alkyl alcohols, alkynyl-alkyl alcohols, aryl-
alkenyl and cycloalkanols, with good to excellent selectivity (Figure 17).56,64 Challenging 
tertiary alcohol also have recently been resolved using HyperBTM 48 giving good 
selectivity.65 However, among all the cases that have been reported so far, only alcohols 
with C(sp3)-OH bonds possessing point chirality have been resolved. The resolution of 
alcohols with C(sp2)-OH bonds bearing axial chirality has not been attempted using any 
isothiourea to date. 
 





1.5 Aims and Objectives 
 
Scheme 13. Proposed project aims 
 
Although various pathways have been reported for obtaining enantioenriched biaryl 
products, the organocatalytic KR of these compounds still remains very challenging. The aim 
of this project is to develop a new isothiourea-catalysed acylative method for the KR of 
biaryl compounds. As the KR of this class of compounds has not been attempted before 
using isothioureas, optimisation of this process will require successive screening of catalyst, 
solvent and anhydride in order to generate a successful procedure. Following optimisation 
of the KR reaction conditions, a range of racemic biaryl compounds will be synthesised to 




















Chapter 2: Reaction optimisation 
Overview 
This chapter details work concerned with the optimisation of reaction conditions to allow an 
isothiourea catalysed enantioselective acylative KR of (±)-BINOL (±)-6. The screenings of 
catalyst, solvent, acyl donor, catalyst loading and temperature are reported and discussed in 
the following sections that lead to optimal selectivity (Scheme 14). 
 
 
Scheme 14. General scheme for reaction optimisation 
 
2.1 Catalyst and solvent 
Initial studies focused on the acylative KR of (±)-BINOL as a model substrate using isobutyric 
anhydride 53 (0.55 equiv) as an acyl donor. Three isothiourea catalyst candidates (R)-BTM 44, 
(2R,3S)-HyperBTM 48 and (S)-TM·HCl 52 that are either readily prepared or commercially 
available were tested for their ability to promote the acylation in CHCl3 over 18 h (Table 1, 
entries 1-3). A relatively low catalyst loading of 1 mol% was used as standard with the aim to 
develop an effective resolution procedure. In all cases three products of the reaction were 
observed; enantioenriched BINOL 6, monoester 54 as well as small amounts (<2%) of diester 
55. While all three catalysts were able to promote the reaction close to 55% conversion at 
room temperature, very different selectivities were observed. (R)-BTM 44 gave the highest S 
factor of 26 giving recovered BINOL in 98% ee and 47% isolated yield, followed by TM·HCl 52 
(S = 12) with HyperBTM 48 giving the lowest selectivity (S = 5). Therefore (R)-BTM 44 was 
chosen to be the optimal catalyst for further optimisation work. It was also found that (R)-
BTM 44 gave the opposite enantiomers of BINOL 6 and monoester 54 than (2R,3S)-
HyperBTM 48 and (S)-TM·HCl 52. By comparing the specific rotation of (R)-BINOL 6 reported 
by literature,66 the major enantiomer of recovered BINOL 6 catalysed by (R)-BTM 44 was 










46.5: 53: 0.5 58 39 50 31 54 5 
2 (S)-TM·HCl 52 44: 55: 1 83 37 66 21 55 12 
3 (R)-BTM 44 44.5: 53.5: 2 98 47 71 30 55 26 
*conversion; a)Ratios determined by 1H NMR spectroscopy b) 55 not isolated; c)ee, c and S determined by HPLC 
analysis; racemic sample prepared using DMAP catalysis; d) isolated yields;  
Table 1. Catalyst screening 
 
Subsequent studies tested a further range of 9 common solvents in this reaction process, 
with all giving close to 55% conversion (Table 2). Interestingly, significant changes in 
selectivity (S value) as well as variation in the ratio of monoester 54: diester 55 was observed 
upon changing the solvent. A wide range of selectivity (S = 1.7-37) was observed (Table 2, 
entries 1-10), with CH2Cl2, THF, EtOAc, MeCN and acetone all giving very low selectivity (S < 
10). Whilst Et2O, PhMe and iPr2O gave reasonable selectivity (S = 17-21), tert-amyl alcohol 
was the only solvent (S = 37) that showed higher selectivity than chloroform although 4% of 
diester was observed. 
 
Entry solvent 6 : 54: 55a 6(ee%b, %c) 54(ee%b, %c) 55(ee%b, %c) c (%)b Sb,d 
1 CHCl3 44.5: 53.5: 2 98 47 71 30 - - 55 26 
2 CH2Cl2 48: 51: 1 55 42 50 31 - - 52 5 
3 THF 51: 44: 5 61 38 60 45 72 4 50 7 
4 EtOAc 53: 42: 5 64 41 69 38 68 6 48 10 
5 MeCN 50: 46.5: 3.5 31 34 28 33 63 4 53 2 
6 Et2O 55: 39: 6 73 31 82 38 93 3 47 21 




49: 47: 4 88 37 86 30 94 8 50 37 
9 iPr2O 51.5: 42: 6.5 74 30 77 30 91 4 49 17 
10 acetone 50.5: 40: 9.5 67 32 53 33 77 5 55 6 
a)Ratios determined by 1H NMR spectroscopy; b)ee, c and S determined by HPLC analysis; racemic sample 
prepared using DMAP catalysis; c)isolated yields; d)using only data of 6 and 54, diester 55 not taken into account 




Assuming that the formation of diester in this resolution approach proceeds by initial mono-
acylation of (±)-BINOL, this second acylation could also proceed enantioselectivity. In 
principle this second-acylation could either enhance or reduce the observed 
enantioselectivity of the mono-acylated species via a second KR. To test the selectivity 
observed in the formation of diester, the KR of racemic monoester (±)-54 was investigated 
under the same reaction conditions. Although the reaction proceeded to 44% conversion 
under the same amount of time, a very low S factor of 3 was obtained. This indicated that 
the KR of monoester 54 is not effective under these reaction conditions (Scheme 15). 
Furthermore, hydrolysis of diester 55 gave (S)-BINOL 6 with retained ee confirmed the 
configuration of the major enantiomer of diester as (S)-55, the same as the fast-reacting 
monoester (S)-54.  
 
 
Scheme 15. KR of racemic monoester (±)-54 
 
Using the product ratio and ee of all 3 products, a new S factor that includes a correction for 
the selective generation of monoester 54 can be back calculated. However, this correction 
only resulted in a small change in S (from 43 to 45 in tert-amyl alcohol) and so does not play 
a significant role on the selectivity of the process. 
 
Control reactions in both chloroform and tert-amyl alcohol were then carried out to monitor 
the background acylations (Table 3). In the absence of both catalyst and iPr2NEt in 
chloroform no conversion was observed after 18 hours (Table 2, entry 1). The reaction 
performed with only iPr2NEt (without catalyst) in chloroform gave almost full conversion 
(Table 2, entry 2), indicating a strong and potentially competitive base-mediated background 
reaction. This conclusion was further confirmed by the big difference in S factor obtained in 
the KR performed with and without iPr2NEt, giving S = 26 and S = 36 respectively (Table 3, 
entries 3 & 4). Interestingly, 30% conversion was observed when the reaction was 
performed in tert-amyl alcohol in the absence of both catalyst and iPr2NEt (Table 3, entry 5). 




catalyst), which agrees with the observations in chloroform (Table 3, entry 6). The catalysed 
KR showed that iPr2NEt does not have a big effect on the selectivity of KR in tert-amyl 
alcohol (Table 3, entries 7 & 8). The results obtained in both solvents indicate that iPr2NEt 
has either a negative or no effect on the selectivity of the KR, so therefore it is decided that 
further reactions would be carried out in the absence of iPr2NEt.  
 
The data obtained also shown that only small amounts of diester 55 were generated in the 
KR process (< 3%). Interestingly, iPr2NEt has little or no effect on the generation of diester 55, 
while more significant diacylation was observed in tert-amyl alcohol with excess of 
anhydride 53.  
 
 




- - 0 - - 
2 - 0.6 equiv. 94 - 6: 89: 5  
3 
0.55 equiv. 
1 mol% - 49 36 44: 55 : 1 






- - 30 - 46.5: 34 : 19.5 
6 - 0.6 equiv. 64 - 45: 36 : 19 
7 
0.55 equiv. 
1 mol% - 52 35 50: 47 : 3 
8 1 mol% 0.6 equiv. 50 38 48: 50 : 2 
a) c and S determined by HPLC analysis; racemic sample prepared using DMAP catalysis; b)Ratios determined by 
1H NMR spectroscopy  
Table 3. Background reactions and effects of base 
 
2.2 Homoanhydrides  
Having demonstrated promising reactivity with BTM 44 as the catalyst in CHCl3 and tert-amyl 
alcohol as solvents, variation of the acyl donor was next investigated. Other than isobutyric 
anhydride 53, 18 other homoanhydrides 56 a-r that varied in alkyl or aryl substitution, as 
well as branching, were tested for selectivity in this KR process. Commercially available 
homoanhydrides (56a, 56b, 56i & 56l) were used without further purification, with the 
remainder synthesised either through DCC- or EDCI-mediated coupling from their 





monoalkyl-α-subsitution aromatic-α-subsitution dialkyl-α-subsitution 
R = CH2CH(CH3)2 56d 32% Ar = p-Br-C6H4 56j 52% R = CHEt2 56n 78% 
R = CH2CH2CH(CH3)2 56e 60% Ar = p-NO2-C6H4 56k 56% R = CH(nPr)2 56o 82% 
R = CH2Ph 56f 62% Ar = 3-pyridine 56m 44% R = CHPh2 56p 59% 
R = CH2CH2Ph 56g 55%    R = cyclopentyl 56q 58% 
R = CHCHPh 56h 29%    R = cyclohexyl 56r 32% 
Scheme 16. Synthesis of homoanhydride 53 a-r 
 
The screening started by varying the bulkiness of the homoanhydride (Table 4, 56 a-c). The 
use of acetic anhydride 56a shown high conversion, however, the monoester 57a and BINOL 
6 could not be separated using chromatography, and HPLC conditions to separate the 4 
molecules could also not be found, hence no S factor could be obtained in this case. 
Increasing the steric bulk of the anhydride from propionic anhydride 56b (S =12/13) to 
isobutyric anhydride 53 (S = 36/35) resulted in a big improvement in selectivity of the KR in 
both solvents and a slight drop in the yield (Table 4, 56b, 53). Further increasing the steric 
bulk to pivalic anhydride (56c) resulted in only 2% conversion in chloroform and 16% in tert-
amyl alcohol, with an S factor of 11 in tert-amyl alcohol. Significantly diminished selectivity 
was observed when using the - or -branched anhydride (56d and 56e respectively), giving 
S = 8/6 and S = 11/13 respectively. 
 
anhydride solvent ee% 6a %6b ee% 57a %57b c a S a 6: 57: 58c 
 
CHCl3 - - - - 45b - 55: 44: 1 
tAmOH - - - - 48b - 51.5: 41: 7.5 
 
CHCl3 91 29 61 38 59 12 40.5: 56.5: 3 
tAmOH 84 30 67 22 54 13 45.5: 45.5: 9 
 
CHCl3 83 41 87 36 49 36 47: 53: - 
tAmOH 87 37 86 28 50 35 50: 47: 3 
 
CHCl3 - - - - 2b - 98: 2: - 
tAmOH 16 46 80 13 16 11 84: 16: - 
 
CHCl3 58 40 64 40 47 8 52: 46: 2 





CHCl3 34 30 78 21 31 11 70: 30: - 
tAmOH 36 60 80 40 31 13 69: 31: - 
a)ee, c and S determined by HPLC analysis; b)all isolated yields; c)Ratios determined by 1H NMR spectroscopy;  
Table 4: Data using homoanhydrides 53 & 56 a-e 
 
Further work investigated the incorporation of aryl substituents on the - or β-positions, 
with 56f giving improved selectivity of (S = 25/17) and 56g giving similar selectivity to 56e. 
An S factor of only 3 at c=32% in chloroform was observed when using cinnamic anhydride 
56h (Table 5). 
 
 
anhydride solvent ee% 6a %6b ee% 57a %57b c a S a 6: 57: 58c 
 
CHCl3 75 45 84 29 47 25 52: 47: 1 
tAmOH 67 54 79 26 46 17 55: 41: 4 
 
CHCl3 53 46 75 29 41 12 58: 41: 1 
tAmOH 50 37 75 13 40 12 53: 40.5: 6.5 
 
CHCl3 21 63 45 12 32 3 66.5: 32: 1.5 
tAmOH 44 38 49 28 46 4 54: 41: 5 
a)ee, c and S determined by HPLC analysis; b)all isolated yields; c)Ratios determined by 1H NMR spectroscopy;  
Table 5: Data using homoanhydrides 56 f-h 
 
Further work tested a small number of benzoic anhydrides. Benzoic anhydride 56i gave 
moderate selectivities (S = 15/16) at c < 50% in both solvents, with p-Br and p-NO2 
derivatives (56j and 56k) groups giving similar results. Using the p-OMe derivative led to 
100% conversion using DMAP catalysis. However, the monoester 57l could not be separated 
from BINOL 6, hence KR was not performed and no data was obtained in this case. Nicotinic 
anhydride 56m was also tested to give S = 25 at c = 53% in chloroform and S = 13 at c = 42% 






anhydride solvent ee% 6a %6b ee% 57a %57b c a S a 6: 57: 58c 
 
CHCl3 45 40 81 28 36 15 54: 46: - 
tAmOH 73 43 77 41 49 16 52: 46: 2 
 
CHCl3 84 41 72 44 54 16 49: 50.5: 0.5 
tAmOH 54 35 80 45 40 15 40.5: 53: 6.5 
 
CHCl3 77 37 75 32 51 16 48.5: 51.5: - 
tAmOH 77 35 74 29 51 15 47.5: 52.5: - 
 
CHCl3 - - - - - - - 
tAmOH - - - - - - - 
 
CHCl3 89 32 79 44 53 25 31: 66: 3 
tAmOH 56 29 80 47 42 13 37.5: 57.5: 5 
a)ee, c and S determined by HPLC analysis; b)all isolated yields; c)Ratios determined by 1H NMR spectroscopy;  
Table 6: Data using homoanhydrides 56 i-m 
 
As isobutyric anhydride 53 (S = 36/35) gave the best selectivity by far, alternative α,-
branched substituted homoanhydrides were investigated. Both diethylacetic anhydride 56n 
and dipropylacetic anhydride 56o showed similar selectivities in chloroform (S = 34, S = 38 
respectively), however low conversions (c = 15%, c = 12% respectively) were observed due to 
low solubility. Lower selectivity was observed in tert-amyl alcohol (S = 27, S = 25 respectively) 
while both proceeded to good conversion (c = 48%). Diphenylacetic anhydride 56p gave, at 
52% conversion, S = 43 in chloroform and S = 33 in tert-amyl alcohol. Cyclopentylcarboxylic 
anhydride 56q gave similar selectivities in both solvents (S = 23/22) at c > 50%. 
Cyclohexylcarboxylic anhydride 56r gave S = 39 in chloroform and S = 10 in tert-amyl alcohol 
with good conversion, however the anhydride itself was not bench-stable (Table 7).  It is 
worth commenting that anhydrides 56o and 56p showed no trace of diester product in the 
1H NMR spectroscopy, which might suggest that the bulky di-α-substituents on 





anhydride solvent ee% 6a %6b ee% 57a %57b c a S a 6: 57: 58c 
 
CHCl3 16 70 93 7 15 34 86: 14: - 
tAmOH 78 38 84 37 48 27 51: 47: 2 
 
CHCl3 13 77 94 10 12 38 88.5: 11.5: - 
tAmOH 76 39 84 29 48 25 53: 47: - 
 
CHCl3 93 26 85 34 52 43 46: 54: - 
tAmOH 85 33 86 38 52 33 48: 52: - 
 
CHCl3 88 28 78 30 53 23 47: 52: 1 
tAmOH 84 35 79 35 51 22 48: 47: 5 
 
CHCl3 72 41 89 29 45 39 55.5: 43.5: 1 
tAmOH 55 41 71 39 44 10 55.5: 42.5: 2 
a)ee, c and S determined by HPLC analysis; b)all isolated yields; c)Ratios determined by 1H NMR spectroscopy;  
Table 7: Data using homoanhydrides 56 n-r 
 
Based on the results obtained (Tables 4-7), chloroform gave similar or better selectivity than 
tert-amyl alcohol in all cases. Some low conversions observed with chloroform were either 
due to steric bulkiness (56c) or low solubility (56i & 56j).  The KRs performed in chloroform 
are also less likely to give diester 58. Diphenylacetic anhydride 56k was the best performing 












2.3 Mixed anhydride and catalyst loading 
Many publications have reported the use of mixed anhydrides in the selective acylation of 
alcohols.66 For example, Shiina and co-workers reported an efficient KR method to resolve 
racemic α-arylalkanoic acids using achiral alcohols and mixed anhydrides (Scheme 17). It was 
proposed that by generating the mixed anhydride using a bulky homoanhydride and a 
carboxylic acid in situ through a catalysed reaction, the mixed anhydride would remain at 
low concentration throughout the reaction. Hence, less background reaction would be 
observed with the mixed anhydride than with the use of homoanhydride, giving better 
selectivity in the KR. 
 
Scheme 17. KR of carboxylic acids reported by Shiina 
 
A similar strategy could be employed in the KR of biaryl diols (Scheme 18). Based on the 
previous results (Table 4), pivalic anhydride 56c gave only 2% conversion to the monoester 
57c over 18 hours in chloroform, making it an ideal candidate for synthesising mixed 
anhydrides as the background reaction can be kept minimum. 
 




Since diphenylacetic anhydride 56p was the best performing homoanhydride (Table 7), the 
first attempt was made by generating the mixed anhydride in situ using pivalic anhydride 56c 
and diphenylacetic acid 59a with the aid of iPr2NEt. Although high S factor (around 55) was 
observed, inconsistent conversion over multiple repeats, ranging from 7% to 40% indicated 
this method was not appropriate (Table 8, entries 1-6). Further attempts to improve the 
conversion by either increasing the catalyst loading or the equivalents of the acid did not 
provide any improvements (Table 8, entries 7-9). Interestingly, the base did not seem to 
have any effect on the selectivity of the reaction. It is worth noticing that diester 58p is not 
observed in these reactions. 
 
 
Entry 44 iPr2NEt equiv. 59 equiv. ee% 6a % 6 b ee% 57pa % 57pb c (%)a S a 
1 1% 0.55 0.55 8 41 96 4 7.6 57 
2 1% 0.55 0.55 28 30 95 31 22 54 
3 1% 0.55 0.55 33 60 95 13 26 55 
4 1% - 0.55 63 38 94 31 40 64 
5 1% - 0.55 50 70 94 10 35 55 
6 1% - 0.55 11 65 96 13 11 54 
7 5% - 0.55 57 32 94 35 38 56 
8 5% - 1.1 33 54 95 16 26 51 
9 10% - 0.55 67 44 92 31 42 50 
a)ee, c and S determined by HPLC; b)all isolated yields  
Table 8. KR using mixed anhydride generated in situ 
 
Since generating mixed anhydride in situ did not give ideal results, isolated mixed anhydrides 
56 were next tested. Three mixed anhydrides 60 a-c were synthesised using trimethylacetyl 
chloride 61 and the corresponding parent carboxylic acids of the best performing 
homoanhydrides (53, 56p and 56r) (Scheme 19). The mixed anhydride was obtained as the 
only product when using diphenylacetic acid 59a, however, when using isobutyric acid 59b 
and cyclohexanecarboxylic acid 59c, mixtures of anhydrides were confirmed by 1H NMR 
spectroscopy. Chromatographic separation was not possible therefore 62b and 62c were 




Scheme 19: Synthesis and mixed anhydrides 
 
The three mixed anhydrides 62 a-c were tested in the KR of BINOL (±)-6 in chloroform (Table 
9 entries 1-4). 2,2-Diphenylacetic pivalic anhydride 62a proved to be the best candidate, 
giving S=54 at c=51% (Table 9, entry 1), with both mixed anhydrides 62b and 62c also 
showing good selectivity and reactivity (S = 32 and 37 respectively). The reproducibility of 
the optimised procedure using anhydride 62a was confirmed by 2 repeat reactions with 
S=54±1 at 50% conversion.  
 
 
Entry R ee%6 a % 6 b ee% 57a % 57b c (%)a S a 
1 -CHPh2 62a 90 38 89 36 50 55 
2 -CHPh2 62a 94 38 88 40 51 54 
3 -CHiPr2 62b 99 30 71 34 58 32 
4 -C6H11 62c 60 40 90 31 40 37 
a)ee, c and S determined by HPLC; b)all isolated yields  









2.4 Catalyst loading 
The effect of catalyst loading upon selectivity was next investigated. Interestingly, when the 
catalyst loading was raised to 5 mol% using mixed anhydride 62a to resolve BINOL (±)-6, a 
large decrease in selectivity (S =33) was observed (Table 6, entries 1 & 2). To confirm this 
trend, different catalyst loadings were tested in the KR of BINOL (±)-6 using homoanhydride 
56p. By raising the catalyst loading from 1 mol% to 10 mol%, the S factor dropped 
successively from 43 to 25 (Table 10, entries 3-5). As no diacylation was observed in these 
reactions, an explanation for this decrease in selectivity is not immediately apparent, 
although this presumably reflects a higher proportion of a racemic acylation pathway 
resulting in overall lower selectivity. Although no definite reason could be proposed in this 




Entry anhydride 44 (mol%) ee% 6 a % 6 b ee% 57ka  % 57kb c (%)a S a 
1 62a 1 90 38 89  36 50 54 
2 62a 5 88 25 85  34 51 33 
3 56P 1 93 26 85  34 52 43 
4 56P 5 86 41 74  38 51 31 
5 56P 10 84 44 80  41 51 25 
a)ee, c and S determined by HPLC; b)all isolated yields  














2.5 Temperature dependence 
The effect of reaction temperature on the KR was the final variable to be investigated. The 
reactions were performed at 4 different temperatures (45˚C, rt, 0˚C and -40˚C) in CHCl3 using 
the mixed anhydride 62a and the homoanhydride 56p in parallel reactions using BTM (1 
mol%). For anhydride 62a, the S factor raised from 38 to 55 by going from 45 °C to room 
temperature. Further dropping the temperature to 0 °C and −40 °C gave S < 40 (Table 11, 
entries 1-4). Similar trend was given by anhydride 56p with the highest S factor (S = 43) also 
obtained at room temperature (Table 11, 5-8). Interestingly, no diacylation was observed in 
all cases. The substrate scope was hence carried on at room temperature.  
 
Entry Anhydride T/ °C ee% 6a % 6b ee% 57ka % 57kb c (%)a S a 
1 62a 45 91 24 85 26 52 38 
2 62a r.t. 90 38 89 36 50 55 
3 62a 0 88 35 82 21 52 30 
4 62a -40 42 35 92 14 31 35 
5 57k 45 87 28 85 45 52 34 
6 57k r.t. 93 26 85 34 52 43 
7 57k 0 92 48 86 39 52 42 
8 57k -40 83 30 86 30 49 31 
a)ee, c and S determined by HPLC analysis; b)all isolated yields  
Table 11. Investigation on temperature dependence 
 
Following these studies, the optimal conditions for the KR of (±)-BINOL using 0.55 
equivalents of mixed anhydride 62a and (R)-BTM 44 (1 mol%) in chloroform for 18 hours at 
room temperature. To further showcase the robustness of this procedure, a gram-scale of 
the KR of BINOL (±)-6 was then performed, giving S = 51 at c= 50%, with both recovered 
BINOL (R)-6 and monoester recovered in excellent overall yield and in good enantiopurity 
(Scheme 20). 
 




Chapter 3: Substrate scope 
Overview 
Having demonstrated an effective KR of (±)-BINOL (±)-6 using the isothiourea BTM 44 (1 
mol%) and mixed anhydride 62a, this chapter demonstrates the scope and limitations of this 
procedure when applied to a range of (±)-biaryl diols. 
 
3.1 BINOL derivatives  
Having successfully optimised the isothiourea-catalysed KR of (±)-BINOL (±)-6, the synthesis 
of a range of biaryl diols was next targeted in order to probe the scope and limitations of this 
KR methodology. Substitution on rings B and B’ (positions 5/5’ to 8/8’) of (±)-BINOL (±)-6 
were first synthesised and investigated, followed by substitution on rings A and A’ (positions 
3/3’ & 4/4’) (Figure 18). 
 
 
Figure 18. Ring A and ring B of BINOL 
 
Direct modification of BINOL 6 was first attempted. 6,6'-Dibromo-[1,1'-binaphthalene]-2,2'-
diol (±)-63a was isolated in high yield through direct bromination of BINOL (±)-6, with 
products from bromination at other positions not observed (Scheme 21). 
 
 








To prepare a number of other derivatives, the methodology reported by Koga and co-
workers for the aerobic oxidative coupling of 2-naphthol derivatives using a CuCl-TMEDA 
complex was applied. 7,7'-Dibromo-[1,1'-binaphthalene]-2,2'-diol (±)-63b and  7,7'-
dimethoxy-[1,1'-binaphthalene]-2,2'-diol (±)-63c were isolated in high yields after 
chromatographic purification through a silica plug. However 2,2'-dihydroxy-[1,1'-
binaphthalene]-6,6'-dicarbonitrile (±)-63d was obtained in extremely low yield (around 10%) 
after multiple attempts, with competitive polymerisation suspected as the cause for this. 
Unfortunately, due to the low isolated yield, insufficient quantity of (±)-63d was isolated for 
use in a KR (Scheme 22). 
 
Scheme 22. Synthesis of racemic binaphthol derivatives 63 b-d 
 
The 3 BINOL derivatives 63 a-c were then tested under the previously developed KR 
conditions to assess the generality of the procedure (0.55 equivalent of 2,2-diphenylacetic 
pivalic anhydride 62a, (R)-BTM 44 (1 mol%), chloroform, r.t., 18 h). All examples were 
repeated until S = n±1, and no diester product was observed with any of the diols tested. 
 
6,6'-Dibromo-BINOL (±)-63a gave an S factor of 25 with full conversion (55%), and the 
alcohol 65a was recovered with 92% ee and good yield (43%) (Table 12, entry 1). 
Interestingly, by moving the bromo groups to the 7/7’ positions, an S factor of only 10 was 
observed at 54% of conversion. Both recovered (R)-diol 63b and (S)-monoester 65b were 
isolated in good yields but moderate ee (Table 12, entry 2). However, with methoxy groups 
on the 7/7’ positions, 7,7'-dimethoxy-BINOL (±)-63c was resolved with high selectivity S = 56 
at c=52%, with the recovered alcohol obtained in high ee (96%) (Table 12, entry 3). Although 
the reason behind the differences in the selectivity is not immediately apparent, this 






Entry Diol T/°C Cat. iPr2NEt ee% 63a %63b ee% 65a %65b c (%)a Sa 
1 63a r.t. 1% 44 - 92 43 77 49 55 25 
2 63b r.t. 1% 44 - 77 50 64 47 54 10 
3 63c r.t. 1% 44 - 97 52 87 44 52 56 
a)ee, c and S determined by HPLC analysis; b)all isolated yields;  
Table 12. KR of BINOL derivatives 
 
Substitution on ring A of (±)-BINOL (±)-6 were next investigated (Figure 18). Using 
commercially available 2-naphthol derivatives 64 e-f with substitution at 3-position and the 
same aerobic oxidative coupling method as before,68 dimethyl 2,2'-dihydroxy-[1,1'-
binaphthalene]-3,3'-dicarboxylatediol (±)-63f was isolated in high yields after 
chromatographic purification through a silica plug. However, [9,9'-biphenanthrene]-10,10'-
diol (±)-63e was obtained in low yield, but enough sample was successfully isolated for KR 
tests (Scheme 23).  
 





[9,9'-Biphenanthrene]-10,10'-diol (±)-63e was first tested, with 1H NMR spectroscopy 
confirming that the reaction only proceeded to less than 10% conversion after 18 hours 
under the developed conditions (Table 13, entry 1). Leaving the reaction for a further 24 
hours showed no change in the conversion. The reaction did proceed to 27% of conversion 
after 18 hours by raising the catalyst loading to 10 mol%, however, the selectivity was very 
low in this case (S = 6) (Table 13, entry 2).  
 
The derivative with ester groups at the 3/3’- positions (63f) was then investigated. The 
racemic sample of monoester 65f was successfully isolated using DMAP catalysis. However, 
dimethyl 2,2'-dihydroxy-[1,1'-binaphthalene]-3,3'-dicarboxylatediol (±)-63f did not show any 
conversion under the optimal condition (Table 13, entry 3). No trace of the monoester 65f 
was observed after catalyst loading was raised to up to 10 mol%, temperature raised up to 
65 °C, with the addition of iPr2NEt (Table 8, entries 7). Further investigations including 
changing the catalyst to HyperBTM 48 at high catalyst loading and high temperature, raising 
the amount of anhydride 62a to 1.5 equivalent, as well as switching to less bulky isobutyric 
anhydride 53 also showed no improvement in conversion. These observations suggest that 
substitution at the 3/3’-position creates a steric barrier to acylation that disfavours reaction 
with the acylated catalyst. Substitution at this position also leads to low enantioselectivity, 
potentially disrupting a key element of stereocontrol compared to the parent (±)-BINOL. 
 
Entry Diol T/°C Cat. iPr2NEt ee% 63a %63b ee% 65a %65b c (%)a Sa 
1 63e r.t. 1% 44 - - - - - <10c - 
2 63e r.t. 10% 44 - 23 45 65 25 27 6 
3 63f r.t. 1% 44 - - - - - 0 - 
4 63f 65 
10%  
44 or 48 
0.6 - - - - 0 - 
a)ee, c and S determined by HPLC analysis; b)all isolated yields;  




3.2 Biphenyl derivatives  
With the data obtained from the BINOL derivatives 63 in hand, biphenyl derivatives 66 were 
next investigated. Biphenyl derivatives 66 with substitution in the 6/6’ positions are 
expected to exhibit restricted rotation resulting in axial chirality (Figure 19).  
 
Figure 19. General structures of 63 and 66 
 
Derivatives of (±)-BINOL (±)-6 with saturated ring B were first synthesised and investigated. 
Hydrogenation of BINOL 6 gave 5,5',6,6',7,7',8,8'-octahydro-1,1'-bi-2-naphthol (H8-BINOL) 
66a in good yield (76%),69 which was further treated with bromine to give 3,3'-dibromo-
5,5',6,6',7,7',8,8'-octahydro-[1,1'-binaphthalene]-2,2'-diol 66b  in 91% yield (Scheme 24).70 
 
 
Scheme 24. Synthesis of 66a and 66b from BINOL 6 
 
H8-BINOL 66a was first tested in the KR. Interestingly, with 1 mol% of BTM 44, no conversion 
was observed (Table 14, entry 1). By raising the catalyst loading to 5 mol%, the reaction 
proceeded to 45% of conversion but with very low selectivity (S = 3); further raising the 
catalyst loading to 10 mol% showed no improvement in either conversion or selectivity 
(Table 14, entries 2 & 3). HyperBTM 48 was then tested in this case. Interestingly, the 
reaction proceeded to 41% conversion with improved selectivity of S = 10 with only 1 mol% 
of HyperBTM 48. By raising the catalyst loading to 5 mol%, improvements in conversion was 
observed while the selectivity remained the same (Table 14, entries 4 & 5). In order to have 
a direct comparison, the HyperBTM 48 catalysed KR of BINOL 6 was also performed. As 
expected from initial screening (Table 1), very poor selectivity of S = 3 was observed (Table 





3,3'-Dibromo-5,5',6,6',7,7',8,8'-octahydro-[1,1'-binaphthalene]-2,2'-diol 66b was next tested. 
The racemic sample of monoester 69b was successfully isolated using DMAP catalysis, 
however, under the developed conditions of KR, no conversion was observed following 
changing the catalyst loading, catalyst, temperature or by adding base (Table 14, entries 7 & 
8). Replacement of the bulky mixed anhydride 62a with acetic anhydride 56a also did not 
show any reactivity with various catalyst loadings. This observation further confirms that this 
newly developed KR procedure is not suitable for resolving biaryl structures with 
substituents on 3/3’-positions.  
 
Entry Diol T/°C Cat. iPr2NEt ee% 66a %66b ee% 69a %69b c (%)a Sa 
1 66a r.t. 1% 44 - - - - - 0 - 
2 66a r.t. 5% 44 - 30 23 37 13 45 3 
3 66a r.t. 10% 44 - 34 43 38 44 47 3 
4 66a r.t. 1% 48 - 51 50 72 40 41 10 
5 66a r.t. 5% 48 - 74 50 66 17 53 11 
6 6 r.t. 1% 48 - 43 43 39 38 53 3 
7 66b r.t. 1% 44 - - - - - 0 - 
8 66b 65 10% 44/48 0.6 - - - - 0 - 
a)ee, c and S determined by HPLC analysis; b)all isolated yields 
Table 14. KR of biphenol derivatives  
 
Next, biphenol derivatives with acyclic substitutions were synthesised and investigated. 
5,5',6,6'-Tetramethyl-[1,1'-biphenyl]-2,2'-diol 66d was obtained in high yield (83%) from 
cheap and commercially available 3,3'-di-tert-butyl-5,5',6,6'-tetramethyl-[1,1'-biphenyl]-2,2'-
diol 66c through a dealkylation reaction (Scheme 25).71  
 




The synthesis of 5,5'-dichloro-4,4',6,6'-tetramethyl-[1,1'-biphenyl]-2,2'-diol 66e was 
attempted using commercially available 4-chloro-3,5-dimethylphenol 67. The aerobic 
oxidative coupling method used to synthesise BINOL derivatives 63 was first tested,68 
however, no conversion was observed in this case (Scheme 26a). Another method 
employing AlCl3 and excessive propionic acid was tested at different temperatures72, 
however, no sign of the desired product was observed by 1H NMR spectroscopy (Scheme 
26b). A third method was tested using Cu-exchanged K-10 clay synthesised in house73, with 
this method affording the desired product in a moderate yield of 34% (Scheme 26c).74 
Subsequent removal of the chlorine substituents from 66e by using Raney-Nickel however 
was unsuccessful.75 
 
Scheme 26. Synthesis of 5,5'-dichloro-4,4',6,6'-tetramethyl-[1,1'-biphenyl]-2,2'-diol 66e 
 
The synthesis of dimethyl 2,2'-dihydroxy-[1,1'-binaphthalene]-3,3'-dicarboxylatediol 66g 
from cheap commercially available natural product sesamol 68 was attempted using aerobic 
oxidative coupling with CuCl-amine complex (Scheme 26a).68 However, no product was 
observed with polymerisation postulated. Another reported oxidative coupling method was 
next tested using AlCl3 and FeCl3 (Scheme 26b).76 Unfortunately, none of the desired product 
was observed.  
 






5,5',6,6'-Tetramethyl-[1,1'-biphenyl]-2,2'-diol 66d was then resolved to give good selectivity 
with S = 37 at c=48%, with both the recovered alcohol 66d and monoester 69d obtained 
with high ee (Table 15, entry 1). The KR of 5,5'-dichloro-4,4',6,6'-tetramethyl-[1,1'-biphenyl]-
2,2'-diol 66e also proceeded to high conversion (48%), however a diminished S factor of 14 
was obtained using BTM 44 (Table 15, entry 2). The high conversion suggests that 
substitution on the 4/4’-positions does not affect the reactivity of the reaction. The relatively 
low selectivity of this case might be due to the steric effects or electronic effects of the 
chorine groups on 5/5’ positions. Interestingly, by switching the catalyst to HyperBTM 48, 
reduced selectivity (S < 5) was observed (Table 15. Entry 3).  
 
 
Entry Diol T/°C Cat. iPr2NEt ee% 66a %66b ee% 69a %69b c (%)a Sa 
1 66d r.t. 1% 44 - 81 44 87 40 48 37 
2 66e r.t. 1% 44 - 69 48 74 40 48 14 
3 66e r.t. 1% 48 - 56 44 46 54 55 5 
a)ee, c and S determined by HPLC analysis; b)all isolated yields 














3.3 Mono-protected biaryl diols and NOBIN derivatives 
As the KR of monoester (±)-54 did not proceed with high selectivity (Scheme 15), the reason 
behind this was next investigated. Multiple computational studies of Lewis base catalysed 
acylation processes have suggested the carboxylate generated in situ from reaction of an 
anhydride could act as a H-bond acceptor in the TS of acylation/KR of alcohols.65,77 As 
monoester (±)-54 could not be resolved with good selectivity, it was suspected that both of 
the hydroxy groups within the biaryl diol structure might be involved in the transition state 
through H-bonding, or the bulkiness of the mono-protecting ester group changed the 
conformation of the TS. To investigate these hypothesis, i) mono-protected biaryl diols were 
synthesised and tested to verify the reason for the lack of selectivity with only one hydroxy 
group available on the diol, and ii) N-protected NOBIN derivatives were synthesised and 
tested to investigate if two hydrogen donors on the biaryls are needed for good selectivity. 
 
A racemic sample of monoester 57p was prepared in moderate yield (43%) using DMAP 
catalysis, with methyl and allyl protected BINOL derivatives also synthesised by alkylation of 
(±)-BINOL (±)-6 in moderate yields (53% and 59% respectively) (Scheme 27). In all cases the 











The KR of mono-protected diols was then performed under the previously developed 
conditions (Table 16). KR of monoester 57p gave only low selectivity (S = 1) and conversion 
(10%), consistent with previous observation (Table 16, entry 1; Scheme 15). Methylated 
BINOL 70a was tested next. Interestingly, with less bulky alkyl O-substituent, the selectivity 
of the KR was still low (S < 2). Raising the catalyst loading resulted in improved yield but no 
change was observed in selectivity (Table 16, entries 2-4). Although racemic sample was 
isolated by DMAP catalysis, the more bulky O-allyl-BINOL 70b showed no conversion at 
various catalyst loadings in the KR procedure (Table 16, entry 5).  
 
 
Entry alcohol Cat. eealcohola %alcoholb eeestera %esterb c (%)a S a 
1 57p 1% 44 0.3 5* 3.2 14 10 1.1 
2 70a 1% 44 1.1 87 28 3 4 1.8 
3 70a 5% 44 6 78 25 19 20 1.8 
4 70a 10% 44 8 61 24 23 25 1.8 
5 70b 10% 44 - - - - 0 - 
a)ee, c and S determined by HPLC analysis; b)all isolated yields ; *diester 
Table 16. KR of mono-protected BINOL derivatives 
 
As the KR of mono-protected BINOL derivatives has proven ineffective, the synthesis of 
NOBIN 75 and an N-protected NOBIN derivative was next investigated. Commercially 
available BINAM 73 was converted to NOBIN 75 in moderate yield using benzoyl peroxide 
73.78 Boc-protected NOBIN 76 was also isolated in moderate yield79 (Scheme 28). However, 
the purification of both 75 and 76 through column chromatography and recrystallisation 
proved to be challenging. The potential KR of N-Boc-NOBIN 76 therefore used material 





Scheme 28. Synthesis of NOBIN 75 and NOBIN-Boc 76 
 
The KR of NOBIN-Boc 76 was then performed under the previously developed conditions 
(Scheme 29). The KR proceeded with high conversion (51%) and good selectivity (S = 14), 
with both recovered (R)-NOBIN-Boc 76 and ester (S)-77 isolated in good yield and 




Scheme 29. KR of NOBIN-Boc 76 
 
Taken together, these results indicate that biaryl diols containing only one H-bond donor 
were resolved with poor selectivity and reactivity, while NOBIN-Boc 76 could be resolved 
with reasonable levels of selectivity (S = 14) at high conversion. These results suggest that 
the biaryl needs to carry two H-bond donors in order to obtain good selectivity and reactivity 














Chapter 4: Mechanism insights 
4.1 Proposed catalytic cycle 
Based on previous experiments and computational work the following mechanism can be 
proposed.65 Reversible N-acylation of the catalyst 44 by mixed anhydride 62a gives acyl 
ammonium intermediate 78. The carbonyl group is postulated to lie in the same plane as the 
S and N atoms of the catalyst due to a non-bonding S---O interaction.64a The phenyl group is 
forced to adopt a pseudoaxial orientation to avoid 1,2 strain, providing enough steric 
hindrance to effectively block the “bottom” face (Re) of the acylated catalyst.64b Selective 
nucleophilic attack of BINOL (±)-6 proceeds anti-to the stereodirecting phenyl unit, giving 
enantioenriched (R)-BINOL (R)-6 and (S)-monoester (S)-57p upon deprotonation and 
regeneration of the catalyst (R)-BTM 44. As the KR is performed in the absence of base, the 
carboxylate generated in situ is expected to act as the deprotonating species in the catalytic 
cycle. The selectivity of the KR is determined by the difference in the energies of the 









4.2 Proposed acylation transition states 
Three major observations from the substrate scope are as follows:  
1) The biaryl must contain two H-bond donors (2 × OH or 1 OH + 1 NH) in order to obtain 
good selectivity and reactivity in this KR procedure. 
2) Saturation of B/B’ ring (H8-BINOL) leads to significantly reduced selectivity in the KR;  
3) Biaryl structures with substituents at the 3/3’-positions gave very low or no conversion in 
this KR procedure. 
 
Based upon these observations a simple stereochemical model for the acylation TS can be 
proposed. 
 
Multiple computational studies have suggested the non-innocent role of the carboxylate 
counterion generated in situ in the acylation/KR of alcohols.65,76 The H-bond acceptor ability 
of carboxylates has been proposed  to stabilise the acylation TS though two-point H-bonding 
to both the alcohol substrate and acylated catalyst in the KR of tertiary alcohol substrates 
(Figure 21 left). Based on the necessity for two H-bond donors in the substrate in the current 
methodology, it is suspected that the carboxylate binds with the two H-bond donors of the 
substrate through two-point binding to stabilise the acylation TS and promote reactivity 
(Figure 21 right). This two-point coordination is not possible for the KR of mono-protected 
diols and hence results in less efficient acylation. The lack of this stabilising coordination also 
appears to result in a smaller energy difference between the diastereomeric TSs for 
acylation of the two enantiomers of the substrate, due to the lower selectivity factors 
obtained. In contrast, the requisite dual H-bond donating ability of the substrate is still 
present in mono N-protected NOBIN derivative 77, explaining its effective KR under standard 
conditions (S = 14 and c > 50%). 
 
Figure 21. Proposed two-point binding between the carboxylate counterion and the alcohol 




Assuming the necessity of this two-point carboxylate binding with the substrate in both 
diastereomeric acylation TS, the selectivity of the developed KR procedure can then be 
rationalised (Figure 22). For the KR using (R)-BTM 44, (S)-BINOL (S)-6 is the faster reacting 
enantiomer of (±)-BINOL 6, providing enantioenriched (R)-BINOL (R)-6 and (S)-monoester (S)-
57p after the KR procedure. In the acylation TS for the fast reacting (S)-BINOL,  π-π and/or π-
cation interactions between the extended naphthylene -system of BINOL 6 and the cationic 
N-acylated isothiouronium could serve to stabilise this TS (Figure 22 left). For the acylation 
of (R)-BINOL, these additional stabilising π-π and/or π-cation interactions are not present 
(Figure 22 right).  
 
Figure 22. Interactions between (R)-BTM and two enantiomers of BINOL 
 
Incorporation of substituents at the 6/6’ and 7/7’ positions of BINOL 6 leads to perturbation 
of the steric and electronic nature of the naphthylene unit, thus modulating the magnitude 
of these stabilising π-π and/or π-cation interactions and leading to changes in the selectivity 
of these KR processes. Semisaturation of the naphthalene unit to give H8-BINOL 66a would 
result in a loss of these stabilising π-π and/or π-cation interactions, consistent with the 
reduced selectivity observed in the KR (S = 3). Substitution at the 3/3’ positions leads to 
reduced reactivity, which can be rationalised as the 3-substituent would provide a steric 
barrier to reaction of the alcohol with the carbonyl group of the acylated catalyst, thus 
preventing attack of the hydroxy group to the carbonyl at the optimal angle (Figure 23).   
 




Chapter 5: Conclusions 
5.1 Conclusions  
In conclusion, this work describes the first method of isothiourea-catalyzed acylative KR of 
biaryl diols. In the model system, of the 3 isothioureas tested, (R)-BTM was found to be the 
optimal catalyst for the KR of (±)-BINOL. Of the 10 common solvents tested, chloroform was 
found to be the optimal solvent. Although the choice of the solvent has an effect on the 
monoester:diester product ratio in the KR, the generation of diesters does not have a 
significant effect on the selectivity of the KR as shown by control experiments. After testing 
18 homoanhydrides and 3 mixed anhydrides (generated in situ or isolated), 2,2-
diphenylacetic pivalic anhydride was found to be the best performing anhydride for 
enantioselective acylation, giving S = 55 at c = 50%. It was also found that higher selectivity 
was observed with the lower catalyst loading (1 mol%), while previous publications on 
acylative KR of biaryls reported the necessary use of ≥ 10 mol% Lewis base catalyst. It was 
also found that the KR shows better selectivity without the use of base. A total of 13 BINOL, 
biphenol and NOBIN derivatives were tested in the KR process, showing moderate to good 
selectivity (S up to 56). Substitution on the 3/3’-positions of the symmetrical biaryl diols was 
found to be not suitable to this newly established procedure, however this feature could be 
utilized to benefit future work on KR of asymmetrical biaryl diols (see section 5.2 Future 
work). Interestingly to obtain good reactivity and selectivity two H-bond donor groups are 
required within the starting material. Mono-methylated BINOL gave low selectivity (S = 1.8) 
at 25% conversion with 10 mol% catalyst loading and no reactivity observed with mono-
allylated BINOL under various conditions, while Boc-protected NOBIN could be resolved with 
S =14 at c > 50%. 
 
 







5.2 Future work  
This work has shown that symmetrical biaryl diols bearing 3/3’-substituents are not suitable 
for this newly established KR procedure, however, this feature could be utilized in the KR of 
asymmetric biaryl diols in order to avoid the generation of diastereoisomers (Scheme 31). As 
the 2-hydroxy group will be effectively blocked by the adjacent 3-substitution, only one ester 
product can be obtained from the KR. The substitution could be incorporated on either 
aromatic moiety before the coupling reaction to afford the biaryl, based on the availability 
and cost of the starting material. The substitution on the 3/3’- position can be selected so 
that it can be easily removed after the KR procedure.  
 
Scheme 31. KR of asymmetric biaryl diols 
 
Kinetic resolution is a popular method for obtaining enantioenriched products. Despite the 
high selectivity of the results obtained in this project, it is limited by the nature of racemates 
and the inherent disadvantage of KR, where the theoretical maximum yield of one 
enantiomer is only 50%. This limitation can be overcome through employing a dynamic 
kinetic resolution (DKR), in which constant in situ racemization of the diol will be coupled 
with a KR to allow quantitative product yields under optimal conditions. In order to obtain 
one single enantiomer with high enantiopurity after the DKR, the rate constant k’ of 
interconversion needs to be bigger than the rate constant of KR of the slower reacting 





Figure 24. DKR of biaryl alcohols using BTM 
 
Although most biaryl alcohols are configurationally stable to heating, there are known cases 
where racemization of atropisomers can be promoted by either photochemical irradiation79 
or acid catalysis.80 Future studies on this subject will focus on finding reaction conditions for 
an efficient DKR of biaryl alcohols. Upon optimisation of the reaction conditions, the scope 
and limitations of these DKR processes could be developed. Kinetic and mechanistic studies 



















Chapter 6: Experimental 
6.1 General Information  
Moisture sensitive reactions were carried out under a nitrogen (N2) atmosphere using 
standard vacuum line techniques and anhydrous solvents. All glassware used were flame-
dried and allowed to cool to room temperature under vacuum before use. Anhydrous 
solvents (THF and CH2Cl2) were obtained after passing through an alumina column (Mbraun 
SPS-800). All other solvents and commercial reagents were used as supplied without further 
purification.  
 
Room temperature (r.t.) refers to 20-25 °C. Temperatures of 0 °C were obtained using 
ice/water bath while −78 °C obtained using CO2(s)/acetone baths. In vacuo refers to the use 
of a Büchi Rotavapor R-2000 or a Heidolph Laborota 4001 rotary evaporator with a vacuum 
controller.  
 
Analytical thin layer chromatography was performed on pre-coated aluminium plates 
(Kieselgel 60 F254 silica). TLC visualisation was carried out with ultraviolet light (254 nm), 
followed by staining with a 1% aqueous KMnO4 solution. Automated chromatography was 
performed on a Biotage Isolera Four running Biotage OS578 with a UV/Vis detector using the 
method stated and cartridges filled with Kieselgel 60 silica. 
 
Melting points were recorded on an Electrothermal 9100 melting point apparatus and are 
uncorrected. Infrared spectra (νmax /cm-1) were recorded on a Shimadzu IRAffinity-1 using a 
Pike attenuated total reflectance (ATR) accessory. Only the characteristic peaks are quoted.   
 
1H and 13C {1H} nuclear magnetic resonance (NMR) spectra were acquired on a Bruker 
Avance II 400 (500 MHz, 1H, 127 MHz 13C) spectrometer at room temperature in CDCl3 
(solvent reference peak for CDCl3 in the 1H NMR = 7.26 ppm, and in 13C{1H} NMR = 77). All 
chemical shifts are quoted in parts per million (ppm) relative to the residual solvent as the 
internal standard. All coupling constants, J, are quoted in Hertz (Hz). Multiplicities are 
indicated by: s (singlet), d (doublet), t (triplet), dd (doublet of doublets), ddd (doublet of 
doublet of doublets), ddt (doublet of doublet of triplets), dt (doublet of triplets), tt (triplet of 
triplets) and m (multiplet). The abbreviation Ar is used to denote aromatic, br to denote 
broad and app to denote apparent. NMR peak assignments were confirmed using 2D 1H 




spectroscopy (HMBC), and 2D 1H−13C heteronuclear single quantum coherence spectroscopy 
(HSQC) where necessary. 
 
HPLC traces of enantiomerically enriched compounds were compared with authentic 
racemic spectra. HPLC analyses were obtained operated on a Shimadzu HPLC instrument 
consisting of a DGU20A5 degasser, LC-20AT liquid chromatograph, SIL-20AHT autosampler, 
CMB-20A communications bus module, SPD-M20A diode array detector and a CTO-20A 
column oven which allowed the temperature to be set from 25-40 °C. Separation was 
achieved using either a DAICEL CHIRALCEL OD-H and OJ-H column or DAICEL CHIRALPAK AD-
H, AS-H and IB columns using the method stated. 
 
Mass spectrometry (m/z) data were acquired by atmospheric solids analysis probe (ASAP) or 
nanospray ionisation (NSI) either at the EPSRC UK National Mass Spectrometry Facility at 
Swansea University ([A]+ quoted). 
 
Optical rotations were measured on a Perkin Elmer Precisely/Model-341 polarimeter 





















6.2 General Procedures  
General Procedure A: Preparation of homoanhydrides using EDCI·HCl 
Carboxylic acid (1 equiv.) was dissolved in CH2Cl2 (0.8 M) and EDCI·HCl (0.5-1 equiv.) was then 
added. The resulting mixture was stirred for 3 hours at room temperature. The solution was 
diluted with CH2Cl2 and washed with distilled water and subsequently with saturated 
aqueous solution of NaHCO3. The organic layer was dried over MgSO4, filtered and 




General Procedure B: DMAP-catalyzed acylation for racemic samples 
Alcohol (1 equiv.) and DMAP (10 mol%) were added into CH2Cl2 (0.05 M) at room 
temperature. Homoanhydride (1.5 equiv.) and iPr2NEt (1 equiv.) were added to the previous 
solution. The resulting solution was left stirring for 18 hours at room temperature. The 




General Procedure C: Isothiourea-catalyzed acylation for enantioenriched samples 
Alcohol (1 equiv.) and isothiourea (1-10 mol%) were added into solvent (0.05 M) at stated 
temperature. Stated anhydride (0.55 equiv.) was added to the previous solution. The 
resulted solution was left stirring for 18 hours at room temperature. The reaction mixture 








General Procedure D: Aerobic cross coupling to synthesis symmetrical biaryl compounds 
Naphthol derivative (1 equiv.) was dissolved in MeOH (0.1 M) at room temperature. Cu-
TMEDA catalyst (1-10 mol %) was added and the solution was stirred for the stated time 
































6.3 Experimental  
Preparation of anhydrides: 
 
Isovaleric anhydride 56d 
 
Following general procedure A: EDCI·HCl (479 mg, 2.5 mmol) and isovaleric acid (511 mg, 5.0 
mmol) were added to CH2Cl2 (6 mL, 0.83 M) to give a clear solution, which was stirred for 4 
hours at room temperature. The solution was diluted with CH2Cl2 (50 mL) was and the 
washed with distilled water (2 × 50 mL) then saturated aqueous solution of NaHCO3 (50 mL). 
The organic layer was dried (MgSO4), filtered and removed in vacuo to give isovaleric 
anhydride as a pale yellow oil (0.15 g, 32%). νmax (ATR): 2961 (C-H), 1815 (C=O), 1024 (C-O); 
1H NMR (500 MHz, CDCl3) δH: 2.31 (d, J 7.2, 4H, 2 × CH2), 2.14 (septet, J 6.8, 2H, 2 × -CH), 0.99 
(d, J 6.7, 12H, 4 × -CH3); 13C {1H} NMR (125 MHz, CDCl3) δC: 169.0 (2 × C=O), 44.3 (2 × -CH2), 
25.4 (2 × -CH), 22.4 (4 × -CH3) 
 
4-Methylpentanoic anhydride 56e 
 
Following general procedure A: 4-Methylpentanoic acid (581 mg, 5.0 mmol) was added to 
CH2Cl2 (6 mL, 0.8 M), giving a cloudy solution. EDCI·HCl (959 mg, 5.0 mmol) was then added 
to give a clear solution, which was stirred for 3 hours at room temperature. CH2Cl2 (50 mL) 
was added and the solution was washed with distilled water (2 × 50 mL) then saturated 
aqueous solution of NaHCO3 (50 mL). The organic layer was dried (MgSO4), filtered and 
removed in vacuo to give 4-methylpentanoic anhydride as colorless liquid (0.408 g, 1.5 mmol, 
60%). νmax (ATR): 2957 (C-H), 1817 (C=O), 1034 (C-O); 1H NMR (500 MHz, CDCl3) δH: 2.43 (t, J 
7.5, 2H, -CO-CH2-), 1.64-1.51 (m, 3H, -CH2CH2CH-, -CH2CH-), 0.89 (d, J 6.5, 6H, -CH3); 13C {1H} 
NMR (125 MHz, CDCl3) δC: 170.0 (2 × C=O), 33.5 (2 × -CO-CH2-), 33.0 (2 × -CH2CH2CH-), 27.6 (2 
× -CH-), 22.3 (2 × -CH3) 
 
Phenylacetic anhydride 56f 
 
Following general procedure A: EDCI·HCl (959 mg, 5.0 mmol) and phenylacetic acid (681 mg, 




5 hours at room temperature. The solution was diluted with CH2Cl2 (50 mL) was and the 
washed with distilled water (2 × 50 mL) then saturated aqueous solution of NaHCO3 (50 mL). 
The organic layer was dried (MgSO4), filtered and removed in vacuo to give phenylacetic 
anhydride as white crystals (0.40 g, 1.56 mmol, 62%); 1H NMR (500 MHz, CDCl3) δH: 7.35-7.30 
(m, 6H, ArH), 7.22-7.19 (m, 4H, ArH), 3.76 (s, 4H, 2 × -CH2-). Data in agreement with 
literature.82 
 
3-Phenylpropanoic anhydride 56g 
 
Following general procedure A: Phenylpropanoic acid (751 mg, 5.0 mmol) was added to 
CH2Cl2 (6 mL, 0.8 M), giving a cloudy solution. EDCI·HCl (959 mg, 5.0 mmol) was then added 
to give a clear solution, which was stirred for 3 hours at room temperature. CH2Cl2 (50 mL) 
was added and the solution was washed with distilled water (2 × 50 mL) then saturated 
aqueous solution of NaHCO3 (50 mL). The organic layer was dried (MgSO4), filtered and 
removed in vacuo to give 3-phenylpropanoic anhydride as colorless liquid (0.388 g, 55%). 
νmax (ATR): 3028 (C-H), 1815 (C=O), 1454 (C=C), 1028 (C-O); 1H NMR (500 MHz, CDCl3) δH: 
7.36-7.32 (m, 4H, ArH), 7.28-7.23 (m, 6H, ArH), 7.58-7.60 (m, 4H, ArH), 3.00 (t, J 7.9, 2H, -
CH2-), 2.78 (t, J 8.0, 2H, -CH2-). Data in agreement with literature.83 
 
(E)-Cinnamic anhydride 56h 
 
Following general procedure A: (E)-Cinnamic acid (741 mg, 5.0 mmol) was added to 
anhydrous CH2Cl2 (6 mL, 0.8 M), giving a cloudy solution. EDCI·HCl (959 mg, 5.0 mmol) was 
then added to give a clear solution, which was stirred for 2 hours at room temperature. 
CH2Cl2 (50 mL) was added and the solution was washed with distilled water (2 x 50 mL) then 
saturated aqueous solution of NaHCO3 (50 mL). The organic layer was dried (MgSO4), filtered 
and removed in vacuo to give (E)-Cinnamic anhydride as colorless solid (0.41 g, 1.7 mmol, 
29%), mp 132-133 °C [lit68 135-136 °C]; 1H NMR (500 MHz, CDCl3) δH: 6.54 (2H, d, J 15.9, 
ArCH=CH), 7.41-7.47 (6H, m, ArH), 7.58-7.60 (4H, m, ArH) 7.87 (2H, d, J 15.9, ArCH=CH). Data 





4-Bromobenzoic anhydride 56j 
 
Following general procedure A: EDCI·HCl (959 mg, 5.0 mmol) and 4-bromobenzoic acid (1005 
mg, 5.0 mmol) were added to CH2Cl2 (6 mL, 0.83 M) to give a cloudy solution, which was 
stirred for 3 hours at room temperature. The solution was diluted with CH2Cl2 (50 mL) was 
and the washed with distilled water (2 × 50 mL) then saturated aqueous solution of NaHCO3 
(50 mL). The organic layer was dried (MgSO4), filtered and removed in vacuo, the pale yellow 
residue was recrystallized in EtOAc to give 4-bromobezoic anhydride as yellow crystals (0.50 
g, 1.3 mmol, 52%); νmax (ATR): 3100 (C-H), 1782 (C=O), 1585 (C=C), 1067 (C-O); 1H NMR (500 
MHz, CDCl3) δH: 8.90 (d, J 8.6, 4H), 7.68 (d, J 8.6, 4H). Data in agreement with literature.85 
 
4-Nitrobezoic anhydride 56k 
 
Following general procedure A: EDCI·HCl (959 mg, 5.0 mmol) and 4-nitrobenzoic acid (836 
mg, 5.0 mmol) were added to CH2Cl2 (6 mL, 0.83 M) to give a cloudy solution, which was 
stirred for 3 hours at room temperature. The solution was diluted with CH2Cl2 (50 mL) was 
and the washed with distilled water (2 × 50 mL) then saturated aqueous solution of NaHCO3 
(50 mL). The organic layer was dried (MgSO4), filtered and removed in vacuo to give 4-
nitrobezoic anhydride as white solids (0.44 g, 1.4 mmol, 56%), νmax (ATR): 3080 (C-H), 1790 
(C=O), 1607 (C=C), 1525 (N-O), 1346 (N-O), 1059 (C-O); 1H NMR (500 MHz, CDCl3) δH: 8.41 (m, 
d, J 8.9, 4H), 8.35 (m, d, J 8.9, 1H). Data in agreement with literature.86 
 
Nicotinic anhydride 56m 
 
Following general procedure A: EDCI·HCl (959 mg, 5.0 mmol) and nicotinic acid (616 mg, 5.0 
mmol) were added to CH2Cl2 (6 mL, 0.83 M) to give a clear solution, which was stirred for 5 
hours at room temperature. The solution was diluted with CH2Cl2 (50 mL) was and the 
washed with distilled water (2 × 50 mL) then saturated aqueous solution of NaHCO3 (50 mL). 




anhydride as white solids (0.25 g, 1.1 mmol, 44%); 1H NMR (500 MHz, CDCl3) δH: 9.36 (dd, J 
2.3, 0.8, 2H), 8.92 (dd, J 4.9, 1.7, 2H), 8.43 (ddd, J 8.0, 1.8, 1.8, 2H), 7.53 (ddd, J 8.0, 4.9, 0.9, 
2H). Data in agreement with literature.87 
 
2-Ethylbutanoic anhydride 56n 
 
Following general procedure A: EDCI·HCl (479 mg, 2.5 mmol) and 2-ethylbutanoic acid (581 
mg, 5.0 mmol) were added to CH2Cl2 (6 mL, 0.83 M) to give a clear solution, which was stirred 
for 18 hours at room temperature. The solution was diluted with CH2Cl2 (50 mL) was and the 
washed with brine (3 × 50 mL), saturated aqueous solution of NaHCO3 (2 × 50 mL), then brine 
(50 mL). The organic layer was dried (MgSO4), filtered and removed in vacuo to give 2-
ethylbutanoic anhydride as a colorless liquid (0.42 g, 1.95 mmol, 78%). νmax (ATR): 2967 (C-H), 
1807 (C=O), 1001 (C-O); 1H NMR (500 MHz, CDCl3) δH: 2.33-2.28 (m, 2H, 2 × -CH-), 1.74-1.65 
(m, 4H, 2 × -CH2-), 1.62-1.54 (m, 4H, 2 × -CH2-), 0.96 (t, J 7.4, 12H, 4 × -CH3). Data in 
agreement with literature.88 
 
2-Propylpentanoic anhydride 56o 
 
Following general procedure A: EDCI·HCl (479 mg, 2.5 mmol) and 2-propylpentanoic acid 
(721 mg, 5.0 mmol) were added to CH2Cl2 (6 mL, 0.83 M) to give a clear solution, which was 
stirred for 18 hours at room temperature. The solution was diluted with CH2Cl2 (50 mL) was 
and the washed with brine (3 × 50 mL), saturated aqueous solution of NaHCO3 (2 × 50 mL), 
then brine (50 mL). The organic layer was dried (MgSO4), filtered and removed in vacuo to 
give 2-propylpentanoic anhydride as a colorless liquid (0.55 g, 2.05 mmol, 82%). νmax (ATR): 
2959 (C-H), 1809 (C=O), 1018 (C-O); 1H NMR (500 MHz, CDCl3) δH: 2.44 (tt, J 8.7, 5.4, 2H, 2 × -
C(2)H), 1.68-1.61 (m, 4H, 2 × -C(3)H2), 1.50-1.44 (m, 4H, 2 × -C(3)H2), 1.42-1.29 (m, 8H, 4 × -
C(4)H2), 0.92 (t, J 7.3, 12H, 4 × -CH3); 13C {1H} NMR (125 MHz, CDCl3) δC: 172.1 (2 × C=O), 46.4 







Diphenylacetic anhydride 56p 
 
DCC (412 mg, 2 mmol) was added to CH2Cl2 (20 mL, 0.5 M) under N2, followed by the addition 
of diphenylacetic anhydride (848 mg, 4.0 mmol) to give a cloudy mixture, which was stirred 
for 2 hours at room temperature. CH2Cl2 was removed in vacuo and the residue was 
dissolved in a mixture of EtOAc:petrol (3:7, 100 mL). The mixture was filtered and the 
resulting clear solution was washed saturated aqueous solution of NaHCO3 (3 × 100 mL) and 
brine (100 mL). The organic layer was dried (MgSO4), filtered and removed in vacuo to give 
diphenylacetic anhydride as colorless crystals (0.601 g, 1.5 mmol, 59%), mp 89-90 °C [lit1 90-
93 °C]. νmax (ATR): 2930 (C-H), 1800 (C=O), 1454 (C=C), 1059 (C-O); 1H NMR (500 MHz, CDCl3) 
δH: 7.34-7.26 (m, 12H, ArH), 7.19-7.15 (m, 8H, ArH), 5.02 (s, 1H, -CHPh2). Data in agreement 
with literature.89 
 
Cyclopentanecarboxylic anhydride 56q 
 
Following general procedure A: EDCI·HCl (479 mg, 2.5 mmol) and cyclopentanecarboxylic 
acid (641 mg, 5.0 mmol) were added to CH2Cl2 (6 mL, 0.83 M) to give a clear solution, which 
was stirred for 18 hours at room temperature. The solution was diluted with CH2Cl2 (50 mL) 
was and the washed with HCl (1M, 2 × 50 mL), saturated aqueous solution of NaHCO3 (2 × 50 
mL) then brine (2 × 50 mL). The organic layer was dried (MgSO4), filtered and removed in 
vacuo to give cyclopentanecarboxylic anhydride as a colorless liquid (0.31 g, 1.45 mmol, 58%). 
νmax (ATR): 2955 (C-H), 1807 (C=O), 1022 (C-O); 1H NMR (500 MHz, CDCl3) δH: 2.85 (quintet, J 
8.0, 2H), 1.96-1.84 (m, 8H, C(3)H2), 1.76-1.68 (m, 4H, C(2)H2), 1.64-1.56 (m, 4H, C(2)H2); 13C 
{1H} NMR (125 MHz, CDCl3) δC: 172.6 (2 × C=O), 44.8 (2 × C(1)H), 29.6 (4 × C(3)H2), 25.9 (4 × 
C(2)H2) 
 




Following general procedure A: EDCI·HCl (479 mg, 2.5 mmol) and cyclohexanecarboxylic acid 




stirred for 18 hours at room temperature. The solution was diluted with CH2Cl2 (50 mL) was 
and the washed with HCl (1M, 2 × 50 mL), saturated aqueous solution of NaHCO3 (2 × 50 mL) 
then brine (2 × 50 mL). The organic layer was dried (MgSO4), filtered and removed in vacuo 
to give cyclohexanecarboxylic anhydride as a yellow oil (0.15 g, 0.8 mmol, 32%). νmax (ATR): 
2930 (C-H), 1805 (C=O), 984 (C-O); 1H NMR (500 MHz, CDCl3) δH: 2.40 (tt, J 11.2, 3.7, 2 H), 
1.98–1.94 (m, 4H), 1.81–1.76 (m, 4H), 1.67–1.62 (m, 2H), 1.52–1.44 (m, 4H), 1.34–1.22 (m, 
6H). Data in agreement with literature.90 
 




BINOL (859 mg, 3 mmol) was dissolved in CH2Cl2 (17 mL, 0.18 M) and cooled to -78 °C. Br2 
(0.43 mL, 1.29 g, 8.1 equiv.) was added dropwise over 10 mins at -78 °C while stirring. The 
solution was left stirring for 3 hours while gradually warm to room temperature. Saturated 
NaHSO3 solution (20 mL) was added in to the previous solution and layers separated. 
Organic layer was washed with brine (3 × 20 mL) and dried over MgSO4. The solvent was 
removed in vacuo to give 6,6'-dibromo-[1,1'-binaphthalene]-2,2'-diol (1.12 g, 84%) as white 
solids. mp 193-195  °C [lit2 197-198 °C]; 1H NMR (500 MHz, CDCl3) δH:  8.05 (d, J 2.0, 2H, ArH), 
7.89 (d, J 9.0, 2H, ArH), 7.39 (d, J 9.0, 2H, ArH), 7.36 (dd, J 9.0, 2.0, 2H, ArH), 6.95 (d, J 8.9, 2H, 




Following general procedure D: 7-Bromo-2-naphthol (669.21 mg, 3 mmol) was dissolved in 
CH2Cl2 (30 mL, 0.1 M) at room temperature. Cu-TMEDA catalyst (14 mg, 0.03 mmol) was 
added and the solution was stirred for 18 hours. The mixture was filtered through silica plug 
and concentrated in vacuo to 7,7'-dibromo-[1,1'-binaphthalene]-2,2'-diol (613 mg, 92%) as 




7.47 (dd, J 8.7, 1.9, 2H, ArH), 7.39 (J 9.0, 2H, ArH), 7.23 (d, J 1.9, 2H, ArH), 5.03 (s, 2H, 2 × -




Following general procedure D: 7-Methoxy-2-naphthol (523 mg, 3 mmol) was dissolved in 
CH2Cl2 (30 mL 0.1 M) at room temperature. Cu-TMEDA catalyst (14 mg, 0.03 mmol) was 
added and the solution was stirred for 2 hours. The mixture was filtered and concentrated in 
vacuo to give a brown oil, which was purified by column chromatography (Isolera 4, Et2O in 
petrol, 0% -> 50% over 40 CV), giving 7,7'-dimethoxy-[1,1'-binaphthalene]-2,2'-diol (380 mg, 
73%) as pale yellow solids. mp 147-148  °C [lit2 144-146 °C]; 1H NMR (500 MHz, CDCl3) δH:  
7.88 (d, J 8.9, 2H, ArH), 7.79 (d, J 8.2, 2H, ArH), 7.23 (d, J 8.9, 2H, ArH), 7.04 (dd, J 9.0, 2.5, 2H, 





Following general procedure D: 9-Phenanthrol (456 mg, 2.5 mmol) was dissolved in CH2Cl2 
(25 mL, 0.1 M) at room temperature. Cu-TMEDA catalyst (11.6 mg, 0.025 mol) was added 
and the solution was stirred for 2 hours. The mixture was filtered and concentrated in vacuo 
to give a pale brown oil, which was purified by column chromatography (Isolera 4, EtOAc in 
petrol, 0% -> 20% over 20 CV), giving [9,9'-biphenanthrene]-10,10'-diol (168 mg, 0.43 mmol, 
35%) as yellow crystals, mp 218-220  °C [lit2 231-233 °C]; 1H NMR (500 MHz, CDCl3) δH:  8.81 
(d, J 8.4, 2H, ArH), 8.75 (d, J 8.3, 2H, ArH), 8.48 (dd, J 8.2, 1.0, 2H, ArH), 7.85-7.82 (m, 2H, 
ArH), 7.75-7.72 (m, 2H, ArH), 7.56-7.53 (m, 2H, ArH), 7.38-7.35 (m, 2H, ArH), 8.27 (dd, J 8.2, 








Following general procedure D: Methyl 3-hydroxy-2-naphthoate (607 mg, 3 mmol) was 
dissolved in MeOH (30 mL, 0.1 M) at room temperature. Cu-TMEDA catalyst (14 mg, 0.03 
mmol) was added and the solution was stirred for 144 hours under reflux. The mixture was 
filtered and concentrated in vacuo to give dimethyl 2,2'-dihydroxy-[1,1'-binaphthalene]-3,3'-
dicarboxylatediol (58.6 mg, 97%) as bright yellow solids, mp 270-272  °C [lit2 285-287 °C]; 1H 
NMR (500 MHz, CDCl3) δH: 10.72 (s, 2 × -OH), 8.69 (s, 2 H, ArH), 7.94-7.90 (m, 2 H, ArH), 7.36-





BINOL (1.72 g, 6 mmol) and Pd/C (10% wt, 447 mg,  0.42 mmol) and ethanol (30 mL, 0.2 M) 
were placed into a 150 mL autoclave and stirred under 50 bar H2 at 100 °C for 1 hour. The 
reaction mixture was cooled to room temperature, the metal catalyst was filtered off and 
washed with CH2Cl2 (3 × 10 mL). The combined filtrates were concentrated in vacuo and the 
residue was purified by column chromatography (0% -> 20% EtOAc in hexane over 30 CV) to 
give 5,5',6,6',7,7',8,8'-Octahydro-1,1'-bi-2-naphthol (1.34 g, 76%) as white solids. mp 132-
134  °C [lit2 156-157 °C]; 1H NMR (500 MHz, CDCl3) δH:  7.07 (d, J 8.3, 2H, ArH), 6.83 (d, J 8.3, 
2H, ArH), 4.54 (s, 2H, 2 × -OH), 2.75 (t, J 6.2, 4H, -CH2-), 2.29 (dt, J 17.6, 6.2, 2H, -CH2-), 2.16 
(dt, J 17.5, 6.5, 2H, -CH2-), 1.76–1.72 (m, 4H, -CH2-), 1.70–1.65 (m, 4H, -CH2-). Data in 











5,5',6,6',7,7',8,8'-Octahydro-1,1'-bi-2-naphthol (736 mg, 2.5 mol) was dissolved in CH2Cl2 (25 
mL, 0.1 M) at -40 °C. Bromine (800 mg, 5 mol) was added and the solution was stirred for 1.5 
hour. Saturated NaHSO3 solution (20 mL) was added to the solution and the resulted mixture 
was warmed up to room temperature. The organic phase was washed with NaHCO3 (sat. 3 × 
20 mL) and cold H2O (3 × 20 mL), dried over MgSO4, filtered and concentrated in vacuo to 
give 3,3'-dibromo-5,5',6,6',7,7',8,8'-octahydro-[1,1'-binaphthalene]-2,2'-diol (926 mg, 91%) 
as white solid. mp 159-160  °C [lit2 166.5-170 °C]; 1H NMR (500 MHz, CDCl3) δH:  7.28 (s, 2H, 
C(4)H, C(4’)H, -ArH), 5.10 (s, 2H, 2 × -OH), 2.78-2.69 (m, 4H, 2 × -CH2-), 2.31-2.25 (m, 2H, 2 × -





3,3'-di-tert-butyl-5,5',6,6'-tetramethyl-[1,1'-biphenyl]-2,2'-diol (355 mg, 1 mmol) dissolved in 
benzene (5 mL) at 0 °C. AlCl3 (200 mg, 1.5 mmol) in benzene (1 mL) and MeNO2 (2 mL) was 
added dropwise. The mixture was quenched by water after left stirring for 20 mins. The 
aqueous layer was extracted with Et2O (3 × 10 mL). The combined organic layer washed  
with brine (3 × 10 mL), filtered and concentrated in vacuo to give the crude, which was 
purified by column chromatography (0% -> 10% EtOAc in petrol over 50 CV) to give 5,5',6,6'-
tetramethyl-[1,1'-biphenyl]-2,2'-diol (200.4 mg, 83.7%), mp 191-193  °C [lit2 198.5-200 °C]; 
1H NMR (500 MHz, CDCl3) δH:  7.13 (d, J 8.2, 2H, ArH), 6.81 (d, J 8.3, 2H, ArH), 4.51 (s, 2H, 2 × 











4-Chloro-3,5,-dimethylphenol (470 mg, 3 mmol) and Cu-exchanged clay (1.5 g, 7) were 
stirred vigorously in chlorobenzene (30 mL, 0.1 M), the resulted mixture was stirred at 140 °C 
for 6 hours with air bubbled through. The mixture was filtered and the catalyst washed by 
CH2Cl2 (2 × 30 mL), followed by acetone (2 × 30 mL), the combined filtrate was concentrated 
in vacuo and the resulting crude was purified by column chromatography (0%-20% EtOAc in 
petrol over 40 CV) to give 5,5'-dichloro-4,4',6,6'-tetramethyl-[1,1'-biphenyl]-2,2'-diol (124.9 
mg, 27%) as yellow solids, mp 215-217 °C [lit2 233-235 °C], Rf = 0.29 (20% EtOAc in 
petroleum ether); 1H NMR (500 MHz, CDCl3) δH: 6,84 (s, 2 H, ArH), 4.57 (s, 2 H), 2.41 (s, 6H, 2 




BINOL (1.43 g, 5 mmol) and K2CO3 (829 mg, 6 mmol) were stirred in acetone (6 mL, 0.83 M) 
for 1 hour at room temperature under N2. Methyl iodide (851 mg, 0.37 mL, 6 mmol) was 
added and the resulted mixed was stirred overnight. The mixture was filtered and solid 
washed with acetone. Filtrate was concentrated in vacuo and the residue was purified by 
column chromatography (0% -> 10% EtOAc in petrol over 50 CV) to give 2'-methoxy-[1,1'-
binaphthalen]-2-ol (0.80 g, 53%) as white solids. mp 152-154  °C [lit2 152-153 °C]; 1H NMR 
(500 MHz, CDCl3) δH:  8.05 (d, J 9.1, 1H, ArH), 7.91 (d, J 8.9, 1H, ArH), 7.90 (d, J 8.3, 1H, ArH), 
7.87 (d, J 8.1, 1H, ArH), 7.48 (d, J 9.0, 1H, ArH), 7.40-7.36 (m, 1H, ArH), 7.36 (d, J 8.9, 1H, ArH), 
7.34-7.29 (m, 2H, ArH), 7.25-7.22 (m, 1H, ArH), 7.18 (d, J 8.5, 1H, ArH), 7.18 (d, J 8.5, 1H, ArH), 










BINOL (1.43 g, 5 mmol) and K2CO3 (829 mg, 6 mmol) were stirred in acetone (6 mL, 0.83 M) 
for 1 hour at room temperature under N2. Methyl iodide (851 mg, 0.37 mL, 6 mmol) was 
added and the resulted mixed was stirred overnight. The mixture was filtered and solid 
washed with acetone. Filtrate was concentrated in vacuo and the residue was purified by 
column chromatography (0% -> 10% EtOAc in petrol over 50 CV) to give 2,2'-dimethoxy-1,1'-
binaphthalene (277.3 mg, 17.6%) as white solids. 1H NMR (500 MHz, CDCl3) δH:  7.99 (d, J 9.1, 
2H, ArH), 7.89 (d, J 8.3, 2H, ArH), 7.47 (d, J 9.1, 2H, ArH), 7.36-7.33 (m, 2H, ArH), 7.26-7.22 (m, 




BINOL (1.43 g, 5 mmol) and K2CO3 (829 mg, 6 mmol) were stirred in acetone (6 mL, 0.83 M) 
for 1 hour at room temperature under N2. Allyl bromide (736 mg, 6 mmol) was added and 
the resulted mixed was stirred overnight. The mixture was filtered and solid washed with 
acetone. Filtrate was concentrated in vacuo, dissolved in CH2Cl2 (20 mL) and filtered. The 
filtrate was concentrated in vacuo and the residue was purified by column chromatography 
(0% -> 10% EtOAc in hexane over 50 CV) to give 2'-(allyloxy)-[1,1'-binaphthalen]-2-ol (0.96 g, 
59%) as white solids. mp 105-107  °C [lit2 109.5-111 °C]; 1H NMR (500 MHz, CDCl3) δH:  8.01 
(d, J 9.0, 1H, ArH), 7.95 (d, J 8.9, 1H, ArH), 7.94-7.90 (m, 2H, ArH), 7.44 (d, J 9.0, 1H, ArH), 
7.41 (d, J 8.9, 1H, ArH), 7.44-7.40 (m, 1H, ArH), 7.39-7.35 (m, 1H, ArH), 7.34-7.30 (m, 1H, 
ArH), 7.29-7.25 (m, 2H, ArH), 7.15 (d, J 8.5, 1H, ArH), 5.83-5.76 (m, 1H, ArH), 5.12-5.09 (m, 
1H, ArH), 5.09-5.07 (m, 1H, ArH), 5.06 (s, 1H, -OH), 4.62-4.54 (m, 2H, -CH2-). Data in 










BINAM (427 mg, 1.5 mmol), benzoyl peroxide (727 mg, 3 mmol), HCl (12 M, 21 mL) 1,4-
dioxane (42 mL) and deionised water (126 mL) were mixed and stirred at 85 °C for 4 hours 
then cooled to room temperature. The pH was brought to 8 using sat. NaHCO3 solution. All 
solvents were removed. The crude was dissolved in EtOAc: DI water (1:1) and extracted by 
EtOAc. The combined organic phases were concentrated in vacuo and the residue was 
purified by column chromatography (0% -> 30% EtOAc in hexane over 45 CV) to give crude 
NOBIN (276 mg, 65%) as black solids. 1H NMR (500 MHz, CDCl3) δH: 7.92 (d, J = 8.8 Hz, 1H), 
7.89-7.85 (m, 2H), 7.82-7.80 (m, 1H), 7.37 (d, J = 8.9 Hz, 1H), 7.37-7.33 (m, 1H), 7.30-7.21 (m, 
3H), 7.19-7.15 (m, 2H), 7.06-7.04 (m, 1H), 5.11 (br, s, 1H, -OH), 3.74 (br, s, 2H, -NH2). Data in 
agreement with literature.32,100 
 
Tert-butyl (2'-hydroxy-[1,1'-binaphthalen]-2-yl)carbamate 76 
 
NOBIN (645 mg, 2.26 mmol) and (BOC)2O (493 mg, 2.26 mmol) were dissolved in benzene 
(6.4 mL) and stirred at 80 °C for 24 hrs then cooled to room temperature. Solvents were 
removed in vacuo and the crude was purified by column chromatography (Isolera 4, EtOAc in 
petrol, 0% -> 20% over 25 CV), the crude product was recrystallized from hexane to give 
NOBIN-BOC (381 mg, 52%) as black solids; 1H NMR (500 MHz, CDCl3) δH: 8.49 (d, J 9.2, 1H, 
ArH), 8.04 (d, J 9.1, 1H, ArH), 7.98 (d, J 8.9, 1H, ArH), 7.92-7.88 (m, 2H, ArH), 7.42-7.36 (m, 3H, 
ArH), 7.29-7.25 (m, 2H, ArH), 7.06 (d, J 8.5, 1H, ArH), 7.01 (d, J 8.4, 1H, ArH), 6.25 (s, 1H, -









Preparation of Monoesters: 
 
2'-Hydroxy-[1,1'-binaphthalen]-2-yl acetate 57a 
 
Following general procedure B: BINOL (57.3 mg, 0.2 mmol) and DMAP (2.5 mg, 0.02 mmol) 
were added into CH2Cl2 (4 mL, 0.05 M) at room temperature, giving a clear solution. Acetic 
anhydride (30.6 mg, 28 µL, 0.3 mmol) and iPr2NEt (27.9 mg, 35 µL, 0.2 mmol) were added to 
the previous solution. The resulted clear solution was left stirring for 18 hours at room 
temperature. The solution was diluted with EtOAc (10 mL), washed with HCl (1 M. 2 × 10 mL), 
NaHCO3 (sat., 2 × 10 mL) and brine (10 mL). The organic layer was dried over MgSO4, filtered 
and concentrated in vacuo, to give pale brown oil, which was purified by column 
chromatography (Isolera 4, EtOAc in petrol, 0% -> 20% over 20 CV) to give 2'-hydroxy-[1,1'-
binaphthalen]-2-yl acetate as (16.8 mg, 26%) white solids; Rf = 0.23 (20% EtOAc in petroleum 
ether); mp 121-122  °C [lit1 125-127 °C]; νmax (ATR): 3455 (O-H, br), 1757 (C=O), 1550 (C=C), 
1201 (C-O); 1H NMR (500 MHz, CDCl3) δH:  8.08 (d, J 8.9, 1H, C(4)H), 7.97 (d, J 8.4, 1H, C(5)H), 
7.91 (d, J 8.8, 1H, C(4’)H), 7.86 (d, J 8.2, 1H, C(5’)H), 7.53-7.49 (m, 1H, C(6)H), 7.40 (d, J 8.3, 
1H, C(3)H), 7.6-7.32 (m, 3H, C(7)H, C(3’)H, C(6’)H), 7.27-7.23 (m, 2H, C(8)H, C(7’)H), 7.03 (d, J 
8.5, 1H, C(8’)H),  5.19 (s, 1H, -OH), 1.87 (s, 3H -CH3); 13C {1H} NMR (125 MHz, CDCl3) δC: 170.6 
(C=O), 151.8 (C(2’)), 148.2 (C(2)), 133.6 (C(8a)), 133.6 (C(8a’)), 132.4 (C(4a)), 131.0 (C(4)), 
130.5 (C(4’), 129.1 (C(4a’)), 128.4 (C(5)), 128.1 (C(5’)), 127.6 (C(7)), 126.9 (C(7’)), 126.5 (C(6)), 
125.9 (C(8)), 124.7 (C(8’)), 123.7 (C(6’)), 123.2 (C(1)), 121.9 (C(3)), 118.4 (C(3’)), 114.1 (C(1’)), 
20.6 (-CH3); HRMS (NSI+) C22H16O3 [M+H]+ found 329.1176, requires 329.1172 (+1.2 ppm). 
Data in agreement with literature.101 
 
2'-Hydroxy-[1,1'-binaphthalen]-2-yl propionate 57b 
 
Following general procedure C: BINOL (57.3 mg, 0.2 mmol) and (+)-BTM (0.5 mg, 0.002 mmol) 
were added into tert-Amyl alcohol (4 mL, 0.05 M) at room temperature, giving a clear 




solution. The resulted clear solution was left stirring for18 hours at room temperature. The 
solution was diluted with EtOAc (10 mL), washed with HCl (1 M. 2 × 10 mL), NaHCO3 (sat., 2 × 
10 mL) and brine (10 mL). The organic layer was dried over MgSO4, filtered and concentrated 
in vacuo to give a pale brown oil, which was purified by column chromatography (Isolera 4, 
EtOAc in petrol, 0% -> 20% over 30 CV) to give 2'-hydroxy-[1,1'-binaphthalen]-2-yl 
propionate (15.3 mg, 22%) as white solids; Rf = 0.16 (20% EtOAc in petroleum ether); mp 
146-147 °C [lit1 140-142 °C];  20D  −76.3 (c = 0.1 in CHCl3); Chiral HPLC analysis: ChiralCel OJ-
H (10% iPrOH:hexane, flow rate 1.0 mL min-1, 211 nm, 30 °C), tR major: 16.4 min, tR minor: 
24.0 min, 83.5:16.5 er; νmax (ATR): 3408 (O-H), 2936 (C-H), 1726 (C=O), 1506 (C=C), 1180 (C-
O); 1H NMR (500 MHz, CDCl3) δH:  8.08 (d, J 8.9, 1H, C(4)H), 7.98 (d, J 8.3, 1H, C(5)H), 7.90 (d, 
J 8.8, 1H, C(4’)H), 7.84 (d, J 8.1, 1H, C(5’)H), 7.53-7.50 (m, 1H, C(6)H), 7.40 (d, J 8.9, 1H, 
C(3)H), 7.37-7.31 (m, 3H, C(7)H, C(3’)H, C(6’)H), 7.29 (d, J 8.4, 1H, C(8)H), 7.27-7.23 (m, 1H, 
C(7’)H), 7.04 (d, J 8.5, 1H, C(8’)H), 5.17 (s, 1H, -OH), 2.20-2.04 (m, 2H, -CH2CH3), 0.70 (t, J 7.6, 
3H, -CH2CH3); 13C {1H} NMR (125 MHz, CDCl3) δC: 174.1 (C=O), 151.9 (C(2’)), 146.9 (C(2)), 
133.6 (C(8a), C(8a’)), 132.4 (C(4a)), 130.7 (C(4)), 130.5 (C(4’), 129.1 (C(4a’)), 128.5 (C(5)), 
128.1 (C(5’)), 127.6 (C(7)), 126.8 (C(7’)), 126.4 (C(6)), 125.8 (C(8)), 124.7 (C(8’)), 123.7 (C(6’)), 
123.1 (C(1)), 122.0 (C(3)), 118.4 (C(3’)), 114.2 (C(1’)), 27.6 (-CH2-), 8.9 (-CH3); HRMS (NSI+) 
C23H18O3 [M+H]+ found 343.1333, requires 333.1329 (+1.3 ppm). Data in agreement with 
literature.101 
 
2'-Hydroxy-[1,1'-binaphthalen]-2-yl isobutyrate 54 
 
Following general procedure C: BINOL (57.3 mg, 0.2 mmol) and (+)-BTM (0.5 mg, 0.002 mmol) 
were added into CH2Cl2 (4 mL, 0.05 M) at room temperature, giving a clear solution. 
Isobutyric anhydride (47.5 mg, 49.7 µL, 0.3 mmol) and iPr2NEt (27.9 mg, 35 µL, 0.2 mmol) 
were added to the previous solution. The resulted clear solution was left stirring for 18 hours 
at room temperature. The solution was diluted with EtOAc (10 mL), washed with HCl (1 M, 2 
× 10 mL), NaHCO3 (sat., 2 × 10 mL) and brine (10 mL). The organic layer was dried over 
MgSO4, filtered and concentrated in vacuo, to give pale brown oil, which was purified by 
column chromatography (Isolera 4, EtOAc in petrol, 0% -> 20% over 20 CV) to give 2'-




petroleum ether); mp 147-149  °C [lit1 147-148 °C];  20D  −97.5 (c = 0.1 in CHCl3); Chiral HPLC 
analysis: ChiralCel OJ-H (20% iPrOH:hexane, flow rate 1.0 mL min-1, 211 nm, 30 °C), tR major: 
8.3 min, tR minor: 13.1 min, 95:5 er; νmax (ATR): 3389 (O-H), 2890 (C-H), 1717 (C=O), 1504 
(C=C), 1207 (C-O); 1H NMR (500 MHz, CDCl3) δH:  8.08 (d, J 8.8, 1H, ArH), 7.98 ( dt, J 8.2, 0.9, 
1H, ArH), 7.89 (d, J 8.9, 1H, ArH), 7.84 (d, J 8.1, 1H, ArH), 7.53-7.50 (m, 1H, ArH), 7.40 (d, J 8.9, 
1H, ArH), 7.38-7.31 (m, 4H, ArH), 7.27-7.24 (m, 1H, ArH), 7.05 (d, J 8.5, 1H, ArH), 5.04 (s, 1H, -
OH), 2.39 (sept, J 6.9, 1H), 0.78 (d, J 7.1, 3H), 0.60 (d, J 7.1, 3H); HRMS (ASAP+) C24H20O3 
[M+H]+ found 357.1492, requires 357.1491 (+0.3 ppm). Data in agreement with literature.51 
 
2'-Hydroxy-[1,1'-binaphthalen]-2-yl pivalate 57c 
 
Following general procedure C: BINOL (57.3 mg, 0.2 mmol) and (+)-BTM (0.5 mg, 0.002 mmol) 
were added into tert-Amyl alcohol (4 mL, 0.05 M) at room temperature, giving a clear 
solution. Trimethylacetic anhydride (20.5 mg, 0.11 mmol) was added to the previous 
solution. The resulted clear solution was left stirring for 18 hours at room temperature. The 
solution was diluted with EtOAc (10 mL), washed with HCl (1 M. 2 × 10 mL), NaHCO3 (sat., 2 × 
10 mL) and brine (10 mL). The organic layer was dried over MgSO4, filtered and concentrated 
in vacuo, to give pale brown oil, which was purified by column chromatography (Isolera 4, 
EtOAc in petrol, 0% -> 20% over 20 CV) to give 2'-hydroxy-[1,1'-binaphthalen]-2-yl pivalate 
(27.1 mg, 37%) as colorless crystals; Rf = 0.43 (20% EtOAc in petroleum ether); mp 123.5-
125 °C;  20D  −70.1 (c = 0.1 in CHCl3); Chiral HPLC analysis: ChiralPak AD-H (10% 
iPrOH:hexane, flow rate 1.0 mL min-1, 211 nm, 30 °C), tR major: 6.2 min, tR minor: 8.2 min, 
90:10 er; νmax (ATR): 3391 (O-H), 2900 (C-H), 1717 (C=O), 1506 (C=C), 1142 (C-O); 1H NMR 
(500 MHz, CDCl3) δH:  8.08 (d, J 8.8, 1H, C(4)H), 7.98 (d, J 8.2, 1H, C(5)H), 7.88 (d, J 8.9, 1H, 
C(4’)H), 7.83 (d, J 8.2, 1H, C(5’)H), 7.53-7.50 (m, 1H, C(6)H), 7.39-7.30 (m, 5H, C(3)H, C(7)H, 
C(8)H, C(6’)H, C(3’)H), 7.47-7.24 (m, 1H, C(7’)H), 7.06 (d, J 8.5, 1H, C(9’)H), 5.17 (s, 1H, -OH), 
0.78 (s, 9H, -(CH3)3); 13C {1H} NMR (125 MHz, CDCl3) δC: 178.3 (C=O), 151.9 (C(2’)), 148.2 
(C(2)), 133.7 (C(8a’)), 133.6 (C(8a)), 132.4 (C(4a)), 130.9 (C(4)), 130.4 (C(4’), 129.1 (C(4a’)), 
128.5 (C(5)), 128.0 (C(5’)), 127.6 (C(7)), 126.8 (C(7’)), 126.4 (C(6)), 125.7 (C(8)), 124.7 (C(8’)), 




HRMS (ASAP+) C25H22O3 [M+H]+ found 371.1647, requires 371.1647 (0 ppm). Data in 
agreement with literature.102 
 
 
2'-Hydroxy-[1,1'-binaphthalen]-2-yl 3-methylbutanoate 57d 
 
Following general procedure C: BINOL (57.3 mg, 0.2 mmol) and (+)-BTM (0.5 mg, 0.002 mmol) 
were added into chloroform (4 mL, 0.05 M) at room temperature, giving a clear solution. 3-
Methylbutanoic anhydride (22 mg, 0.12 mmol) was added to the previous solution. The 
resulted clear solution was left stirring for 18 hours at room temperature. The solution was 
diluted with EtOAc (10 mL), washed with HCl (1 M. 2 × 10 mL), NaHCO3 (sat., 2 × 10 mL) and 
brine (10 mL). The organic layer was dried over MgSO4, filtered and concentrated in vacuo to 
give a pale brown oil, which was purified by column chromatography (Isolera 4, EtOAc in 
petrol, 0% -> 20% over 20 CV) to give 2'-hydroxy-[1,1'-binaphthalen]-2-yl 3-methylbutanoate 
(29.7 mg, 41%) as white solid; mp 250.5-251.5 °C; Rf = 0.44 (20% EtOAc in petroleum ether); 
 20D  −63.2 (c = 0.1 in CHCl3); Chiral HPLC analysis: ChiralPak AD-H 2% iPrOH:hexane, flow 
rate 1.0 mL min-1, 211 nm, 30 °C), tR major: 23.7 min, tR minor: 48.4 min, 82:18 er; νmax (ATR): 
3430 (O-H), 2959 (C-H), 1748 (C=O), 1508 (C=C), 1150 (C-O); 1H NMR (500 MHz, CDCl3) δH:  
8.07 (d, J 8.9, 1H, C(4)H), 7.97 (d, J 8.3, 1H, C(5)H), 7.89 (d, J 8.9, 1H, C(4’)H), 7.84 (d, J 8.0, 1H, 
C(5’)H), 7.52-7.49 (m, 1H, C(6)H), 7.38 (d, J 8.9, 1H, C(3)H), 7.36-7.31 (m, 3H, C(7)H, C(6’)H, 
C(3’)H), 7.27-7.23 (m, 2H, C(8)H, C(7’)H), 7.03(d, J 8.4, 1H, C(8’)H), 5.25 (s, 1H, -OH), 2.09-
1.98 (m, 2H, -CH2-), 1.68 (sept, J 6.8, 1H, -CH-), 0.60 (d, J 6.6, 3H, -CH3), 0.58 (d, J 6.6, 3H, -
CH3); 13C {1H} NMR (125 MHz, CDCl3) δC: 172.7 (C=O), 151.9 (C(2’)), 148.2 (C(2)), 133.6 (C(8a’), 
C(8a)), 132.3 (C(4a)), 131.0 (C(4)), 130.5 (C(4’), 129.2 (C(4a’)), 128.4 (C(5)), 128.1 (C(5’)), 
127.6 (C(7)), 126.8 (C(7’)), 126.4 (C(6)), 125.9 (C(8)), 124.7 (C(8’)), 123.6 (C(6’)), 123.3 (C(1)), 
122.0 (C(3)), 118.5 (C(3’)), 114.3 (C(1’)), 43.0 (-CH2-), 25.6 (-CH-), 22.0 (-CH3), 22.0 (-CH3); 
HRMS (ASAP+) C25H22O3 [M+H]+ found 371.1652, requires 371.1647 (+1.3 ppm). Data in 







2'-Hydroxy-[1,1'-binaphthalen]-2-yl 4-methylpentanoate 57e 
 
Following general procedure C: BINOL (57.3 mg, 0.2 mmol) and (+)-BTM (0.5 mg, 0.002 mmol) 
were added into CH2Cl2 (4 mL, 0.05 M) at room temperature, giving a clear solution. 4-
methylpentanoic anhydride (64.3 mg, 0.3 mmol) and iPr2NEt (27.9 mg, 35 µL, 0.2 mmol) 
were added to the previous solution. The resulted clear solution was left stirring for 18 hours 
at room temperature. The solution was diluted with EtOAc (10 mL), washed with HCl (1 M. 2 
× 10 mL), NaHCO3 (sat., 2 × 10 mL) and brine (10 mL). The organic layer was dried over 
MgSO4, filtered and concentrated in vacuo, to give pale brown oil, which was purified by 
column chromatography (Isolera 4, EtOAc in petrol, 0% -> 20% over 20 CV) to give 2'-
hydroxy-[1,1'-binaphthalen]-2-yl 4-methylpentanoate (33.1 mg, 43%) as cloudy gum; Rf = 
0.47 (20% EtOAc in petroleum ether);  
20
D  −77.6 (c = 0.1 in CHCl3); Chiral HPLC analysis: 
ChiralCel OD-H (1% iPrOH:hexane, flow rate 1.0 mL min-1, 211 nm, 30 °C), tR major:  15.0 min, 
tR minor: 18.5 min, 90:10 er; νmax (ATR): 3440 (O-H), 2955 (C-H), 1746 (C=O), 1508 (C=C), 
1206 (C-O); 1H NMR (500 MHz, CDCl3) δH:  8.08 (d, J 8.9, 1H, C(4)H), 7.98 (d, J 8.3, 1H, C(5)H), 
7.90 (d, J 8.9, 1H, C(4’)H), 7.85 (d, J 8.0, 1H, C(5’)H), 7.53-7.49 (m, 1H, C(6)H), 7.39 (d, J 8.9, 
1H, C(3)H), 7.37-7.31 (m, 3H, C(7)H, C(6’)H, C(3’)H), 7.30 (d, J 8.4, 1H, C(8)H), 7.29-7.24 (m, 
1H, C(7’)H), 7.05 (d, J 8.4, 1H, C(8’)H), 5.21 (s, 1H, -OH), 2.18-2.08 (m, 2H, -OC-CH2-CH2-), 1.05 
(sept, J 6.6, 1H, -CH(CH3)2), 0.99-0.88 (m, 2H, -CH2-CH(CH3)2), 0.62 (d, J 6.5, 3H, -CH3), 0.56 (d, 
J 6.5, 3H, -CH3); 13C {1H} NMR (125 MHz, CDCl3) δC: 173.6 (C=O), 151.9 (C(2’)), 148.2 (C(2)), 
133.6 (C(8a’)), 133.6 (C(8a)), 132.4 (C(4a)), 131.0 (C(4)), 130.5 (C(4’), 129.2 (C(4a’)), 128.4 
(C(5)), 128.1 (C(5’)), 127.6 (C(7)), 126.9 (C(7’)), 126.4 (C(6)), 125.8 (C(8)), 124.6 (C(8’)), 123.7 
(C(6’)), 123.3 (C(1)), 121.9 (C(3)), 118.4 (C(3’)), 114.3 (C(1’)), 33.5 (-CH2-CH-), 32.3 (-CO-CH2-), 
27.2 (-CH-), 22.1 (-CH3), 22.0 (-CH3); HRMS (ASAP+) C26H24O3 [M+H]+ found 385.1800, requires 










2'-Hydroxy-[1,1'-binaphthalen]-2-yl 2-phenylacetate 57f 
 
Following general procedure C: BINOL (57.3 mg, 0.2 mmol) and (+)-BTM (0.5 mg, 0.002 mmol) 
were added into chloroform (4 mL, 0.05 M) at room temperature, giving a clear solution. 
Phenylacetic anhydride (28.0 mg, 0.11 mmol) was added to the previous solution. The 
resulted clear solution was left stirring for 18 hours at room temperature. The solution was 
diluted with EtOAc (10 mL), washed with HCl (1 M. 2 × 10 mL), NaHCO3 (sat., 2 × 10 mL) and 
brine (10 mL). The organic layer was dried over MgSO4, filtered and concentrated in vacuo to 
give a pale brown oil, which was purified by column chromatography (Isolera 4, EtOAc in 
petrol, 0% -> 20% over 40 CV) to give 2'-hydroxy-[1,1'-binaphthalen]-2-yl 2-phenylacetate 
(23.2 mg, 29%) as white solid; Rf = 0.28 (20% EtOAc in petroleum ether); mp 127-128 °C [lit1 
104.5-105.5 °C];  20D  −60.8 (c = 0.1 in CHCl3); Chiral HPLC analysis: ChiralPak AD-H (10% 
iPrOH:hexane, flow rate 1.0 mL min-1, 211 nm, 30 °C), tR major: 16.2 min, tR minor: 21.4 min, 
92:8 er; νmax (ATR): 3451 (O-H), 2890 (C-H), 1746 (C=O), 1597 (C=C), 1117 (C-O); 1H NMR (500 
MHz, CDCl3) δH:  8.05 (d, J 8.9, 1H, C(4)H), 7.96 (d, J 8.2, 1H, C(5)H), 7.86 (d, J 8.9, 1H, C(4’)H), 
7.84 (d, J 8.0, 1H, C(5’)H), 7.52-7.48 (m, 1H, C(6)H), 7.37 (d, J 8.9, 1H, C(3)H), 7.36-7.31 (m, 
2H, C(7)H, C(6’)H), 7.24 (d, J 8.9, 1H, C(8)H), 7.27-7.20 (m, 2H, C(3’)H, C(7’)H), 7.14-7.10 (m, 
1H, p-ArCH), 7.07-7.03 (m, 2H, 2 × m-ArCH), 7.01-6.98 (m, 1H, C(8’)H), 6.76-6.73 (m, 2H, 2 × 
o-ArCH), 5.12 (s, 1H, -OH), 3.42 (s, 2H, -CH2-); 13C {1H} NMR (125 MHz, CDCl3) δC: 170.9 (C=O), 
151.8 (C(2’)), 148.2 (C(2)), 133.6 (C(8a), C(8a’)), 132.7 (i-ArCH), 132.4 (C(4a)), 131.0 (C(4)), 
130.6 (C(4’), 129.2 (C(4a’)), 129.0 (2×  o-ArCH), 128.5 (2 × m-ArCH), 128.4 (C(5)), 128.2 (C(5’)), 
127.6 (C(7)), 127.1 (p-ArCH), 126.8 (C(7’)), 126.5 (C(6)), 125.8 (C(8)), 124.6 (C(8’)), 123.7 
(C(6’)), 123.3 (C(1)), 121.7 (C(3)), 118.4 (C(3’)), 114.0 (C(1’)), 41.0 (-CH2-); HRMS (ASAP+) 











2'-Hydroxy-[1,1'-binaphthalen]-2-yl 3-phenylpropanoate 57g 
 
Following general procedure C: BINOL (57.3 mg, 0.2 mmol) and (+)-BTM (0.5 mg, 0.002 mmol) 
were added into chloroform (4 mL, 0.05 M) at room temperature, giving a clear solution. 3-
Phenylpentanoic anhydride (31.1 mg, 0.11 mmol) was added to the previous solution. The 
resulted clear solution was left stirring for 18 hours at room temperature. The solution was 
diluted with EtOAc (10 mL), washed with HCl (1 M. 2 × 10 mL), NaHCO3 (sat., 2 × 10 mL) and 
brine (10 mL). The organic layer was dried over MgSO4, filtered and concentrated in vacuo to 
give 2'-hydroxy-[1,1'-binaphthalen]-2-yl 3-phenylpropanoate (23.9 mg, 29%) as white solids; 
Rf = 0.32 (20% EtOAc in petroleum ether); mp 127-128 °C;  20D  −57.5 (c = 0.1 in CHCl3); 
Chiral HPLC analysis: Chiral HPLC analysis, ChiralPak IB (2% iPrOH:hexane, flow rate 1.0 mL 
min-1, 211 nm, 30 °C), tR major: 15.4 min, tR minor: 23.2 min, 87.5:12.5 er; νmax (ATR): 3400 
(O-H, br), 2885 (C-H), 1713 (C=O), 1508 (C=C), 1157 (C-O); 1H NMR (500 MHz, CDCl3) δH:  8.08 
(d, J 8.8, 1H, C(4)H), 7.98 (d, J 8.4, 1H. C(5)H), 7.90 (d, J 9.0, 1H, C(4’)H), 7.85 (d, J 8.0, 1H, 
C(5’)H), 7.54-7.50 (m, 1H, C(6)H), 7.38-7.30 (m, 5H, C(7)H, C(3)H, C(6’)H, C(3’)H, C(8)H), 7.28-
7.25 (m, 1H, C(7’)H), 7.23-7.20 (m, 2H, 2 × m-ArCH), 7.18-7.14 (m, 1H, p-ArCH), 7.06 (d, J 8.5, 
1H, C(8’)H), 6.95-6.93 (m, 2H, 2 × o-ArCH) 5.17 (s, 1H, -OH), 2.50-2.33 (m, 4H, 2 × -CH2-); 13C 
{1H} NMR (125 MHz, CDCl3) δC: 172.4 (C=O), 151.9 (C(2’)), 148.1 (C(2)), 140.0 (i-ArCH), 133.6 
(C(8a), C(8a’)), 132.4 (C(4a)), 131.0 (C(4)), 130.6 (C(4’), 129.1 (C(4a’)), 128.6 (2 × m-ArCH), 
128.5 (C(5)), 128.2 (2 × o-ArCH), 128.2 (C(5’)), 127.7 (C(7)), 126.9 (C(7’)), 126.5 (C(6)), 126.4 
(p-ArCH), 125.8 (C(8)), 124.7 (C(8’)), 123.7 (C(6’)), 123.1 (C(1)), 121.9 (C(3)), 118.4 (C(3’)), 
114.2 (C(1’)), 35.6 (-CO-CH2-), 30.5 (-CH2-Ph); HRMS (ASAP+) C29H22O3 [M+H]+ found 419.1653, 
requires 419.1647 (+1.4 ppm) 
 
2'-Hydroxy-[1,1'-binaphthalen]-2-yl cinnamate 57h 
 
Following general procedure C: BINOL (57.3 mg, 0.2 mmol) and (+)-BTM (0.5 mg, 0.002 mmol) 
were added into tert-Amyl alcohol (4 mL, 0.05 M) at room temperature, giving a clear 




resulted clear solution was left stirring for 18 hours at room temperature. The solution was 
diluted with EtOAc (10 mL), washed with HCl (1 M. 2 × 10 mL), NaHCO3 (sat., 2 × 10 mL) and 
brine (10 mL). The organic layer was dried over MgSO4, filtered and concentrated in vacuo to 
give a pale brown oil, which was purified by column chromatography (Isolera 4, EtOAc in 
petrol, 0% -> 20% over 50 CV) to give 2'-hydroxy-[1,1'-binaphthalen]-2-yl 2,2-
diphenylacetate (23.6 mg, 28%) as white solid; Rf = 0.35 (20% EtOAc in petroleum ether); mp 
150-152 °C [lit1 134-135 °C];  20D  −93 (c = 0.1 in CHCl3); Chiral HPLC analysis: ChiralPak AD-
H (20% iPrOH:hexane, flow rate 1.0 mL min-1, 211 nm, 30 °C), tR major: 11.6 min, tR minor: 
16.6 min, 74.5:25.5 er; νmax (ATR): 3400 (O-H, br), 2924 (C-H), 1717 (C=O), 1634 (C=C), 1550 
(C=C, aromatic), 1138 (C-O); 1H NMR (500 MHz, CDCl3) δH:  8.11 (d, J 8.9, 1H, C(4)H), 7.99 (d, 
J 8.2, 1H, C(5)H), 7.85 (d, J 8.9, 1H, C(4’)H), 7.82 (d, J 8.1, 1H, C(5’)H), 7.54-7.50 (m, 1H, 
C(6)H), 7.49 (d, J 8.9, 1H, C(3)H),  7.40 (d, J 16.0, 1H, -CH=CH-Ph),  7.37-7.26 (m, 10H, ArH), 
7.10 (d, J 8.1, 1H, C(8)H), 6.24 (d, J 16.0, 1H, -CO-CH=), 5.37 (s, 1H, -OH); 13C {1H} NMR (125 
MHz, CDCl3) δC: 166.5 (C=O), 152.0 (C(2’)), 149.0 (C(2)), 147.2 (-CH=CH-Ph), 134.0 (i-ArCH), 
133.6 (C(8a), C(8a’)), 132.4 (C(4a)), 131.0 (p-ArCH), 131.0 (C(4)), 130.5 (C(4’), 129.2 (C(4a’)), 
129.0 (2 × ArCH), 128.4 (C(5), 2 × ArCH), 128.2 (C(5’)), 127.6, 126.8, 126.4 (C(6)), 125.9, 124.7 
(C(8)), 123.6, 123.5 (C(1)), 122.0 (C(3)), 118.5 (C(3’)), 114.2 (C(1’)); HRMS (ASAP+) C29H20O3 
[M+H]+ found 417.1497, requires 417.1391 (+1.4 ppm). Data in agreement with literature.103 
 
2'-Hydroxy-[1,1'-binaphthalen]-2-yl benzoate 57i 
 
Following general procedure C: BINOL (57.3 mg, 0.2 mmol) and (+)-BTM (0.5 mg, 0.002 mmol) 
were added into tert-Amyl alcohol (4 mL, 0.05 M) at room temperature. Benzoic anhydride 
(24.9 mg, 0.11 mmol) was added to the previous solution. The resulted clear solution was 
left stirring for 18 hours at room temperature. The crude product was purified by column 
chromatography (Isolera 4, EtOAc in petrol, 0% -> 20% over 25 CV) giving 2'-hydroxy-[1,1'-
binaphthalen]-2-yl benzoate (32 mg, 41%) as white solids; Rf = 0.24 (20% EtOAc in petroleum 
ether); mp 214-216 °C;  20D  −133.4 (c = 0.1 in CHCl3); Chiral HPLC analysis: ChiralPak AS-H 
(1% iPrOH:hexane, flow rate 1.0 mL min-1, 211 nm, 30 °C), tR major:  18.0 min, tR minor: 34.7 
min, 88.5:11.5 er; νmax (ATR): 3424 (O-H), 2963 (C-H), 1703 (C=O), 1508 (C=C), 1256 (C-O); 1H 




2H, C(4’)H, C(5’)H), 7.68-7.66 (m, 2H, 2 × o-ArCH), 7.55 (d, J 8.2, 1H, C(3)H), 7.55-7.52 (m, 1H, 
d, C(6)H), 7.47-7.44 (m, 1H, p-ArCH), 7.39-7.36 (m, 1H, C(7)H), 7.33- 7.28 (m, 3H, C(8)H, 
C(6’)H, C(7’)H), 7.27-7.23 (m, 3H, 2 × m-ArCH, C(3’)H), 7.17-7.15 (m, 1H, C(8’)H), 5.32 (s, 1H, -
OH); 13C {1H} NMR (125 MHz, CDCl3) δC: 166.1 (C=O), 151.9 (C(2’)), 148.4 (C(2)), 133.7 (C(8a), 
C(8a’)), 133.6 (p-ArCH), 132.4 (C(4a)), 131.0 (C(4)), 130.5 (C(4’), 130.1 (2 × o-ArCH), 129.1 
(C(4a’)), 128.9 (i-ArCH), 128.5 (C(5)), 128.4 (2 × m-ArCH), 128.1 (C(5’)), 127.7 (C(7)), 126.8 
(C(7’)), 126.5 (C(6)), 125.9 (C(8)), 124.7 (C(8’)), 123.6 (C(6’)), 123.3 (C(1)), 122.0 (C(3)), 118.3 
(C(3’)), 114.0 (C(1’)); HRMS (NSI+) C27H18O3 [M+H]+ found 391.1329, requires 391.1329 (+0.1 
ppm) 
 
2'-hydroxy-[1,1'-binaphthalen]-2-yl 4-bromobenzoate 57j 
 
Following general procedure C: BINOL (57.3 mg, 0.2 mmol) and (+)-BTM (0.5 mg, 0.002 mmol) 
were added into chloroform (4 mL, 0.05 M) at room temperature, giving a clear solution. 4-
Bromobezoic anhydride (31.1 mg, 0.11 mmol) was added to the previous solution. The 
resulted clear solution was left stirring for 18 hours at room temperature. The solution was 
diluted with EtOAc (10 mL), washed with HCl (1 M. 2 × 10 mL), NaHCO3 (sat., 2 × 10 mL) and 
brine (10 mL). The organic layer was dried over MgSO4, filtered and concentrated in vacuo to 
give a pale brown oil, which was purified by column chromatography (Isolera 4, EtOAc in 
petrol, 0% -> 20% over 40 CV) to give 2'-hydroxy-[1,1'-binaphthalen]-2-yl 4-bromobenzoate 
(40.9 mg, 44%) as white solids; Rf = 0.30 (20% EtOAc in petroleum ether); mp 161-162 °C; 
 20D  −123.3 (c = 0.1 in CHCl3); Chiral HPLC analysis: ChiralPak AD-H (20%  iPrOH:hexane, 
flow rate 1.0 mL min-1, 211 nm, 30 °C), tR major: 9.3 min, tR minor: 14.7 min, 86:14 er; νmax 
(ATR) 3455 (O-H), 2890 (C-H), 1721 (C=O), 1587 (C=C), 1198 (C-O); 1H NMR (500 MHz, CDCl3) 
δH: 8.13 (d, J 8.9, 1H, C(4)H), 8.01 (d, J 8.4, 1H, C(5)H), 7.80 (d, J 8.9, 1H, C(4’)H), 7.80-7.78 (m, 
1H, C(5’)H), 7.55 (d, J 8.9, 1H, C(3)H), 7.56-7.53 (m, 1H, C(6)H), 7.49-7.46 (m, 2H, 2 × ArCH), 
7.40-7.36 (m, 3H, C(7)H, 2 × ArCH), 7.36-7.34 (m, 1H, C(8)H), 7.34-7.27 (m, 2H, C(6’)H, C(7’)H), 
7.24 (d, J 8.9, 1H, C(3’)H), 7.24 (m, 1H, C(8’)H), 5.21 (s, 1H, -OH); 13C {1H} NMR (125 MHz, 
CDCl3) δC: 165.2 (C=O), 151.8 (C(2’)), 148.2 (C(2)), 133.6 (C(8a), C(8a’)), 132.5 (C(4a)), 131.1 
(C(4)), 131.8 (2 × o/m-ArCH), 131.5 (2 × o/m-ArCH), 130.6 (C(4’), 129.1 (C(4a’)), 128.9 (p/i-




125.9 (C(8)), 124.6 (C(8’)), 123.6 (C(6’)), 123.1 (C(1)), 121.8 (C(3)), 118.2 (C(3’)), 113.8 (C(1’)); 
HRMS (ASAP+) C27H17BrO3 [M+H]+ found 469.0444, requires 469.0439 (+1.1 ppm) 
 
2'-Hydroxy-[1,1'-binaphthalen]-2-yl 4-nitrobenzoate 57k 
 
Following general procedure C: BINOL (57.3 mg, 0.2 mmol) and (+)-BTM (0.5 mg, 0.002 mmol) 
were added into chloroform (4 mL, 0.05 M) at room temperature, giving a clear solution. 4-
Nitrobenzoic anhydride (31.1 mg, 0.11 mmol) was added to the previous solution. The 
resulted clear solution was left stirring for 18 hours at room temperature. The solution was 
diluted with EtOAc (10 mL), washed with HCl (1 M. 2 × 10 mL), NaHCO3 (sat., 2 × 10 mL) and 
brine (10 mL). The organic layer was dried over MgSO4, filtered and concentrated in vacuo to 
give a pale brown oil, which was purified by column chromatography (Isolera 4, EtOAc in 
petrol, 0% -> 20% over 40 CV) to give 2'-hydroxy-[1,1'-binaphthalen]-2-yl 4-nitrobenzoate 
(24.6 mg, 29%) as yellow gum; Rf = 0.14 (20% EtOAc in petroleum ether);  20D  −100.9 (c = 
0.1 in CHCl3); Chiral HPLC analysis: ChiralPak IB (5% iPrOH:hexane, flow rate 1.0 mL min-1, 
211 nm, 30 °C), tR major: 27.8 min, tR minor: 35.4 min, 86.5:13.5 er; νmax (ATR): 3454 (O-H), 
3050 (C-H), 1738 (C=O), 1526 (N-O), 1346 (N-O), 1207 (C-O); 1H NMR (500 MHz, CDCl3) δH:  
8.16 (d, J 8.9, 1H, C(4)H), 8.07-8.03(m, 3H, 2 × m-ArCH, C(5)H), 7.80 (d, J 8.9, 1H, C(4’)H), 
7.80-7.78 (m, 1H, C(5’)H), 7.72 (m, 2H, 2 × o-ArCH), 7.59 (d, J 8.9, 1H, C(3)H), 7.59-7.55 (m, 
1H, C(6)H), 7.44-7.39 (m, 2H, C(7)H, C(8)H), 7.35-7.29 (m, 2H, C(6’)H, C(7’)H), 7.23 (d, J 8.9, 
1H, C(3’)H), 7.18-7.15 (m, 1H, C(8’)H), 5.11 (s, 1H, -OH); 13C {1H} NMR (125 MHz, CDCl3) δC: 
163.9 (C=O), 151.7 (C(2’)), 150.8 (p-ArCH), 148.0 (C(2)), 134.2 (i-ArCH), 133.5 (C(8a)), 133.4 
(C(8a’)), 132.6 (C(4a)), 131.2 (C(4)), 131.0 (2 × o-ArCH), 130.8 (C(4’), 129.1 (C(4a’)), 128.6 
(C(5)), 128.3 (C(5’)), 127.9 (C(7)), 127.1 (C(7’)), 126.8 (C(6)), 125.9 (C(8)), 124.5 (C(8’)), 123.8 
(C(6’)), 123.5 (2 × m-ArCH), 123.0 (C(1)), 121.5 (C(3)), 118.1 (C(3’)), 113.5 (C(1’)); HRMS 









2'-Hydroxy-[1,1'-binaphthalen]-2-yl nicotinate 57m 
 
Following general procedure C: BINOL (57.3 mg, 0.2 mmol) and (+)-BTM (0.5 mg, 0.002 mmol) 
were added into chloroform (4 mL, 0.05 M) at room temperature, giving a clear solution. 
Nicotinic anhydride (25.0 mg, 0.11 mmol) was added to the previous solution. The resulted 
clear solution was left stirring for 18 hours at room temperature. The solution was diluted 
with EtOAc (10 mL), washed with HCl (1 M. 2 × 10 mL), NaHCO3 (sat., 2 × 10 mL) and brine 
(10 mL). The organic layer was dried over MgSO4, filtered and concentrated in vacuo to give 
a pale brown oil, which was purified by column chromatography (Isolera 4, MeOH in CH2Cl2, 
0% -> 2% over 20 CV, then 2% over 10 CV) to give 2'-hydroxy-[1,1'-binaphthalen]-2-yl 
nicotinate (43.1 mg, 44%) as white solid; Rf = 0.17 (2% MeOH in CH2Cl2), mp 250.5-251.5 °C; 
 20D  −101.7 (c = 0.1 in CHCl3); Chiral HPLC analysis: ChiralPak AD-H (10% iPrOH:hexane, 
flow rate 1.0 mL min-1, 211 nm, 30 °C), tR major: 24.4 min, tR minor: 38.4 min, 89.5:10.5 er; 
νmax (ATR): 3052 (O-H), 2644 (C-H), 1742 (C=O), 1504 (C=C) 1279 (C-O); 1H NMR (500 MHz, 
CDCl3) δH:  8.77 (d, J 1.4, 1H, hetero-ArH(2)), 8.64 (dd, J 5.0, 1.7, 1H, hetero-ArH(6)), 8.13 (d, J 
8.9, 1H, C(4)H), 8.01 (d, J 8.2, 1H, C(5)H), 7.86 (dt, J 8.0, 2.0, 1H, hetero-ArH(4)), 7.81-7.77 (m, 
2H, C(4’)H, C(5’)H), 7.56 (d, J 8.9, 1H, C(3)H), 7.57-7.53 (m, 1H, C(6)H), 7.42-7.36 (m, 2H, 
C(7)H, C(8)H), 7.33-7.27 (m, 2H, C(6’)H, C(7’)H), 7.24 (d, J 8.9, 1H, C(3’)H), 7.19 (dd, J 8.0, 5.0, 
1H, hetero-ArH(5)), 7.16-7.14 (m, 1H, C(8’)H), 5.30 (s, 1H, -OH); 13C {1H} NMR (125 MHz, 
CDCl3) δC: 164.5 (C=O), 154.0 (hetero-ArCH(6)), 151.8 (C(2’)), 151.1 (hetero-ArCH(2)), 147.8 
(C(2)), 137.4 (hetero-ArCH(4)), 133.5 (C(8a), C(8a’)), 132.5 (C(4a)), 131.1 (C(4)), 130.7 (C(4’), 
129.1 (C(4a’)), 128.6 (C(5)), 128.2 (C(5’)), 127.8 (C(7)), 127.0 (C(7’)), 126.7 (C(6)), 125.9 (C(8)), 
124.9 (hetero-ArCH(3)), 124.6 (C(8’)), 123.7 (C(6’)), 123.3 (hetero-ArCH(5)),  123.2 (C(1)), 
121.7 (C(3)), 118.1 (C(3’)), 113.6 (C(1’)); HRMS (NSI+) C26H17NO3 [M+H]+ found 392.1281, 










2'-Hydroxy-[1,1'-binaphthalen]-2-yl 2-ethylbutanoate 57n 
 
Following general procedure C: BINOL (57.3 mg, 0.2 mmol) and (+)-BTM (0.5 mg, 0.002 mmol) 
were added into tert-Amyl alcohol (4 mL, 0.05 M) at room temperature, giving a clear 
solution. 2-Ethylbutanoic anhydride (22 mg, 0.12 mmol) was added to the previous solution. 
The resulted clear solution was left stirring for 18 hours at room temperature. The solution 
was diluted with EtOAc (10 mL), washed with HCl (1 M. 2 × 10 mL), NaHCO3 (sat., 2 × 10 mL) 
and brine (10 mL). The organic layer was dried over MgSO4, filtered and concentrated in 
vacuo to give a pale brown oil, which was purified by column chromatography (Isolera 4, 
EtOAc in petrol, 0% -> 20% over 20 CV) to give 2'-hydroxy-[1,1'-binaphthalen]-2-yl 2-
ethylbutanoate (29.0 mg, 38%) as white solids; Rf = 0.44 (20% EtOAc in petroleum ether); mp 
72-74 °C;  
20
D  −61.9 (c = 0.1 in CHCl3); Chiral HPLC analysis: ChiralPak AD-H (2% 
iPrOH:hexane, flow rate 1.0 mL min-1, 211 nm, 30 °C), tR major: 19.1 min, tR minor: 26.4 min, 
92:8 er; νmax (ATR): 3450 (O-H), 1744 (C=O), 1508 (C=C), 1204 (C-O); 1H NMR (500 MHz, CDCl3) 
δH:  8.07 (d, J 8.9, 1H, C(4)H), 7.97 (d, J 8.1, 1H, C(5)H), 7.88 (d, J 8.9, 1H, C(4’)H), 7.83 (d, J 8.1, 
1H, C(5’)H), 7.53-7.49 (m, 1H, C(6)H), 7.36 (d, J 8.9, 1H, C(3)H), 7.36-7.29 (m, 3H, C(7)H, 
C(3’)H, C(6’)H), 7.28 (d, J 8.4, 1H, C(8)H), 7.26-7.23 (m, 1H, C(7’)H), 7.05 (d, J 8.4, 1H, C(8’)H), 
5.29 (s, 1H, -OH), 2.08 (tt, J 8.6, 5.4, 1H, -CH(CH3)2), 1.33-1.14 (m, 4H, 2× -CH2-), 0.58 (t, J 7.5, 
3H, -CH3), 0.50 (t, J 7.5, 3H, -CH3); 13C {1H} NMR (125 MHz, CDCl3) δC: 175.7 (C=O), 151.9 
(C(2’)), 148.2 (C(2)), 133.7 (C(8a’)), 133.7 (C(8a)), 132.3 (C(4a)), 131.0 (C(4)), 130.5 (C(4’), 
129.2 (C(4a’)), 128.4 (C(5)), 128.0 (C(5’)), 127.6 (C(7)), 126.8 (C(7’)), 126.4 (C(6)), 125.8 (C(8)), 
124.7 (C(8’)), 123.6 (C(6’)), 123.4 (C(1)), 122.0 (C(3)), 118.5 (C(3’)), 114.4 (C(1’)), 48.7 (-CH-), 
24.8 (-CH2-), 24.7 (-CH2-), 11.5 (-CH3), 11.2 (-CH3); HRMS (ASAP+) C26H24O3 [M+H]+ found 
385.1798, requires 385.1804 (−1.6 ppm) 
 
2'-Hydroxy-[1,1'-binaphthalen]-2-yl 2-propylpentanoate 57o 
 
Following general procedure C: BINOL (57.3 mg, 0.2 mmol) and (+)-BTM (0.5 mg, 0.002 mmol) 




solution. 2-Propylpentanoic anhydride (29.7 mg, 0.12 mmol) was added to the previous 
solution. The resulted clear solution was left stirring for 18 hours at room temperature. The 
solution was diluted with EtOAc (10 mL), washed with HCl (1 M. 2 × 10 mL), NaHCO3 (sat., 2 × 
10 mL) and brine (10 mL). The organic layer was dried over MgSO4, filtered and concentrated 
in vacuo to give a pale brown oil, which was purified by column chromatography (Isolera 4, 
EtOAc in petrol, 0% -> 20% over 30 CV) to give 2'-hydroxy-[1,1'-binaphthalen]-2-yl 2-
propylpentanoate (24.1 mg, 29%) as white solids; Rf = 0.47 (20% EtOAc in petroleum ether); 
mp 99-100 °C;  
20
D  −77.8 (c = 0.1 in CHCl3); Chiral HPLC analysis: ChiralPak AD-H (10% 
iPrOH:hexane, flow rate 1.0 mL min-1, 211 nm, 30 °C), tR major: 17.1 min, tR minor: 22.7 min, 
92:8 er; νmax (ATR): 3450 (O-H), 2957 (C-H), 1740 (C=O), 1508 (C=C), 1204 (C-O); 1H NMR (500 
MHz, CDCl3) δH:  8.07 (d, J 8.9, 1H, C(4)H), 7.97 (d, J 8.2, 1H, C(5)H), 7.89 (d, J 8.9, 1H, C(4’)H), 
7.83 (d, J 8.3, 1H, C(5’)H), 7.52-7.49 (m, 1H, C(6)H), 7.36-7.30 (m, 4H, C(3)H, C(7)H, C(6’)H, 
C(3’)H), 7.28-7.23 (m, 2H, C(8)H, C(7’)H), 7.06(d, J 8.4, 1H, C(8’)H), 5.30 (s, 1H, -OH), 2.27-
2.21 (m, 1H, -CH-), 1.27-1.19 (m, 2H, -CH2-), 1.14-1.06 (m, 2H, -CH2-), 1.03-0.80 (m, 4H, 2 × -
CH2-), 0.65 (t, J 7.3, 3H, -CH3), 0.60 (t, J 7.3, 3H, -CH3); 13C {1H} NMR (125 MHz, CDCl3) δC: 
176.0 (C=O), 152.0 (C(2’)), 148.2 (C(2)), 133.7 (C(8a’)), 133.7 (C(8a)), 132.3 (C(4a)), 131.0 
(C(4)), 130.5 (C(4’), 129.3 (C(4a’)), 128.4 (C(5)), 128.1 (C(5’)), 127.6 (C(7)), 126.8 (C(7’)), 126.4 
(C(6)), 125.8 (C(8)), 124.6 (C(8’)), 123.6 (C(6’)), 123.5 (C(1)), 121.9 (C(3)), 118.5 (C(3’)), 114.5 
(C(1’)), 45.3 (-CH-), 34.4 (-CH2-), 34.3 (-CH2-), 20.5 (-CH2-), 20.2 (-CH2-), 14.1 (-CH3), 13.9 (-CH3); 
HRMS (ASAP+) C28H28O3 [M+H]+ found 413.2114, requires 413.2117 (−0.7 ppm) 
 
2'-Hydroxy-[1,1'-binaphthalen]-2-yl 2,2-diphenylacetate 57p 
 
Following general procedure C: BINOL (57.3 mg, 0.2 mmol) and (+)-BTM (0.5 mg, 0.002 mmol) 
were added into tert-Amyl alcohol (4 mL, 0.05 M) at room temperature, giving a clear 
solution. Diphenylacetic anhydride (44.7 mg, 0.11 mmol) was added to the previous solution. 
The resulted clear solution was left stirring for 18 hours at room temperature. The solution 
was diluted with EtOAc (10 mL), washed with HCl (1 M. 2 × 10 mL), NaHCO3 (sat., 2 × 10 mL) 
and brine (10 mL). The organic layer was dried over MgSO4, filtered and concentrated in 
vacuo to give a pale brown oil, which was purified by column chromatography (Isolera 4, 




diphenylacetate (36.1 mg, 38%) as white solid; Rf = 0.22 (20% EtOAc in petroleum ether); ); 
mp 133-134 °C;  20D  −57.3 (c = 0.1 in CHCl3); Chiral HPLC analysis: ChiralPak AD-H (10% 
iPrOH:hexane, flow rate 1.0 mL min-1, 211 nm, 30 °C), tR major: 9.6 min, tR minor: 12.0 min, 
92.5:7.5 er; νmax (ATR): 3455 (O-H), 3050 (C-H), 1736 (C=O), 1452 (C=C), 1202 (C-O); 1H NMR 
(500 MHz, CDCl3) δH  8.04 (d, J 8.9, 1H, C(4)H), 7.96 (d, J 8.0, 1H, C(5)H), 7.87 (d, J 8.9, 1H, 
C(4’)H), 7.85 (d, J 8.1, 1H, C(5’)H), 7.52-7.49 (m, 1H, C(6)H), 7.35-7.32 (m, 2H, C(7)H, C(6’)H), 
7.32 (d, J 8.9, 1H, C(3)H), 7.27-7.24 (m, 2H, C(8)H, C(3’)H), 7.23-7.19 (m, 1H, C(7’)H), 7.17-
7.13 (m, 2H, p-ArCH, p’-ArCH), 7.12-7.08 (m, 4H, 2 × m-ArCH, 2 × m’-ArCH), 7.02-6.99 (m, 1H, 
C(8’)H), 6.93-6.90 (m, 2H, 2 × o-ArCH), 6.83-6.80 (m, 2H, 2 × o’-ArCH), 5.20 (s, 1H, -OH), 4.87 
(s, 1H, -CHPh2); 13C {1H} NMR (125 MHz, CDCl3) δC: 172.1 (C=O), 151.9 (C(2’)), 148.1 (C(2)), 
137.7 (i-ArCH), 137.5 (i’-ArCH), 133.6 (C(8a), C(8a’)), 132.4 (C(4a)), 131.0 (C(4)), 130.6 (C(4’), 
129.2 (C(4a’)), 128.6 (2 × m-ArCH), 128.6 (2 × m’-ArCH), 128.5 (2 × o-ArCH), 128.4 (2 × o’-
ArCH), C(5)), 128.1 (C(5’)), 127.6 (C(7)), 127.3 (p-ArCH), 127.3 (p’-ArCH), 126.9 (C(7’)), 126.5 
(C(6)), 125.9 (C(8)), 124.7 (C(8’)), 123.7 (C(6’)), 123.4 (C(1)), 121.6 (C(3)), 118.5 (C(3’)), 114.1 
(C(1’)), 56.8 (-CH-); HRMS (ASAP+) C34H24O3 [M+H]+ found 481.1802, requires 481.1804 (−0.4 
ppm) 
 
2'-Hydroxy-[1,1'-binaphthalen]-2-yl cyclopentanecarboxylate 57q 
 
Following general procedure C: BINOL (57.3 mg, 0.2 mmol) and (+)-BTM (0.5 mg, 0.002 mmol) 
were added into tert-Amyl alcohol (4 mL, 0.05 M) at room temperature, giving a clear 
solution. Cyclopetanecarboxylic anhydride (23.1 mg, 0.12 mmol) was added to the previous 
solution. The resulted clear solution was left stirring for 18 hours at room temperature. The 
solution was diluted with EtOAc (10 mL), washed with HCl (1 M., 2 × 10 mL), NaHCO3 (sat., 2 
× 10 mL) and brine (10 mL). The organic layer was dried over MgSO4, filtered and 
concentrated in vacuo to give a pale brown oil, which was purified by column 
chromatography (Isolera 4, EtOAc in petrol, 0% -> 20% over 20 CV) to give 2'-hydroxy-[1,1'-
binaphthalen]-2-yl cyclopentanecarboxylate (26.4 mg, 35%) as white solids; Rf = 0.38 (20% 
EtOAc in petroleum ether); mp 99-100  °C;  
20
D  −64 (c = 0.1 in CHCl3); Chiral HPLC analysis: 
ChiralPak AD-H (10% iPrOH:hexane, flow rate 1.0 mL min-1, 211 nm, 30 °C), tR major: 9.3 min, 




1206 (C-O); 1H NMR (500 MHz, CDCl3) δH:  8.08 (d, J 8.9, 1H, C(4)H), 7.98 (d, J 8.2, 1H, C(5)H), 
7.90 (d, J 8.9, 1H, C(4’)H), 7.84 (d, J 8.0, 1H, C(5’)H), 7.53-7.49 (m, 1H, C(6)H), 7.40 (d, J 8.9, 
1H, C(3)H), 7.37-7.30 (m, 4H, C(7)H, C(6’)H, C(3’)H, C(8)H), 7.27-7.23 (m, 1H, C(7’)H), 7.04 (d, 
J 8.4, 1H, C(8’)H), 5.19 (s, 1H, -OH), 2.61-2.56 (m, 1H, C(1’’)H), 1.58-1.02 (m, 8H, 4 × -CH2-); 
13C {1H} NMR (125 MHz, CDCl3) δC: 176.4 (C=O), 151.9 (C(2’)), 148.3 (C(2)), 133.6 (C(8a’)), 
133.6 (C(8a)), 132.3 (C(4a)), 131.0 (C(4)), 130.5 (C(4’), 129.1 (C(4a’)), 128.4 (C(5)), 128.1 
(C(5’)), 127.6 (C(7)), 126.8 (C(7’)), 126.4 (C(6)), 125.8 (C(8)), 124.7 (C(8’)), 123.7 (C(6’)), 123.2 
(C(1)), 122.0 (C(3)), 118.5 (C(3’)), 114.4 (C(1’)), 43.4 (-CH-), 29.8 (-CH2-), 29.2 (-CH2-), 25.6 (-
CH2-), 25.6 (-CH2-); HRMS (ASAP+) C26H22O3 [M+H]+ found 383.1642, requires 383.1647 (−1.3 
ppm) 
 
2'-Hydroxy-[1,1'-binaphthalen]-2-yl cyclohexanecarboxylate 57r 
 
Following general procedure C: BINOL (57.3 mg, 0.2 mmol) and (+)-BTM (0.5 mg, 0.002 mmol) 
were added into chloroform (4 mL, 0.05 M) at room temperature, giving a clear solution. 
Cyclohexanecarboxylic anhydride (26.2 mg, 0.12 mmol) was added to the previous solution. 
The resulted clear solution was left stirring for 18 hours at room temperature. The solution 
was diluted with EtOAc (10 mL), washed with HCl (1 M. 2 × 10 mL), NaHCO3 (sat., 2 × 10 mL) 
and brine (10 mL). The organic layer was dried over MgSO4, filtered and concentrated in 
vacuo to give a pale brown oil, which was purified by column chromatography (Isolera 4, 
EtOAc in petrol, 0% -> 20% over 20 CV) to give 2'-hydroxy-[1,1'-binaphthalen]-2-yl 
cyclohexanecarboxylate (23.1 mg, 29%) as white solids; Rf = 0.44 (20% EtOAc in petroleum 
ether); mp 144-146 °C;  
20
D  −87.9 (c = 0.1 in CHCl3); Chiral HPLC analysis: ChiralPak AD-H 
(10% iPrOH:hexane, flow rate 1.0 mL min-1, 211 nm, 30 °C), tR major: 14.5 min, tR minor: 26.7 
min, 95:5 er; νmax (ATR): 3456 (O-H), 2930 (C-H), 1726 (C=O), 1508 (C=C), 1152 (C-O); 1H NMR 
(500 MHz, CDCl3) δH:  8.07 (d, J 8.9, 1H, C(4)H), 7.97 (d, J 8.2, 1H, C(5)H), 7.89 (d, J 8.9, 1H, 
C(4’)H), 7.84 (d, J 8.1, 1H, C(5’)H), 7.52-7.49 (m, 1H, C(6)H), 7.38 (d, J 8.9, 1H, C(3)H), 7.37-
7.29 (m, 4H, C(7)H, C(6’)H, C(3’)H, C(8)H), 7.27-7.24 (m, 1H, C(7’)H), 7.04 (d, J 8.4, 1H, C(8’)H), 
5.20 (s, 1H, -OH), 2.20-2.14 (m, 1H, C(1’’)H), 1.53-0.84 (m, 10H, 5 × -CH2-); 13C {1H} NMR (125 
MHz, CDCl3) δC: 175.7 (C=O), 151.9 (C(2’)), 148.2 (C(2)), 133.7 (C(8a’)), 133.6 (C(8a)), 132.3 




(C(7’)), 126.4 (C(6)), 125.8 (C(8)), 124.7 (C(8’)), 123.6 (C(6’)), 123.2 (C(1)), 122.0 (C(3)), 118.4 
(C(3’)), 114.3 (C(1’)), 42.7 (-CH-), 28.4 (-CH2-), 28.2 (-CH2-), 25.6 (-CH2-), 25.1 (-CH2-), 25.0 (-
CH2-); HRMS (ASAP+) C27H24O3 [M+H]+ found 397.1794, requires 397.1804 (−2.5 ppm) 
 
6,6'-Dibromo-2'-hydroxy-[1,1'-binaphthalen]-2-yl 2,2-diphenylacetate 65a 
 
Following general procedure C: 6,6'-dibromo-[1,1'-binaphthalene]-2,2'-diol (88.8 mg, 0.2 
mmol) and (+)-BTM (0.5 mg, 0.002 mmol) were added into chloroform (4 mL, 0.05 M) at 
room temperature, giving a clear solution. 2,2-Diphenylacetic pivalic anhydride (32.6 mg, 
0.11 mmol) was added to the previous solution. The resulted clear solution was left stirring 
for 18 hours at room temperature. The solvent was removed in vacuo and the residue was 
purified by column chromatography (Isolera 4, EtOAc in petrol, 0% -> 20% over 30 CV) to 
give 6,6'-dibromo-2'-hydroxy-[1,1'-binaphthalen]-2-yl 2,2-diphenylacetate (63.6 mg, 49.8%) 
as white solid. Rf = 0.47 (20% EtOAc in petroleum ether); mp 130-132 °C;  20D  +1.9 (c = 0.1 
in CHCl3); Chiral HPLC analysis, ChiralPak AD-H (5% iPrOH:hexane, flow rate 1.0 mL min-1, 211 
nm, 30 °C), tR major: 46.1 min, tR minor: 80.6 min, 88:12 er; νmax (ATR): 3408 (O-H), 2922 (C-
H), 1722 (C=O), 1493 (C=C), 1150 (C-O); 1H NMR (500 MHz, CDCl3) δH 8.12 (d, J 1.9, 1H, 
C(5)H), 7.97 (d, J 2.0, 1H, C(5’)H), 7.97 (d, J 9.0, 1H, C(4)H), 7.73 (d, J 9.0, 1H, C(4’)H), 7.40 (dd, 
J 9.0, 2.0, 1H, C(7)H), 7.35 (d, J 8.9, 1H, C(3)H), 7.25 (dd, J 9.0, 2.1, 1H, C(7’)H), 7.21 (d, J 8.9, 
1H, C(3’)H), 7.19-7.16 (m, 2H, p-ArCH, p’-ArCH), 7.14-7.10 (m, 4H, 2 × m-ArCH, 2 × m’-ArCH), 
7.05 (d, J 9.0, 1H, C(8)H), 6.92-6.90 (m, 2H, 2 × o-ArCH), 6.86-6.84 (m, 2H, 2 × o’-ArCH), 7.05 
(d, J 9.0, 1H, C(8’)H), 5.17 (s, 1H, -OH), 4.86 (s, 1H, -CHPh2); 13C {1H} NMR (125 MHz, CDCl3) δC: 
171.8 (C=O), 152.2 (C(2’)), 148.3 (C(2)), 137.4 (i-ArCH/ i’-ArCH), 137.2 (i-ArCH/ i’-ArCH), 133.5 
(C(4a)), 132.0 (C(8a)/ C(8a’)), 131.9 (C(8a)/ C(8a’)), 131.1 (C(7)), 130.5 (C(5)), 130.3 (C(4a’)), 
130.2 (C(5’), C(4)), 130.1 (C(7’)), 129.9 (C(4’)), 128.7 (2 × m/m’-ArCH), 128.6 (2 × m/m’-ArCH), 
128.4 (2 × o/o’-ArCH), 128.3 (2 × o/o’-ArCH), 127.5 (C(8)), 127.4 (p’-ArCH, p’-ArCH), 126.3 
(C(8’)), 123.3 (C(1)), 122.8 (C(3)), 120.9 (C(6)), 119.6 (C(3’)), 117.6 (C(6’)), 113.8 (C(1’)), 56.7 (-







7,7'-Dibromo-2'-hydroxy-[1,1'-binaphthalen]-2-yl 2,2-diphenylacetate 65b 
 
Following general procedure C: 6,6'-dibromo-[1,1'-binaphthalene]-2,2'-diol (88.8 mg, 0.2 
mmol) and (+)-BTM (0.5 mg, 0.002 mmol) were added into chloroform (4 mL, 0.05 M) at 
room temperature, giving a clear solution. 2,2-Diphenylacetic pivalic anhydride (32.6 mg, 
0.11 mmol) was added to the previous solution. The resulted clear solution was left stirring 
for 18 hours at room temperature. The solvent was removed in vacuo and the residue was 
purified by column chromatography (Isolera 4, EtOAc in petrol, 0% -> 20% over 30 CV) to 
give 7,7'-dibromo-2'-hydroxy-[1,1'-binaphthalen]-2-yl 2,2-diphenylacetate (61.4 mg, 48.1%) 
as yellow solids. Rf = 0.47 (20% EtOAc in petroleum ether); mp 167-169 °C;  20D  +10.8 (c = 
0.1 in CHCl3); Chiral HPLC analysis, ChiralPak AD-H (10% iPrOH:hexane, flow rate 1.0 mL min-1, 
211 nm, 30 °C), tR major: 22.1 min, tR minor: 29.1 min, 82:18 er; νmax (ATR): 3401 (O-H), 3040 
(C-H), 1730 (C=O), 1493 (C=C), 1144 (C-O); 1H NMR (500 MHz, CDCl3) δH 8.01 (d, J 8.9, 1H, 
C(4)H), 7.83 (d, J 8.7, 1H, C(5)H), 7.80 (d, J 8.9, 1H, C(4’)H), 7.69 (d, J 8.7, 1H, C(5’)H), 7.59 (dd, 
J 8.7, 1.9, 1H, C(6)H), 7.41 (dd, J 8.7, 1.9, 1H, C(6’)H), 7.34 (d, J 8.9, 1H, C(3)H), 7.32 (d, J 1.9, 
1H, C(8)H), 7.21 (d, J 8.9, 1H, C(3’)H), 7.19-7.09 (m, 12H, p-ArCH, p’-ArCH, 2 × m-ArCH, 2 × 
m’-ArCH), 7.08 (d, J 1.9, 1H, C(8’)H), 6.98-6.96 (m, 2H, 2 × o-ArCH), 6.82-6.81 (m, 2H, 2 × o’-
ArCH), 5.22 (s, 1H, -OH), 4.87 (s, 1H, -CHPh2); 13C {1H} NMR (125 MHz, CDCl3) δC: 172.0 (C=O), 
152.8 (C(2’)), 149.0 (C(2)), 137.4 (i/i’-ArCH), 137.2 (i/i’-ArCH), 134.7 (C(8a), C(8a’)), 131.3 
(C(4)), 131.0 (C(4a)), 130.9 (C(4')), 130.3 (C(6)), 130.2 (C(5)), 130.0 (C(5’)), 128.6 (2 × m-ArCH, 
2  × m’-ArCH), 128.5 (2× o/o’-ArCH), 128.3 (2 × o/o’-ArCH), 127.7 (C(4a’)), 127.6 (C(8)), 127.5 
(p’-ArCH, p’-ArCH), 126.4 (C(8’)), 127.3 (C(6’)), 126.3 (C(8’)), 122.6 (C(7’)), 122.2 (C(1)),  122.1 
(C(3)), 121.7 (C(7)), 119.1 (C(3’)), 112.8 (C(1’)), 56.7 (-CH-); HRMS (ASAP+) C34H22Br2O3 [M+H]+ 
found 637.0005, requires 637.0014 (−1.4 ppm) 
 
2'-Hydroxy-7,7'-dimethoxy-[1,1'-binaphthalen]-2-yl 2,2-diphenylacetate 65c 
 
Following general procedure C: 7,7'-dimethoxy-[1,1'-binaphthalene]-2,2'-diol (69.3 mg, 0.2 




room temperature, giving a clear solution. 2,2-Diphenylacetic pivalic anhydride (32.6 mg, 
0.11 mmol) was added to the previous solution. The resulted clear solution was left stirring 
for 18 hours at room temperature. The solution was diluted with EtOAc (10 mL), washed 
with HCl (1 M. 2 × 10 mL), NaHCO3 (sat., 2 × 10 mL) and brine (10 mL). The organic layer was 
dried over MgSO4, filtered and concentrated in vacuo to give a pale brown oil, which was 
purified by column chromatography (Isolera 4, EtOAc in petrol, 0% -> 20% over 40 CV) to 
give 2'-hydroxy-7,7'-dimethoxy-[1,1'-binaphthalen]-2-yl 2,2-diphenylacetate (51.8 mg, 47.9%) 
as white solids; Rf = 0.25 (20% EtOAc in petroleum ether); mp 142-144 °C;  
20
D  −19.8 (c = 
0.1 in CHCl3); Chiral HPLC analysis: ChiralCel OD-H (2% iPrOH:hexane, flow rate 1.0 mL min-1, 
211 nm, 30 °C), tR major: 37.1 min, tR minor: 31.0 min, 93.5:6.5 er; νmax (ATR): 3510 (O-H), 
1748 (C=O), 1620 (C=C), 1113 (C-O); 1H NMR (500 MHz, CDCl3) δH  7.94 (d, J 8.8, 1H, C(4)H), 
7.85 (d, J 8.9, 1H, C(5)H), 7.78 (d, J 8.9, 1H, C(4’)H), 7.74 (d, J 8.9, 1H, C(5’)H), 7.18-7.09 (m, 
9H, C(3)H, C(6)H, p-ArCH, p’-ArCH, 2 × m-ArCH, 2 × m’-ArCH, C(3’)H), 6.99 (dd, J 8.9, 2.5, 1H, 
C(6’)H), 6.88-6.83 (app. 2 × d, J 7.5, 4H, o-ArCH, 2 × o’-ArCH), 6.57 (d, J 2.4, 1H, C(8)H), 6.35 
(d, J 2.4, 1H, C(8)H),  5.09 (s, 1H, -OH), 4.85 (s, 1H, -CHPh2), 3.55 (s, 1H, -OCH3), 3.49 (s, 1H, -
OCH3); 13C {1H} NMR (125 MHz, CDCl3) δC: 172.9 (C=O), 159.1 (C(7)), 158.5 (C(7’)), 152.3 
(C(2’)), 148.8 (C(2)), 137.8 (i-ArCH/ i’-ArCH), 137.6 (i-ArCH/ i’-ArCH), 135.0 (C(8a)), 134.9 
(C(8a’)), 130.6 (C(4)), 0.3 (C(4’)), 130.0 (C(5)), 130.0 (C(5’)), 128.6 (2 × m-ArCH, 2 × m’-ArCH), 
128.5 (2 × o-ArCH/ 2× o’-ArCH), 128.5 (2 × o-ArCH/2 × o’-ArCH), 127.9 (C(1)), 127.3 (p-ArCH/ 
p’-ArCH), 127.2 (p-ArCH/ p’-ArCH), 124.7 (C(1’)), 121.2 (C(4a)), 119.1 (C(3)/ C(6)), 119.0 (C(3)/ 
C(6)), 115.9 (C(6’)), 115.7 (C(3’)), 113.4 (C(4a)), 104.2 (C(8)), 103.7 (C(8’)), 56.9 (-CH-), 55.3 (-
OCH3), 55.2 (-OCH3); HRMS (NSI+) C36H28O5 [M+H]+ found 541.2005, requires 541.2010 (−0.8 
ppm) 
 
10'-Hydroxy-[9,9'-biphenanthren]-10-yl 2,2-diphenylacetate 65e 
 
Following general procedure C: [9,9'-biphenanthrene]-10,10'-diol (77.3 mg, 0.2 mmol) and 
(+)-BTM (5 mg, 0.02 mmol) were added into chloroform (4 mL, 0.05 M) at room temperature, 
giving a clear solution. 2,2-Diphenylacetic pivalic anhydride (32.6 mg, 0.11 mmol) was added 




temperature. The solvent was removed in vacuo and the residue was purified by column 
chromatography (Isolera 4, EtOAc in petrol, 0% -> 10% over 30 CV) to give 10'-hydroxy-[9,9'-
biphenanthren]-10-yl 2,2-diphenylacetate (35.0 mg, 45.3%) as yellow solids. Rf = 0.44 (20% 
EtOAc in petroleum ether); mp 242-244 °C;  20D  −19.3 (c = 0.1 in CHCl3); Chiral HPLC 
analysis, ChiralCel OD-H (5% iPrOH:hexane, flow rate 1.0 mL min-1, 211 nm, 30 °C), tR major: 
18.8 min, tR minor: 23.0 min, 82:18 er; νmax (ATR): 3055 (C-H), 1738 (C=O), 1449 (C=C), 1119 
(C-O); 1H NMR (500 MHz, CDCl3) δH:  8.82 (d, J 8.4, 1H, ArH), 8.79 (d, J 8.4, 2H, ArH), 8.71 (d, J 
8.4, 1H, ArH), 8.41 (d, J 8.1, 1H, ArH), 7.84-7.80 (m, 1H, ArH), 7.79-7.75 (m, 1H, ArH), 7.74-
7.70 (m, 1H, ArH), 7.68-7.65 (m, 1H, ArH), 7.59-7.47 (m, 3H, ArH), 7.41-7.37 (m, 2H, ArH), 
7.33-7.30 (m, 1H, ArH), 7.20-6.56 (m, 11H, ArH), 5.85 (s, 1H, -OH), 5.01 (s, 1H, -CH-); 13C {1H} 
NMR (125 MHz, CDCl3) δC: 137.4, 137.0, 132.1, 131.9, 131.2, 129.8, 128.8, 128.2, 128.0, 
127.8, 127.5, 127.4, 127.3, 127.1, 126.8, 126.7, 126.4, 124.5, 123.9, 123.2, 123.1, 122.8, 
122.7, 122.3, 56.6 (-CH-); HRMS (NSI+) C42H28O3 [M+H]+ found 581.2112, requires 581.2111  
(+0.1 ppm) 
 
Dimethyl 2-(2,2-diphenylacetoxy)-2'-hydroxy-[1,1'-binaphthalene]-3,3'-dicarboxylate 65f 
 
 
Following general procedure B: 6,6'-dibromo-[1,1'-binaphthalene]-2,2'-diol (88.8 mg, 0.2 
mmol) and DMAP (2.4 mg, 0.02 mmol) were added into CH2Cl2 (4 mL, 0.05 M) at room 
temperature, giving a clear solution. Diphenylacetic anhydride (121.8 mg, 0.3 mmol) and 
iPr2NEt (27.9 mg, 35 µL, 0.2 mmol) were added to the previous solution. The resulted clear 
solution was left stirring for 18 hours at room temperature. The concentrated in vacuo and 
the residue was purified by column chromatography (Isolera 4, CH2Cl2 in petrol, 0% -> 50%) 
to give dimethyl 2-(2,2-diphenylacetoxy)-2'-hydroxy-[1,1'-binaphthalene]-3,3'-dicarboxylate 
(30.1 mg, 25%) as yellow solids. Rf = 0.18 (20% EtOAc in petroleum ether); mp 172-174 °C; 
νmax (ATR): 3181 (O-H), 2951 (C-H), 1721 (C=O), 1680 (C=O), 1446 (C=C), 1211 (C-O); 1H NMR 
(500 MHz, CDCl3) δH  10.47 (s, 1H, -OH), 8.76 (s, 1H, C(4)H), 8.46 (s, 1H, C(4’)H), 8.02 (d, J 8.2, 
1H, C(5)H), 7.82 (d, J 8.2, 1H, C(5’)H), 7.52-7.48 (m, 1H, C(6)H), 7.37-7.28 (m, 3H, C(7)H, 
C(6’)H, C(7’)H), 7.15-7.05 (m, 6H, C(8)H, p-ArCH, 2 × m-ArCH, C(8’)H, p’-ArCH), 7.02 (app. s, br, 




1H, -CHPh2), 4.06 (s, 1H, -CH3’), 3.63 (s, 1H, -CH3); 13C {1H} NMR (125 MHz, CDCl3) δC: 170.3 
(C=O), 170.2 (-CO2Me’), 165.6 (-CO2Me), 153.4 (C(2’)), 145.2 (C(2)), 138.3 (i-ArCH/ i’-ArCH), 
137.9 (i-ArCH/ i’-ArCH), 137.0 (C(8a’)), 135.5 (C(8a)), 134.2 (C(4)), 133.5 (C(4’)), 131.1 (C(4a)), 
129.6 (C(5)), 129.5 (C(5’)), 129.1 (C(7)), 128.7 (2 × o/o’-ArCH), 128.4 (2 × m-ArCH), 128.3 (2 × 
m’-ArCH), 128.2 (2 × o/o’-ArCH), 127.0 (p-ArCH), 126.9 (C(4a’)), 126.8 (C(3)), 126.8 (p’-ArCH), 
126.6 (C(6)), 125.9 (C(8)), 125.2 (C(8’)), 124.1 (C(6’)), 122.7 (C(1)), 115.5 (C(1’)), 113.7 (C(3’)), 
56.3 (-CH-), 52.8 (-CH3’), 52.3 (-CH3); HRMS (NSI+) C38H28O7 [M+H]+ found 614.2168, requires 
614.2173  (−0.9 ppm) 
 
2'-Hydroxy-5,5',6,6',7,7',8,8'-octahydro-[1,1'-binaphthalen]-2-yl 2,2-diphenylacetate 69a 
 
Following general procedure C: 5,5',6,6',7,7',8,8'-Octahydro-1,1'-bi-2-naphthol (58.9 mg, 0.2 
mmol) and (+)-BTM (5.0 mg, 0.02 mmol) were added into chloroform (4 mL, 0.05 M) at room 
temperature, giving a clear solution. 2,2-Diphenylacetic pivalic anhydride (32.6 mg, 0.11 
mmol) was added to the previous solution. The resulted clear solution was left stirring for 18 
hours at room temperature. The solution was diluted with EtOAc (10 mL), washed with HCl 
(1 M. 2 × 10 mL), NaHCO3 (sat., 2 × 10 mL) and brine (10 mL). The organic layer was dried 
over MgSO4, filtered and concentrated in vacuo to give a pale brown oil, which was purified 
by column chromatography (Isolera 4, Et2O in petrol, 0% -> 20% over 40 CV) to give 2'-
hydroxy-5,5',6,6',7,7',8,8'-octahydro-[1,1'-binaphthalen]-2-yl 2,2-diphenylacetate (32.6 mg, 
33.4%) as white solids; Rf = 0.17 (10% Et2O in petroleum ether); mp 157-158 °C;  20D  −51.6 
(c = 0.1 in CHCl3); Chiral HPLC analysis; ChiralPak AD-H (5% iPrOH:hexane, flow rate 1.0 mL 
min-1, 211 nm, 30 °C), tR major: 13.3 min, tR minor: 18.8 min, 86:14 er; νmax (ATR): 3512 (O-H), 
2922 (C-H), 1746 (C=O), 1470 (C=C), 1130 (C-O); 1H NMR (500 MHz, CDCl3) δH:  7.23-7.17 (m, 
6H, p-ArH, p’-ArH, 2 × m-ArH, 2 × m’-ArH), 7.12 (d, J 8.3, 1H, C(4)H), 7.04-7.01 (m, 2H, 2 × o’-
ArH), 6.98 (d, J 8.3, 1H, C(4’)H), 6.93-6.91 (m, 2H, 2 × o-ArH), 6.81 (d, J 8.3, 1H, C(3)H), 6.76 
(d, J 8.3, 1H, C(3’)H), 4.97 (s, 1H, -CH-), 4.87 (s, 1H, -OH), 2.81-2.78 (m, 2H, C(5)H2 ), 2.75-2.63 
(m, 2H, C(5’)H2), 2.40-2.34 (m, 1H, C(8)H2a), 2.15-2.05 (m, 2H, C(8)H2b, C(8’)H2a), 1.94-1.88 
(C(8’)H2b), 1.76-1.47 (m, 8H, C(6)H2, C(6’)H2, C(7)H2, C(7’)H2); 13C {1H} NMR (125 MHz, CDCl3) 
δC: 176.4 (C=O), 150.8 (C(2’)), 147.2 (C(2)), 138.6 (C(8a’)), 138.0 (i-ArCH), 138.0 (i’-ArCH), 




128.7 (2 × m/m’/o’-ArCH), 128.6 (2 × m/m’/o’-ArCH), 128.5 (2 × o-ArCH), 128.4 (C(4a’)), 127.3 
(p’-ArCH), 127.2 (p-ArCH), 122.5 (C(1’)), 119.2 (C(3)), 114.3 (C(3’)), 57.1 (-CH-), 29.8 (C(5)), 
29.4 (C(5’)), 27.3 (C(8’)), 27.0 (C(8)), 23.1 (C(6/ 6’/ 7/ 7’)), 23.1 (C(6/ 6’/ 7/ 7’)), 22.9 (C(6/ 6’/ 7/ 






Following general procedure B: 3,3'-Dibromo-5,5',6,6',7,7',8,8'-octahydro-[1,1'-
binaphthalene]-2,2'-diol (90.4 mg, 0.2 mmol) and DMAP (2.4 mg, 0.02 mmol) were added 
into CH2Cl2 (4 mL, 0.05 M) at room temperature, giving a clear solution. Diphenylacetic 
anhydride (121.8 mg, 0.3 mmol) and iPr2NEt (27.9 mg, 35 µL, 0.2 mmol) were added to the 
previous solution. The resulted clear solution was left stirring for 18 hours at room 
temperature. The concentrated in vacuo and the residue was purified by column 
chromatography (Isolera 4, EtOAc in petrol, 0% -> 8% over 35 CV) to give 3,3'-dibromo-2'-
hydroxy-5,5',6,6',7,7',8,8'-octahydro-[1,1'-binaphthalen]-2-yl 2,2-diphenylacetate (58 mg, 
45%) as yellow gum. Rf = 0.31 (20% EtOAc in petroleum ether); νmax (ATR): 3501 (O-H), 2932 
(C-H), 1759 (C=O), 1447 (C=C), 1113 (C-O); 1H NMR (500 MHz, CDCl3) δH 7.39-6.88 (m, 12H, 
ArH), 5.23 (s, 1H, -OH), 5.06 (s, 1H, -CHPh2), 2.80-1.50 (m, 16H, 8 × -CH2); 13C {1H} NMR (125 
MHz, CDCl3) δC: 143.9, 133.2, 133.3, 131.4, 128.9, 128.7, 128.6, 128.4, 127.4, 127.3, 56.5 (-
CHPh2), 29.6 (-CH2), 29.1 (-CH2), 27.1 (-CH2), 26.8 (-CH2), 22.8 (-CH2), 22.7 (-CH2), 22.7 (-CH2), 
22.5 (-CH2); HRMS (NSI+) C34H30Br2O3 [M+H]+ found 662.0896, requires 662.0900  (−0.6 ppm) 
 
6'-Hydroxy-2',3',5,6-tetramethyl-[1,1'-biphenyl]-2-yl 2,2-diphenylacetate 69d 
 
Following general procedure C: 5,5',6,6'-tetramethyl-[1,1'-biphenyl]-2,2'-diol (48.5 mg, 0.2 
mmol) and (+)-BTM (0.5 mg, 0.002 mmol) were added into chloroform (4 mL, 0.05 M) at 




0.11 mmol) was added to the previous solution. The resulted clear solution was left stirring 
for 18 hours at room temperature. The solvent was removed in vacuo and the residue was 
purified by column chromatography (Isolera 4, EtOAc in petrol, 0% -> 20% over 35 CV), to 
give 6'-hydroxy-2',3',5,6-tetramethyl-[1,1'-biphenyl]-2-yl 2,2-diphenylacetate (34.6 mg, 
39.6%) as a colorless gum. Rf = 0.38 (20% EtOAc in petroleum ether);  20D  −43.1 (c = 0.1 in 
CHCl3); Chiral HPLC analysis, ChiralPak AD-H (2% iPrOH:hexane, flow rate 1.0 mL min-1, 211 
nm, 30 °C), tR major: 55.6 min, tR minor: 43.5 min, 93.5:6.5 er; νmax (ATR): 3503 (O-H), 3028 
(C-H), 1748 (C=O), 1454 (C=C), 1123 (C-O); 1H NMR (500 MHz, CDCl3) δH:  7.23-7.20 (m, 7H, 
C(4)H, p-ArH, p’-ArH, 2 × m-ArH, 2 × m’-ArH), 7.05 (d, J 8.2, 1H, C(4’)H), 7.01-6.99 (m, 2H, 2 × 
o-ArH), 6.94-6.92 (m, 2H, 2 × o’-ArH), 6.84 (d, J 8.2, 1H, C(3)H), 6.75 (d, J 8.2, 1H, C(5’)H), 
4.93(m, 1H, -CH-), 4.71 (s, 1H, -OH), 2.31 (s, 3H, -C(5)-CH3), 2.17 (s, 3H, -C(3’)-CH3), 1.89 (s, 
3H, -C(6)-CH3), 1.67 (s, 3H, -(2’)-CH3); 13C {1H} NMR (125 MHz, CDCl3) δC: 172.2 (C=O), 151.3 
(C(6’)), 147.7 (C(2)), 138.5 (C(6)), 138.0 (i-ArCH), 138.0 (i’-ArCH) 136.0 (C(2’)), 135.7 (C(5)), 
130.8 (C(4)), 130.5 (C(4’)), 129.0 (C(3’)), 128.8 (C(1)), 128.7 (2 × m-ArCH), 128.7 (2 × m’-ArCH), 
128.6 (2 × o-ArCH), 128.5 (2 × o’-ArCH), 127.3 (p-ArCH), 127.2 (p’-ArCH), 123.6 (C(1’)), 119.3 
(C(3)), 113.7 (C(5’)), 57.0 (-CH-), 20.5 (-C(5)-CH3), 20.1 (-C(3’)-CH3), 16.5 (-C(2’)-CH3), 16.3 (-
C(6)-CH3); HRMS (NSI+) C30H28O3 [M+H]+ found 454.2374, requires 454.2377  (−0.6 ppm) 
 
3',5-Dichloro-6'-hydroxy-2',4,4',6-tetramethyl-[1,1'-biphenyl]-2-yl 2,2-diphenylacetate 69e 
 
Following general procedure C: 5,5'-dichloro-4,4',6,6'-tetramethyl-[1,1'-biphenyl]-2,2'-diol 
(62.2 mg, 0.2 mmol) and (+)-BTM (0.5 mg, 0.002 mmol) were added into chloroform (4 mL, 
0.05 M) at room temperature, giving a clear solution. 2,2-Diphenylacetic pivalic anhydride 
(32.6 mg, 0.11 mmol) was added to the previous solution. The resulted clear solution was 
left stirring for 18 hours at room temperature. The solvent was removed in vacuo and the 
residue was purified by column chromatography (Isolera 4, EtOAc in petrol, 0% -> 10% over 
20 CV then 10% -> 10% over 10 CV), to give 3',5-dichloro-6'-hydroxy-2',4,4',6-tetramethyl-
[1,1'-biphenyl]-2-yl 2,2-diphenylacetate (40.5 mg, 40.1%) as a colorless gum. Rf = 0.54 (20% 
EtOAc in petroleum ether);  20D  +15.8 (c = 0.1 in CHCl3); Chiral HPLC analysis, ChiralCel OD-




36.7 min, 81.5:18.5 er; νmax (ATR): 3480 (O-H), 2924 (C-H), 1751 (C=O), 1454 (C=C), 1123 (C-
O); 1H NMR (500 MHz, CDCl3) δH:  7.25-7.21 (m, 6H, p-ArH, p’-ArH, 2 × m-ArH, 2 × m’-ArH), 
7.06-7.05 (m, 2H, 2 × o-ArH), 7.00-6.98 (m, 2H, 2 × o’-ArH), 6.89 (s, 1H, C(3)H), 6.66 (s, 1H, 
C(5’)H), 4.95 (m, 1H, -CH-), 4.73 (s, 1H, -OH), 2.43 (s, 3H, -C(4)-CH3), 2.36 (s, 3H, -C(4’)-CH3), 
2.04 (s, 3H, -C(6)-CH3), 1.84 (s, 3H, -(2’)-CH3); 13C {1H} NMR (125 MHz, CDCl3) δC: 172.0 (C=O), 
151.2 (C(6’)), 147.4 (C(2)), 138.5 (C(6)), 138.2 (C(4)), 137.5 (i-ArCH), 137.5 (i’-ArCH), 137.5 
(C(2’)), 135.6 (C(4’)), 133.6 (C(5)), 128.7 (2 × m-ArCH), 128.7 (2 × m’-ArCH), 128.5 (2 × o-
ArCH), 128.4 (2 × o’-ArCH), 127.5 (p-ArCH), 127.4 (C(3’)), 127.4 (p’-ArCH), 127.0 (C(1)), 122.1 
(C(3)), 121.8 (C(1’)), 116.7 (C(5’)), 56.9 (-CH-), 21.7 (-C(4)-CH3), 21.2 (-C(4’)-CH3), 17.8 (-C(6)-
CH3), 17.8 (-C(2’)-CH3); HRMS (ASAP+) C30H26Cl2O3 [M+H]+ found 505.1335, requires 505.1337  
(−0.4 ppm) 
 
2'-Methoxy-[1,1'-binaphthalen]-2-yl 2,2-diphenylacetate 72a 
 
Following general procedure C: 2'-methoxy-[1,1'-binaphthalen]-2-ol (60.1 mg, 0.2 mmol) and 
(+)-BTM (2.5 mg, 0.01 mmol) were added into chloroform (4 mL, 0.05 M) at room 
temperature, giving a clear solution. 2,2-Diphenylacetic pivalic anhydride (32.6 mg, 0.11 
mmol) was added to the previous solution. The resulted clear solution was left stirring for 18 
hours at room temperature. The solvent was removed in vacuo and the residue was purified 
by column chromatography (Isolera 4, EtOAc in petrol, 0% -> 10% over 30 CV) to give 2'-
methoxy-[1,1'-binaphthalen]-2-yl 2,2-diphenylacetate (18.1 mg, 18.3%) as a colorless gum. Rf 
= 0.44 (20% EtOAc in petroleum ether);  20D  +4.5 (c = 0.1 in CHCl3); Chiral HPLC analysis, 
ChiralPak AD-H (5% iPrOH:hexane, flow rate 1.0 mL min-1, 211 nm, 30 °C), tR major: 26.8 min, 
tR minor: 38.7 min, 62:38 er; νmax (ATR): 3061 (C-H), 1755 (C=O), 1454 (C=C), 1115 (C-O); 1H 
NMR (500 MHz, CDCl3) δH:  7.98-7.92 (m, 3H, C(4)H, C(4’)H, C(5)H), 7.88 (d, J 8.2, 1H, C(5’)H), 
7.46-7.43 (m, 1H, C(6)H), 7.39 (d, J 8.9, 1H, C(3)H), 7.37-7.34 (m, 1H, C(6’)H), 7.29-7.26 (m, 
2H, C(3’)H, C(7)H), 7.24-7.20 (m, 2H, C(7’)H, C(8)H), 7.19-7.12 (m, 5H, C(8’)H, p-ArH, p’-ArH, 2 
× m-ArH), 7.09-7.05 (m, 2H, 2 × m’-ArH), 6.94-6.92 (m, 2H, 2 × o-ArH), 6.80-6.78 (m, 2H, 2 × 
o’-ArH), 4.82 (s, 1H, -CH-), 3.56 (s, 3H, -CH3); 13C {1H} NMR (125 MHz, CDCl3) δC: 170.8 ( C=O), 
155.0 (C(2’)), 147.0 (C(2)), 138.2 (i-ArCH/ i’-ArCH), 138.0 (i’-ArCH/ i-ArCH), 133.8 (C(8a), 




m-ArCH, 2× m’-ArCH), 128.3 (2× o’-ArCH), 128.2 (C(5)), 127.9 (C(5’)), 127.2 (p-ArCH), 127.0 
(p’-ArCH), 126.8 (C(7’)/ C(7)), 126.5 (C(7)/ C(7’)), 126.3 (C(8)), 125.7 (C(6)), 125.5 (C(8’)), 
125.4 (C(1)), 123.8 (C(6’)), 121.8 (C(3)), 117.5 (C(1’)), 113.8 (C(3’)), 56.9 (-CH-), 56.6 (-CH3); 
HRMS (NSI+) C35H26O3 [M+NH4]+ found 512.2214, requires 512.2220  (−1.2 ppm) 
 
2'-(Allyloxy)-[1,1'-binaphthalen]-2-yl 2,2-diphenylacetate 72b 
 
Following general procedure B: 2'-(allyloxy)-[1,1'-binaphthalen]-2-ol (65.3 mg, 0.2 mmol) and 
DMAP (2.4 mg, 0.02 mmol) were added into CH2Cl2 (4 mL, 0.05 M) at room temperature, 
giving a clear solution. Diphenylacetic anhydride (121.8 mg, 0.3 mmol) and iPr2NEt (27.9 mg, 
35 µL, 0.2 mmol) were added to the previous solution. The resulted clear solution was left 
stirring for 18 hours at room temperature. The concentrated in vacuo and the residue was 
purified by column chromatography (Isolera 4, EtOAc in petrol, 0% -> 10% over 20 CV) to 
give 2'-(allyloxy)-[1,1'-binaphthalen]-2-yl 2,2-diphenylacetate (107 mg, 100%) as colorless 
gum. Rf = 0.5 (20% EtOAc in petroleum ether); νmax (ATR): 3059 (C-H), 1751 (C=O), 1591 (C=C), 
1262 (C-O), 1113 (C-O); 1H NMR (500 MHz, CDCl3) δH:  7.95 (d, J 8.9, 1H, C(4)H), 7.93-8.89 (m, 
2H, C(5)H, C(4’)H), 7.86 (d, J 8.1, 1H, C(5’)H), 7.46-7.42 (m, 1H, C(6)H), 7.37 (d, J 8.9, 1H, 
C(3)H), 7.37-7.34 (m, 1H, C(6’)H), 7.27-7.10 (m, 9H, C(3’)H, C(7)H, C(7’)H, C(8)H, C(8’)H, p-ArH, 
p’-ArH, 2 × m-ArH), 7.07-7.03 (m, 2H, 2 × m’-ArH), 6.93-6.90 (m, 2H, 2 × o-ArH), 6.76-6.74 (m, 
2H, 2 × o’-ArH), 5.69-5.61 (m, 1H, -CH=CH2), 4.96-4.92 (m, 2H, -CH=CH2), 4.81 (s, 1H, -CH-), 
4.27 (ddt, J 13.9, 5.0, 1.7, 2H, -CH2-); 13C {1H} NMR (125 MHz, CDCl3) δC: 170.7 ( C=O), 154.1 
(C(2’)), 146.9 (C(2)), 138.1 (i-ArCH/ i’-ArCH), 138.0 (i’-ArCH/ i-ArCH), 133.9 (C(8a)/C(8a’)), 
133.8 (C(8a’)/C(8a)), 133.7 (-CH=CH2), 131.9 (C(4a)), 130.0 (C(4’)),  129.3 (C(4a’)), 129.1 (C(4)), 
128.7 (2 × o-ArCH), 128.5 (2 × m-ArCH, 2 × m’-ArCH), 128.3 (2 × o’-ArCH), 128.2 (C(5)), 127.9 
(C(5’)), 127.2 (p-ArCH), 127.0 (p’-ArCH), 126.8 (C(7’)), 126.5 (C(7)), 126.3 (C(8)), 125.6 (C(6), 
C(8’)), 125.4 (C(1)), 123.9 (C(6’)), 121.7 (C(3)), 118.3 (C(1’)), 116.6 (-CH=CH2), 115.5 (C(3’)), 









2'-((Tert-butoxycarbonyl)amino)-[1,1'-binaphthalen]-2-yl 2,2-diphenylacetate 77 
 
Following general procedure C: Crude tert-butyl (2'-hydroxy-[1,1'-binaphthalen]-2-
yl)carbamate (64.6 mg, 0.2 mmol) and (+)-BTM (2.5 mg, 0.01 mmol) were added into 
chloroform (4 mL, 0.05 M) at room temperature, giving a clear solution. 2,2-Diphenylacetic 
pivalic anhydride (32.6 mg, 0.11 mmol) was added to the previous solution. The resulted 
clear solution was left stirring for 18 hours at room temperature. The solvent was removed 
in vacuo and the residue was purified by column chromatography (Isolera 4, EtOAc in petrol, 
0% -> 8% over 35 CV) to give 2'-((tert-butoxycarbonyl)amino)-[1,1'-binaphthalen]-2-yl 2,2-
diphenylacetate (42.6 mg, 36.7%) as a black gum. Rf = 0.24 (10% EtOAc in petroleum ether); 
Chiral HPLC analysis, ChiralPak AD-H (2% iPrOH:hexane, flow rate 1.0 mL min-1, 211 nm, 
30 °C), tR major: 16.4 min, tR minor: 62.2 min, 88.5:11.5 er; νmax (ATR): 3414 (C=O), 2978 (C-
H), 1726 (C=O), 1495 (C=C), 1155 (C-O); 1H NMR (500 MHz, CDCl3) δH:   8.02 (d, J = 8.8 Hz, 1H, 
C(4)H), 7.94 (d, J = 8.0 Hz, 1H, C(5)H), 7.91 (d, J = 9.2 Hz, 1H, C(4’)H), 7.85 (d, J = 8.1 Hz, 1H, 
C(5’)H), 7.50-7.47 (m, 1H, C(6)H), 7.39-7.35 (m, 1H, C(6’)H), 7.32 (d, J = 8.7 Hz, 1H, C(3)H), 
7.32-7.29 (m, 1H, C(7)H), 7.22-7.07 (m, 9H, C(8)H, C(7’)H, C(3’)H, p-ArH, p’-ArH, 2 × m-ArH, 2 
× m’-ArH), 7.02 (d, J = 8.5 Hz, 1H, C(8’)H), 6.87-6.85 (m, 2H, 2 × o-ArH), 6.75-6.73 (m, 2H, 2 × 
o’-ArH), 6.29 (s, 1H, -NH-), 4.81 (s, 1H, -OH), 1.28 (s, 9H, 3 ×-CH3); 13C{1H} NMR (125 MHz, 
CDCl3) δC: 171.3 (-COCHPh2), 153.1 (-CONHAr), 147.3 (C(2)), 137.6 (i/i’-ArCH), 135.2 (C(2’)), 133.1 
(C(8a)), 132.5 (C(8a’)), 132.2 (C(4a)), 130.6 (C(4)), 130.6 (C(4a’)), 129.3 (C(4’)), 128.6 (2 × m-ArCH, 
2 × m’-ArCH), 128.5 (2 × o-ArCH), 128.4 (C(5), 2 × m’-ArCH), 128.0 (C(5’)), 127.5 (C(7)), 127.3 (p-
ArCH), 127.2 (p’-ArCH), 126.6 (C(7’)), 126.3 (C(6)), 125.9 (C(8)), 125.4 (C(8’)), 124.9 (C(1), C(1’)), 












Preparation of diesters: 
 
[1,1'-Binaphthalene]-2,2'-diyl diacetate  
 
Following general procedure B: BINOL (57.3 mg, 0.2 mmol) and DMAP (2.4 mg, 0.02 mmol) 
were added into CH2Cl2 (4 mL, 0.05 M) at room temperature, giving a clear solution. Acetic 
anhydride (30.6 mg, 28 µL, 0.3 mmol) and iPr2NEt (27.9 mg, 35 µL, 0.2 mmol) were added to 
the previous solution. The resulted clear solution was left stirring for 18 hours at room 
temperature. The solution was diluted with EtOAc (10 mL), washed with HCl (1 M. 2 × 10 mL), 
NaHCO3 (sat., 2 × 10 mL) and brine (10 mL). The organic layer was dried over MgSO4, filtered 
and concentrated in vacuo, to give pale brown gum, which was purified by column 
chromatography (Isolera 4, EtOAc in petrol, 0% -> 20% over 20 CV) to give [1,1'-
binaphthalene]-2,2'-diyl diacetate (16.1 mg, 22%) as white solids; Rf = 0.31 (20% EtOAc in 
petroleum ether); mp 104-105.5  °C; νmax (ATR): 2922 (C-H), 1753 (C=O), 1504 (C=C), 1186 (C-
O); 1H NMR (500 MHz, CDCl3) δH:  8.00 (d, J 8.9, 2H, C(4)H, C(4’)H), 7.93 (d, J 8.3, 2H, C(5)H, 
C(5’)H), 7.48-7.45 (m, 2H, C(6)H, C(6’)H), 7.43 (d, J 8.9, 2H, C(3)H, C(3’)H), 7.30-7.27 (m, 2H, 
C(7)H, C(7’)H), 7.18 (d, J 8.5, 2H, C(8)H, C(8’)H), 1.86 (s, 6H, 2 × -CH3); 13C {1H} NMR (125 MHz, 
CDCl3) δC: 169.6 (2 × C=O), 146.9 (C(2), C(2’)), 133.5 (C(8a), C(8a’)), 131.7 (C(4a), C(4a’)), 
129.7 (C(4), C(4’), 128.2 (C(5), C(5’)), 126.9 (C(7), C(7’)), 126.3 (C(8), C(8’)), 125.9 (C(6), C(6’)), 
123.5 (C(1), C(1’)), 122.0 (C(3), C(3’)), 20.8 ( 2 × -CH3); HRMS (ASAP+) C24H18O4 [M+H]+ found 




Following general procedure B: BINOL (57.3 mg, 0.2 mmol) and DMAP (2.4 mg, 0.02 mmol) 
were added into tert-Amyl alcohol (4 mL, 0.05 M) at room temperature, giving a clear 
solution. Propionic anhydride (67.9 mg, 0.3 mmol) and iPr2NEt (27.9 mg, 35 µL, 0.2 mmol) 
were added to the previous solution. The resulted clear solution was left stirring for 18 hours 




× 10 mL), NaHCO3 (sat., 2 × 10 mL) and brine (10 mL). The organic layer was dried over 
MgSO4, filtered and concentrated in vacuo, to give pale brown oil, which was purified by 
column chromatography (Isolera 4, EtOAc in petrol, 0% -> 20% over 20 CV) to give [1,1'-
binaphthalene]-2,2'-diyl dipropionate (39.2 mg, 49%) as white solids, Rf = 0.38 (20% EtOAc in 
petroleum ether); mp 107-108 °C [lit  105 °C]; νmax (ATR): 2980 (C-H), 1751 (C=O), 1460 (C=C), 
1173 (C-O); 1H NMR (500 MHz, CDCl3) δH:  7.99 (d, J 8.9, 2H, C(4)H, C(4’)H), 7.93 (d, J 8.3, 2H, 
C(5)H, C(5’)H), 7.47-7.44 (m, 2H, C(6)H, C(6’)H), 7.42 (d, J 8.9, 2H, C(3)H, C(3’)H), 7.31-7.28 
(m, 2H, C(7)H, C(7’)H), 7.22 (d, J 8.6, 2H, C(8)H, C(8’)H), 2.14-2.05 ( m, 4H, 2 × -CH2CH3), 0.71 
(d, J 7.6, 6H, 2 × -CH2CH3); 13C {1H} NMR (125 MHz, CDCl3) δC: 172.8 (2 × C=O), 146.9 (C(2), 
C(2’)), 133.5 (C(8a), C(8a’)), 131.6 (C(4a), C(4a’)), 129.5 (C(4), C(4’), 128.1 (C(5), C(5’)), 126.8 
(C(7), C(7’)), 126.3 (C(8), C(8’)), 125.8 (C(6), C(6’)), 123.6 (C(1), C(1’)), 122.1 (C(3), C(3’)), 27.6 
(2 × -CH2-), 8.7 (2 × -CH3); HRMS (ASAP+) C26H22O4 [M+H]+ found 399.1597, requires 399.1596 




Following general procedure B: BINOL (57.3 mg, 0.2 mmol) and DMAP (2.4 mg, 0.02 mmol) 
were added into CH2Cl2 (4 mL, 0.05 M) at room temperature, giving a clear solution. 
Isobutyric anhydride (47.5 mg, 49.7 µL, 0.3 mmol) and iPr2NEt (27.9 mg, 35 µL, 0.2 mmol) 
were added to the previous solution. The resulted clear solution was left stirring for 18 hours 
at room temperature. The solution was diluted with EtOAc (10 mL), washed with HCl (1 M, 2 
× 10 mL), NaHCO3 (sat., 2 × 10 mL) and brine (10 mL). The organic layer was dried over 
MgSO4, filtered and concentrated in vacuo, to give pale brown oil, which was purified by 
column chromatography (Isolera 4, EtOAc in petrol, 0% -> 20% over 20 CV) to give [1,1'-
binaphthalene]-2,2'-diyl bis(2-methylpropanoate) (23.7 mg, 28%) as white solids, Rf = 0.56 
(20% EtOAc in petroleum ether); mp 72-73 °C; νmax (ATR): 2976 (C-H), 1749 (C=O), 1465 (C=C), 
1111 (C-O); 1H NMR (500 MHz, CDCl3) δH 7.98 (d, J 8.9, 2H, C(4)H, C(4’)H), 7.92 (d, J 8.3, 2H, 
C(5)H, C(5’)H), 7.47-7.44 (m, 2H, C(6)H, C(6’)H), 7.41 (d, J 8.8, 2H, C(3)H, C(3’)H), 7.32-7.26 
(m, 4H, C(7)H, C(7’)H, C(8)H, C(8’)H), 2.33 (sept, J 7.0, 2H, -CH(CH3)2), 0.71 (d, J 7.0, 6H, -CH3), 
0.62 (d, J 7.0, 6H, -CH3); 13C {1H} NMR (125 MHz, CDCl3) δC: 175.1 (2 × C=O), 146.8 (C(2), C(2’)), 
133.4 (C(8a), C(8a’)), 131.5 (C(4a), C(4a’)), 129.3 (C(4), C(4’)), 127.9 (C(5), C(5’)), 126.7 (C(7), 




CH(CH3)2), 18.2 (-CH3), 18.1 (-CH3); HRMS (ASAP+) C28H26O4 [M+H]+ found 427.1910, requires 




Following general procedure B: BINOL (57.3 mg, 0.2 mmol) and DMAP (2.4 mg, 0.02 mmol) 
were added into CH2Cl2 (4 mL, 0.05 M) at room temperature, giving a clear solution. 3-
Methylbutanoic anhydride (55.9 mg, 0.3 mmol) and iPr2NEt (27.9 mg, 35 µL, 0.2 mmol) were 
added to the previous solution. The resulted clear solution was left stirring for 18 hours at 
room temperature. The solution was diluted with EtOAc (10 mL), washed with HCl (1 M. 2 × 
10 mL), NaHCO3 (sat., 2 × 10 mL) and brine (10 mL). The organic layer was dried over MgSO4, 
filtered and concentrated in vacuo, to give pale brown oil, which was purified by column 
chromatography (Isolera 4, EtOAc in petrol, 0% -> 20% over 20 CV) to give [1,1'-
binaphthalene]-2,2'-diyl bis(3-methylbutanoate) (32.7 mg, 36%) as colorless crystals; Rf = 
0.59 (20% EtOAc in petroleum ether); mp 82-83 °C; νmax (ATR): 2957 (C-H), 1755 (C=O), 1510 
(C=C), 1076 (C-O); 1H NMR (500 MHz, CDCl3) δH:  7.98 (d, J 8.9, 2H, C(4)H, C(4’)H), 7.91 (d, J 
8.3, 2H. C(5)H, C(5’)H), 7.46-7.43 (m, 2H, C(6)H, C(6’)H), 7.39 (d, J 8.9, 2H, C(3)H, C(3’)H), 
7.30-7.27 (m, 2H, C(7)H, C(7’)H), 7.22 (d, J 8.4, 2H, C(8)H, C(8’)H), 2.03-1.94 (m, 4H, 2  × –
CH2-), 1.64 (sept, J 6.8, 2H, 2× -CH-), 0.56 (d, J 6.6, 6H, 2 × -CH3), 0.55 (d, J 6.6, 6H, 2 × -CH3); 
13C {1H} NMR (125 MHz, CDCl3) δC: 171.4 (2 × C=O), 146.9 (C(2), C(2’)), 133.5 (C(8a), C(8a’)), 
131.7 (C(4a), C(4a’)), 129.6 (C(4), C(4’), 128.0 (C(5), C(5’)), 126.8 (C(7), C(7’)), 126.4 (C(8), 
C(8’)), 125.8 (C(6), C(6’)), 123.8 (C(1), C(1’)), 122.0 (C(3), C(3’)), 43.0 (2 × -CH2-), 25.5 (2 × -CH-
), 22.0 (2 × -CH3), 22.0 (2 × -CH3); HRMS (ASAP+) C30H30O4 [M+H]+ found 455.2227, requires 




Following general procedure B: BINOL (57.3 mg, 0.2 mmol) and DMAP (2.4 mg, 0.02 mmol) 




Phenylacetic anhydride (76.3 mg, 0.3 mmol) was added to the previous solution. The 
resulted clear solution was left stirring for 18 hours at room temperature. The crude oil was 
purified by column chromatography (Isolera 4, EtOAc in petrol, 0% -> 10% over 20 CV then 
10% - 20% over 10 CV) to give [1,1'-binaphthalene]-2,2'-diyl bis(2-phenylacetate) (69.1 mg, 
66%) as colorless gum; Rf = 0.39 (20% EtOAc in petroleum ether); νmax (ATR) 2980 (C-H), 1748 
(C=O), 1497 (C=C), 1125 (C-O); 1H NMR (500 MHz, CDCl3) δH:  7.95 (d, J 8.9, 2H, C(4)H, C(4’)H), 
7.91 (d, J 8.2, 2H, C(5)H, C(5’)H), 7.47-7.43 (m, 2H, C(6)H, C(6’)H), 7.36 (d, J 8.9, 2H, C(3)H, 
C(3’)H), 7.26-7.22 (m, 2H, C(7)H, C(7’)H), 7.15-7.04 (m, 8H, C(8)H, C(8’)H, 4 × m-ArH, 2 × p-
ArH), 6.83-6.80 (m, 4H, 4 × o-ArH), 3.40 (d, J 17.5, 2H, -CH2), 3.36 (d, J 17.5, 2H, -CH2); 13C {1H} 
NMR (125 MHz, CDCl3) δC: 170.0 (2 × C=O), 146.8 (C(2), C(2’)), 133.4 (C(8a), C(8a’)), 133.1 (2 × 
i-ArCH), 131.7 (C(4a), C(4a’)), 129.6 (C(4), C(4’), 129.2 (4 × o-ArCH), 128.4 (4 × m-ArCH), 128.1 
(C(5), C(5’)), 126.9 (2 × p-ArCH), 126.9 (C(7), C(7’)), 126.2 (C(8), C(8’)), 125.8 (C(6), C(6’)), 
123.4 (C(1), C(1’)), 121.9 (C(3), C(3’)), 40.9 (2 × -CH2-); HRMS (ASAP+) C36H26O4 [M+H]+ found 
523.1916, requires 523.1909 (+1.3 ppm) 
 
 [1,1'-Binaphthalene]-2,2'-diyl bis(3-phenylpropanoate) 
 
Following general procedure B: BINOL (57.3 mg, 0.2 mmol) and DMAP (2.4 mg, 0.02 mmol) 
were added into CH2Cl2 (4 mL, 0.05 M) at room temperature, giving a clear solution. 3-
phenylpropionic anhydride (84.7 mg, 0.3 mmol) and iPr2NEt (27.9 mg, 35 µL, 0.2 mmol) were 
added to the previous solution. The resulted clear solution was left stirring for 18 hours at 
room temperature. The solution was diluted with EtOAc (10 mL), washed with HCl (1 M. 2 × 
10 mL), NaHCO3 (sat., 2 × 10 mL) and brine (10 mL). The organic layer was dried over MgSO4, 
filtered and concentrated in vacuo, to give pale brown oil, which was purified by column 
chromatography (Isolera 4, EtOAc in petrol, 0% -> 20% over 30 CV), giving) to give [1,1'-
binaphthalene]-2,2'-diyl bis(3-phenylpropanoate) (19.4 mg, 18%) as white gum; Rf = 0.45 
(20% EtOAc in petroleum ether); νmax (ATR): 2890 (C-H), 1755 (C=O), 1454 (C=C), 1122 (C-O); 
1H NMR (500 MHz, CDCl3) δH: 7.98 (d, J 8.9, 2H, C(4)H, C(4’)H), 7.93 (d, J 8.2, 2H, C(5)H, 
C(5’)H), 7.49-7.46 (m, 2H, C(6)H, C(6’)H), 7.37 (d, J 8.8, 2H, C(3)H, C(3’)H), 7.32-7.29 (m, 2H, 
C(7)H, C(7’)H), 7.24 (d, J 8.3, 2H, C(8)H, C(8’)H), 7.21-7.18 (m, 4H, 4 × m-ArH), 7.16-7.12 (m, 
2H, 2 × p-ArH), 7.00-6.96 (m, 4H, 4 × o-ArH), 2.51-2.34 (m, 8H, 4 × -CH2-); 13C NMR (125 MHz, 




(C(4a), C(4a’)), 129.7 (C(4), C(4’), 128.5 (4 × m-ArCH), 128.3 (4 × o-ArCH), 128.2 (C(5), C(5’)), 
126.9 (C(7), C(7’)), 126.3 (2 × p-ArCH), 126.3 (C(8), C(8’)), 125.9 (C(6), C(6’)), 123.6 (C(1), 
C(1’)), 122.0 (C(3), C(3’)), 35.6 (-CO-CH2-), 30.5 (-CH2-Ph); HRMS (ASAP+) C38H30O4 [M+H]+ 




Following general procedure B: BINOL (57.3 mg, 0.2 mmol) and DMAP (2.4 mg, 0.02 mmol) 
were added into CH2Cl2 (4 mL, 0.05 M) at room temperature, giving a clear solution. (E)-
Cinnamic anhydride (83.5 mg, 0.3 mmol) and iPr2NEt (27.9 mg, 35 µL, 0.2 mmol) were added 
to the previous solution. The resulted clear solution was left stirring for 18 hours at room 
temperature. The solution was diluted with EtOAc (10 mL), washed with HCl (1 M. 2 × 10 mL), 
NaHCO3 (sat., 2 × 10 mL) and brine (10 mL). The organic layer was dried over MgSO4, filtered 
and concentrated in vacuo, to give pale brown oil, which was purified by column 
chromatography (Isolera 4, EtOAc in petrol, 0% -> 20% over 20 CV) to give [1,1'-
binaphthalene]-2,2'-diyl (2E,2'E)-bis(3-phenylacrylate) (26.8 mg, 25%) as colorless crystals, Rf 
= 0.44 (20% EtOAc in petroleum ether); mp 211-212 °C; νmax (ATR): 2890 (C-H), 1736 (C=O), 
1632 (C=C), 1449 (C=C aromatic) 1117 (C-O); 1H NMR (500 MHz, CDCl3) δH:  7.99 (d, J 8.9, 2H, 
C(4)H, C(4’)H), 7.93 (d, J 8.2, 2H, C(5)H, C(5’)H), 7.54 (d, J 8.8, 2H, C(3)H, C(3’)H), 7.49-7.45 (m, 
2H, C(6)H, C(6’)H), 7.36-7.30 (m, 16H, C(8)H, C(8’)H, C(7)H, C(7’)H, 4 × o-ArH, 4 × m-ArH, 2 × 
p-ArH, 2 × -CO-CH=CH-Ph), 6.22 (d, J 16.0, 2H, 2 × -CO-CH=CH-Ph); 13C {1H} NMR (125 MHz, 
CDCl3) δC: 165.1 (2 × C=O), 147.0 (C(2), C(2’)), 146.3 (2 × -CO-CH=CH-Ph), 134.3 (2 × i-ArCH), 
133.6 (C(8a), C(8a’)), 131.7 (C(4a), C(4a’)), 130.6 (2 × p-ArCH), 129.6 (C(4), C(4’), 128.9 (4 × m-
ArCH), 128.4 (4 × o-ArCH), 128.2 (C(5), C(5’)), 126.9 (C(7), C(7’)), 126.3 (C(8), C(8’)), 125.8 
(C(6), C(6’)), 123.7 (C(1), C(1’)), 122.0 (C(3), C(3’)), 117.0 2 × -CO-CH=CH-Ph); HRMS (ASAP+) 












Following general procedure B: BINOL (57.3 mg, 0.2 mmol) and DMAP (2.4 mg, 0.02 mmol) 
were added into CH2Cl2 (4 mL, 0.05 M) at room temperature, giving a clear solution. Benzoic 
anhydride (67.9 mg, 0.3 mmol) and iPr2NEt (27.9 mg, 35 µL, 0.2 mmol) were added to the 
previous solution. The resulted clear solution was left stirring for 18 hours at room 
temperature. The solution was diluted with EtOAc (10 mL), washed with HCl (1 M. 2 × 10 mL), 
NaHCO3 (sat., 2 × 10 mL) and brine (10 mL). The organic layer was dried over MgSO4, filtered 
and concentrated in vacuo, to give pale brown oil, which was purified by column 
chromatography (Isolera 4, EtOAc in petrol, 0% -> 20% over 20 CV), to give [1,1'-
binaphthalene]-2,2'-diyl dibenzoate (18.9 mg, 19%) as white crystals, Rf = 0.32 (20% EtOAc in 
petroleum ether); mp 156.5-158 °C [lit1 162-165 °C]; νmax (ATR): 1730 (C=O), 1600 (C=C, 
aromatic), 1204 (C-O); 1H NMR (500 MHz, CDCl3) δH:  7.98 (d, J 9.1, 2H, C(4)H, C(4’)H), 7.90 (d, 
J 8.4, 2H, C(5)H, C(5’)H), 7.65-7.63 (m, 4H, 4 × o-ArCH), 7.56 (d, J 8.7, 2H, C(3)H, C(3’)H), 7.46-
7.42 (m, 4H, C(6)H, C(6’)H, 2 × p-ArH), 7.40-7.38 (m, 2H, C(8)H, C(8’)H), 7.35-7.31 (m, 2H, 
C(7)H, C(7’)H), 7.27-7.23 (m, 4H, 4 × m-ArCH);  13C {1H} NMR (125 MHz, CDCl3) δC: 164.9 (2 × 
C=O), 147.1 (C(2), C(2’)), 133.5 (C(8a), C(8a’)), 133.3 (2 × p-ArCH), 131.7 (C(4a), C(4a’)), 130.0 
(4 × o-ArCH), 129.7 (C(4), C(4’), 129.4 (2× i-ArCH), 128.4 (4 × m-ArCH), 128.2 (C(5), C(5’)), 
127.0 (C(7), C(7’)), 126.2 (C(8), C(8’)), 125.8 (C(6), C(6’)), 123.8 (C(1), C(1’)), 121.9 (C(3), C(3’)); 
HRMS (NSI+) C34H22O4 [M+H]+ found 495.1584, requires 495.1591 (−1.4 ppm). Data in 




Following general procedure B: BINOL (57.3 mg, 0.2 mmol) and DMAP (2.4 mg, 0.02 mmol) 
were added into CH2Cl2 (4 mL, 0.05 M) at room temperature, giving a clear solution. 4-
Bromobenzoic anhydride (115 mg, 0.3 mmol) was added to the previous solution. The 
resulted clear solution was left stirring for 18 hours at room temperature. The crude oil was 




10% - 20% over 10 CV) to give [1,1'-binaphthalene]-2,2'-diyl bis(4-bromobenzoate) (40.9 mg, 
31%) as white solids; Rf = 0.5 (20% EtOAc in petroleum ether); mp 206.5-207.5 °C; νmax (ATR): 
3050 (C-H), 1732 (C=O), 1520 (C=C) 1206 (C-O); 1H NMR (500 MHz, CDCl3) δH:  7.99 (d, J 8.9, 
2H, C(4)H, C(4’)H), 7.92 (d, J 8.9, 2H, C(5)H, C(5’)H), 7.53 (d, J 8.9, 2H, C(3)H, C(3’)H), 7.48-
7.45 (m, 2H, C(6)H, C(6’)H), 7.44-7.42 (m, 4H, 4 × o-ArH-Br), 7.39-7.33 (m, 4H, C(7)H, C(7’)H, 
C(8)H, C(8’)H), 7.38-7.36 (m, 4H, 4 × m-ArH-NO2); 13C {1H} NMR (125 MHz, CDCl3) δC: 164.2 (2 
× C=O), 146.8 (C(2), C(2’)), 133.4 (C(8a), C(8a’)), 131.8 (4 × m-ArCH), 131.7 (C(4a), C(4a’)), 
131.4 (4 × o-ArCH), 129.8 (C(4), C(4’), 128.6 (2 × i-ArCH), 128.3 (C(5), C(5’)), 128.2 (2 × p-
ArCH), 127.1 (C(7), C(7’)), 126.1 (C(8), C(8’)), 126.0 (C(6), C(6’)), 123.6 (C(1), C(1’)), 121.7 (C(3), 
C(3’)); HRMS (ASAP+) C34H20Br2O4 [M+H]+ found 650.9824, requires 650.9807 (+2.6 ppm) 
 
[1,1'-Binaphthalene]-2,2'-diyl bis(4-nitrobenzoate)  
 
Following general procedure B: BINOL (57.3 mg, 0.2 mmol) and DMAP (2.4 mg, 0.02 mmol) 
were added into CH2Cl2 (4 mL, 0.05 M) at room temperature, giving a clear solution. 4-
Nitrobenzoic anhydride (94.9 mg, 0.3 mmol) was added to the previous solution. The 
resulted clear solution was left stirring for 18 hours at room temperature. The crude oil was 
purified by column chromatography (Isolera 4, EtOAc in petrol, 0% -> 20% over 30 CV) to 
give [1,1'-binaphthalene]-2,2'-diyl bis(4-nitrobenzoate) (44.5 mg, 38%) as yellow crystals; Rf 
= 0.25 (20% EtOAc in petroleum ether); mp 170-171 °C; νmax (ATR); 2920 (C-H), 1740 (C=O), 
1420 (C=C), 1094 (C-O);  1H NMR (500 MHz, CDCl3) δH:  8.07 (d, J 8.9, 4H, 4 × m-ArH-NO2), 
8.02 (d, J 8.9, 2H, C(4)H, C(4’)H), 7.95 (d, J 8.2, 2H, C(5)H, C(5’)H), 7.69 (d, J 8.9, 4H, 4 × o-
ArH-NO2), 7.55 (d, J 8.9, 2H, C(3)H, C(3’)H), 7.53-7.50 (m, 2H, C(6)H, C(6’)H), 7.44-7.38 (m, 4H, 
C(7)H, C(7’)H, C(8)H, C(8’)H); 13C {1H} NMR (125 MHz, CDCl3) δC: 163.1 (2 × C=O), 150.7 (2 × p-
ArC-NO2), 146.6 (C(2), C(2’)), 134.6 (2 × i-ArC-NO2), 133.3 (C(8a), C(8a’), 131.8 (C(4a), C(4a’)), 
130.9 (4 × o-ArC-NO2), 130.2 (C(4), C(4’)), 128.4 (C(5), C(5’)), 127.4 (C(7), C(7’)), 126.4 (C(6), 
C(6’)), 126.0 (C(8), C(8’)), 123.6 (C(1), C(1’), 4 × m-ArC-NO2), 121.4 (C(3), C(3’)); HRMS (ASAP+) 








[1,1'-Binaphthalene]-2,2'-diyl dinicotinate  
 
Following general procedure B: BINOL (57.3 mg, 0.2 mmol) and DMAP (2.4 mg, 0.02 mmol) 
were added into tert-Amyl alcohol (4 mL, 0.05 M) at room temperature, giving a clear 
solution. Nicotinic anhydride (76.3 mg, 0.3 mmol) was added to the previous solution. The 
resulted clear solution was left stirring for 18 hours at room temperature. The crude oil was 
purified by column chromatography (Isolera 4, MeOH in DCM, 0% -> 2% over 25 CV, then 2% 
over 10 CV) to give [1,1'-binaphthalene]-2,2'-diyl dinicotinate (7.5 mg, 8%) as white solids; Rf 
= 0.11 (2% MeOH in CH2Cl2); mp 158-159 °C; νmax (ATR): 2890 (C-H), 1740 (C=O), 1587 (C=C), 
1269 (C=C), 1080 (C-O); 1H NMR (500 MHz, CDCl3) δH: 8.75 (d, J 1.4, 2H, hetero-ArH(2), 
hetero-ArH(2’)), 8.65 (dd, J 4.8, 1.7, 2H, hetero-ArH(6), hetero-ArH(6’)) 8.01 (d, J 8.9, 2H, 
C(4)H, C(4’)H), 7.93 (d, J 8.2, 2H, C(5)H, C(5’)H), 7.87 (dt, J 8.0, 2.0, 2H, hetero-ArH(4), 
hetero-ArH(4’)), 7.54 (d, J 8.9, 2H, C(3)H, C(3’)H), 7.50-7.47 (m, 2H, C(6)H, C(6’)H), 7.40-7.35 
(m, 4H, C(8)H, C(8’)H), C(7)H, C(7’)H), 7.21 (dd, J 8.0, 4.8, 2H, hetero-ArH(5), hetero-ArH(5’)); 
13C {1H} NMR (125 MHz, CDCl3) δC: 163.6 (2 × C=O), 153.8 (hetero-ArC(6)H, hetero-ArC(6’)H), 
151.1 (hetero-ArC(2)H, hetero-ArC(2’)H), 146.5 (C(2), C(2’)), 137.3 (hetero-ArC(4)H, hetero-
ArC(4’)H), 133.3 (C(8a), C(8a’)), 131.8 (C(4a), C(4a’)), 130.1 (C(4), C(4’), 128.3 (C(5), C(5’)), 
127.3 (C(7), C(7’)), 126.2 (C(6), C(6’)), 126.1 (C(8), C(8’)), 123.6 (C(1), C(1’)), 123.3 (hetero-
ArC(5)H, hetero-ArC(5’)H), 121.5 (C(3), C(3’)); HRMS (NSI+) C32H20N2O4 [M+H]+ found 




Following general procedure B: BINOL (57.3 mg, 0.2 mmol) and DMAP (2.4 mg, 0.02 mmol) 
were added into CH2Cl2 (4 mL, 0.05 M) at room temperature, giving a clear solution. 2-
Ethylbutanoic anhydride (64.3 mg, 0.3 mmol) and iPr2NEt (27.9 mg, 35 µL, 0.2 mmol) were 
added to the previous solution. The resulted clear solution was left stirring for 18 hours at 
room temperature. The solution was diluted with EtOAc (10 mL), washed with HCl (1 M. 2 × 




filtered and concentrated in vacuo, to give pale brown oil, which was purified by column 
chromatography (Isolera 4, EtOAc in petrol, 0% -> 20% over 25 CV) to give [1,1'-
binaphthalene]-2,2'-diyl bis(2-ethylbutanoate) (26.5 mg, 28%) as a colorless gum; Rf = 0.61 
(20% EtOAc in petroleum ether); νmax (ATR): 2965 (C-H), 1753 (C=O), 1458 (C=C), 1107 (C-O); 
1H NMR (500 MHz, CDCl3) δH: 7.98 (d, J 8.9, 2H, C(4)H, C(4’)H), 7.90 (d, J 8.3, 2H. C(5)H, 
C(5’)H), 7.45-7.42 (m, 2H, C(6)H, C(6’)H), 7.38 (d, J 8.9, 2H, C(3)H, C(3’)H), 7.30-7.29 (m, 2H, 
C(7)H, C(7’)H), 7.26-7.24 (m, 2H, C(8)H, C(8’)H) 2.04 (tt, J 8.7, 5.4, 2H, 2 × -CH-), 1.29-1.08 (m, 
8H, 4× -CH2-), 0.55 (t, J 6.5, 6H, 2 × -CH3), 0.43 (t, J 6.5, 6H, 2 × -CH3); 13C {1H} NMR (125 MHz, 
CDCl3) δC: 174.3 (2 × C=O), 147.0 (C(2), C(2’)), 133.6 (C(8a), C(8a’)), 131.7 (C(4a), C(4a’)), 129.5 
(C(4), C(4’), 128.0 (C(5), C(5’)), 126.8 (C(7), C(7’)), 126.4 (C(8), C(8’)), 125.7 (C(6), C(6’)), 123.8 
(C(1), C(1’)), 122.0 (C(3), C(3’)), 48.7 (2 × -CH-), 24.7 (-CH2-), 24.6 (-CH2-), 11.4 (2 × -CH3), 11.1 




Following general procedure B: BINOL (57.3 mg, 0.2 mmol) and DMAP (2.4 mg, 0.02 mmol) 
were added into CH2Cl2 (4 mL, 0.05 M) at room temperature, giving a clear solution. 3-
Propylpentanoic anhydride (81.1 mg, 0.3 mmol) and iPr2NEt (27.9 mg, 35 µL, 0.2 mmol) were 
added to the previous solution. The resulted clear solution was left stirring for 18 hours at 
room temperature. The solution was diluted with EtOAc (10 mL), washed with HCl (1 M. 2 × 
10 mL), NaHCO3 (sat., 2 × 10 mL) and brine (10 mL). The organic layer was dried over MgSO4, 
filtered and concentrated in vacuo, to give pale brown oil, which was purified by column 
chromatography (Isolera 4, EtOAc in petrol, 0% -> 20% over 30 CV) to give [1,1'-
binaphthalene]-2,2'-diyl bis(2-propylpentanoate) (28.4 mg, 26%) as a cloudy gum; Rf = 0.64 
(20% EtOAc in petroleum ether; νmax (ATR): 2957 (C-H), 1751 (C=O), 1508 (C=C), 1103 (C-O); 
1H NMR (500 MHz, CDCl3) δH:  7.96 (d, J 8.9, 2H, C(4)H, C(4’)H), 7.90 (d, J 8.1, 2H. C(5)H, 
C(5’)H), 7.45-7.42 (m, 2H, C(6)H, C(6’)H), 7.36 (d, J 8.9, 2H, C(3)H, C(3’)H), 7.30-7.26 (m, 2H, 
C(7)H, C(7’)H), 7.23 (d, J 8.5, 2H, C(8)H, C(8’)H), 2.19 (sept, J 5.3, 2H, 2 × -CH-),  1.26-0.76 (m, 
16H, 8 × -CH2-),  0.66 (t, J 7.3, 6H, 2 × -CH3), 0.60 (t, J 7.3, 6H, 2 × -CH3); 13C {1H} NMR (125 
MHz, CDCl3) δC: 174.5 (2 × C=O), 147.0 (C(2), C(2’)), 133.7 (C(8a), C(8a’)), 131.7 (C(4a), C(4a’)), 




123.7 (C(1), C(1’)), 122.0 (C(3), C(3’)), 45.4 (2 × -CH-), 20.4 (2 × -CH2-), 20.2 (2 × -CH2-), 14.1 (2 




Following general procedure B: BINOL (57.3 mg, 0.2 mmol) and DMAP (2.4 mg, 0.02 mmol) 
were added into CH2Cl2 (4 mL, 0.05 M) at room temperature, giving a clear solution. 
Diphenylacetic anhydride (121.8 mg, 0.3 mmol) was added to the previous solution. The 
resulted clear solution was left stirring for 18 hours at room temperature. The crude oil was 
purified by column chromatography (Isolera 4, EtOAc in petrol, 0% -> 20% over 25 CV) to 
give 2,3-dihydro-[1,1'-binaphthalene]-2,2'-diyl bis(2,2-diphenylacetate) as white solids (54.8 
mg, 41%); Rf = 0.33 (20% EtOAc in petroleum ether); mp 149-150 °C; νmax (ATR): 2990 (C-H), 
1748 (C=O), 1497 (C=C), 1109 (C-O); 1H NMR (500 MHz, CDCl3) δH:  7.88 (d, J 8.7, 4H, C(4)H, 
C(4’)H, C(5)H, C(5’)H), 7.45-7.41 (m, 2H, C(6)H, C(6’)H), 7.25 (d, J 9.0, 2H, C(3)H, C(3’)H), 7.22-
7.20 (m, 2H, C(7)H, C(7’)H), 7.19-7.17 (m, 2H, 2 × p-ArCH), 7.16-7.11 (m, 6H, C(8)H, C(8’)H, 4 
× o-ArCH), 7.08-7.06 (m, 2H, 2 × p-ArCH), 7.05-7.02 (m, 4H, 4 × m-ArCH), 7.00-6.97 (m, 4H, 4 
× m-ArCH), 6.72-7.71 (m, 4H, 4 × o-ArCH), 4.80 (s, 2H, -CHPh2); 13C {1H} NMR (125 MHz, CDCl3) 
δC: 170.8 (2 × C=O), 146.8 (C(2), C(2’)), 137.9 (i-ArCH), 137.8 (i-ArCH), 133.3 (C(8a), C(8a’), 
131.7 (C(4a), C(4a’)), 129.7 (C(4), C(4’)), 128.8 (2 × m-ArCH), 128.6 (2 × o-ArCH), 128.3 (2 × m-
ArCH), 128.2 (2 × o-ArCH), 128.1 (C(5), C(5’)), 127.3 (p-ArCH), 126.9 (p-ArCH), 126.9 (C(7), 
C(7’)), 126.4 (C(8), C(8’)), 125.8 (C(6), C(6’)), 123.5 (C(1), C(1’)), 121.6 (C(3), C(3’)), 56.8 (-CH-); 




Following general procedure B: BINOL (57.3 mg, 0.2 mmol) and DMAP (2.4 mg, 0.02 mmol) 
were added into CH2Cl2 (4 mL, 0.05 M) at room temperature, giving a clear solution. 
Cyclopetanecarboxylic anhydride (63.1 mg, 0.3 mmol) and iPr2NEt (27.9 mg, 35 µL, 0.2 mmol) 




at room temperature. The solution was diluted with EtOAc (10 mL), washed with HCl (1 M. 2 
× 10 mL), NaHCO3 (sat., 2 × 10 mL) and brine (10 mL). The organic layer was dried over 
MgSO4, filtered and concentrated in vacuo, to give pale brown oil, which was purified by 
column chromatography (Isolera 4, EtOAc in petrol, 0% -> 20% over 30 CV) to give [1,1'-
binaphthalene]-2,2'-diyl dicyclopentanecarboxylate (28.3 mg, 30%) as a white solid; Rf = 0.53 
(20% EtOAc in petroleum ether); mp 164-166  °C; νmax (ATR): 2955 (C-H), 1749 (C=O), 1508 
(C=C), 1117 (C-O); 1H NMR (500 MHz, CDCl3) δH:  7.98 (d, J 8.9, 2H, C(4)H, C(4’)H), 7.92 (d, J 
8.2, 2H, C(5)H, C(5’)H), 7.47-7.43 (m, 2H, C(6)H, C(6’)H), 7.41 (d, J 8.9, 2H, C(3)H, C(3’)H), 
7.31-7.26 (m, 4H, C(7)H, C(7’)H, C(8)H, C(8’)H), 2.56-2.49 (m, 2H, 2 × -C(1’’)H-), 1.43-0.98 (m, 
16H, 4 × -C(2’’)H2-, 4 × -C(3’’)H2-); 13C {1H} NMR (125 MHz, CDCl3) δC: 174.8 ( 2× C=O), 147.0 
(C(2), C(2’)), 133.5 (C(8a), C(8a’)), 131.6 (C(4a), C(4a’)), 129.4 (C(4), C(4’), 128.0 (C(5), C(5’)), 
126.8 (C(7), C(7’)), 126.3 (C(8), C(8’)), 125.7 (C(6), C(6’)), 123.8 (C(1), C(1)’), 122.1 (C(3), C(3’)), 
43.6 (2 × -CH-), 29.5 (2 × -CH2-), 29.3 (2 × -CH2-), 25.6 (2 × -CH2-), 25.5 (2 × -CH2-); HRMS 




Following general procedure B: BINOL (57.3 mg, 0.2 mmol) and DMAP (2.4 mg, 0.02 mmol) 
were added into CH2Cl2 (4 mL, 0.05 M) at room temperature, giving a clear solution. 
Cyclohexanecarboxylic anhydride (71.5 mg, 0.3 mmol) and iPr2NEt (27.9 mg, 35 µL, 0.2 mmol) 
were added to the previous solution. The resulted clear solution was left stirring for 18 hours 
at room temperature. The solution was diluted with EtOAc (10 mL), washed with HCl (1 M. 2 
× 10 mL), NaHCO3 (sat., 2 × 10 mL) and brine (10 mL). The organic layer was dried over 
MgSO4, filtered and concentrated in vacuo, to give pale brown oil, which was purified by 
column chromatography (Isolera 4, EtOAc in petrol, 0% -> 20% over 30 CV) to give [1,1'-
binaphthalene]-2,2'-diyl dicyclohexanecarboxylate (20.3 mg, 20%) as a white solid; Rf = 0.61 
(20% EtOAc in petroleum ether); mp 164-166  °C; νmax (ATR): 2926 (C-H), 1753 (C=O), 1447 
(C=C), 1109 (C-O); 1H NMR (500 MHz, CDCl3) δH: 7.97 (d, J 8.9, 2H, C(4)H, C(4’)H), 7.91 (d, J 
8.3, 2H, C(5)H, C(5’)H), 7.47-7.43 (m, 2H, C(6)H, C(6’)H), 7.39 (d, J 8.9, 2H, C(3)H, C(3’)H), 
7.32-7.28 (m, 4H, C(7)H, C(7’)H, 7.28-7.26 (m, 2H, C(8)H, C(8’)H), 2.12-2.06 (m, 2H, 2 × -
C(1’’)H-), 1.47-0.73 (m, 20H, 4 × -C(2’’)H2-, 4 × -C(3’’)H2-, 2 × -C(4’’)H2-); 13C {1H} NMR (125 




129.4 (C(4), C(4’), 128.0 (C(5), C(5’)), 126.8 (C(7), C(7’)), 126.3 (C(8), C(8’)), 125.7 (C(6), C(6’)), 
123.8 (C(1), C(1)’), 122.1 (C(3), C(3’)), 42.8 (2 × –C(1’’)H-), 28.2 (2 × -CH2-), 28.2 (2 × -CH2-), 
25.6 (2 × -CH2-), 25.1 (2 × -CH2-),25.1 (2 × -CH2-); HRMS (ASAP+) C34H34O4 [M+H]+ found 




Following general procedure B: 6,6'-dibromo-[1,1'-binaphthalene]-2,2'-diol (88.8 mg, 0.2 
mmol) and DMAP (2.4 mg, 0.02 mmol) were added into CH2Cl2 (4 mL, 0.05 M) at room 
temperature, giving a clear solution. Diphenylacetic anhydride (121.8 mg, 0.3 mmol) and 
iPr2NEt (27.9 mg, 35 µL, 0.2 mmol) were added to the previous solution. The resulted clear 
solution was left stirring for 18 hours at room temperature. The concentrated in vacuo and 
the residue was purified by column chromatography (Isolera 4, EtOAc in petrol, 0% -> 10% 
over 30 CV) to give 6,6'-dibromo-[1,1'-binaphthalene]-2,2'-diyl bis(2,2-diphenylacetate) (78.2 
mg, 47%) as colorless gum. Rf = 0.71 (20% EtOAc in petroleum ether); νmax (ATR): 3040 (C-H), 
1757 (C=O), 1495 (C=C), 1115 (C-O); 1H NMR (500 MHz, CDCl3) δH:  8.00 (d, J 2.0, 2H, C(5)H, 
C(5’)H), 7.76 (d, J 9.0, 2H, C(4)H, C(4’)H), 7.26 (d, J 8.9, 2H, C(3)H, C(3’)H), 7.25 (dd, J 9.0, 2.0, 
2H, C(7)H, C(7’)H), 7.22-7.10 (m, 8H, 2 × p-ArH, 4 × m-ArH, 2 × p’-ArH), 7.04 (d, J 7.5, 4H, 4 × 
o-ArH), 7.01 (d, J 7.5, 4H, 4 × m’-ArH),  6.94 (d, J 9.0, 2H, C(8)H, C(8’)H)), 6.75 (d, J 7.5, 4H, 4 × 
o’-ArH), 4.78 (s, 2H, 2 × -CH-); 13C {1H} NMR (125 MHz, CDCl3) δC: 171.6 (2 × C=O), 147.0 (C(2), 
C(2’)), 137.6 (i-ArCH), 137.5 (i’-ArCH), 132.7 (C(4a), C(4a’)), 131.6 (C(8a), C(8a’)), 130.3 (C(7), 
C(7’)), 130.2 (C(5), C(5’)), 128.9 (C(4), C(4’), 128.6 (2 × m-ArCH), 128.6 (2 × m’-/o-ArCH), 128.4 
(2 × m’-/o-ArCH), 128.1 (2 × o’-ArCH), 127.8 (C(8), C(8’)), 127.4 (p-ArCH), 127.4 (p’-ArCH), 
123.2 (C(1), C(1)’), 122.8 (C(3), C(3’)), 120.2 (C(6), C(6’)), 56.6 (2 × -CH-); HRMS (NSI+) 












Following general procedure B: 7,7'-dibromo-[1,1'-binaphthalene]-2,2'-diol (88.8 mg, 0.2 
mmol) and DMAP (2.4 mg, 0.02 mmol) were added into CH2Cl2 (4 mL, 0.05 M) at room 
temperature, giving a clear solution. Diphenylacetic anhydride (121.8 mg, 0.3 mmol) and 
iPr2NEt (27.9 mg, 35 µL, 0.2 mmol) were added to the previous solution. The resulted clear 
solution was left stirring for 18 hours at room temperature. The concentrated in vacuo and 
the residue was purified by column chromatography (Isolera 4, EtOAc in petrol, 0% -> 15% 
over 35 CV) to give 7,7'-dibromo-[1,1'-binaphthalene]-2,2'-diyl bis(2,2-diphenylacetate) (78.9 
mg, 47%) as yellow solids. Rf = 0.52 (20% EtOAc in petroleum ether); mp 126-128 °C; νmax 
(ATR): 3028 (C-H), 1757 (C=O), 1495 (C=C), 1110 (C-O); 1H NMR (500 MHz, CDCl3) δH:  7.82 (d, 
J 8.8, 2H, C(4)H, C(4’)H), 7.70 (d, J 8.8, 2H, C(5)H, C(5’)H), 7.49 (d, J 8.7, 2.0, 2H, C(5)H, C(5’)H), 
7.28 (d, J 8.9, 2H, C(3)H, C(3’)H), 7.24 (d, J 1.9, 2H, C(8)H, C(8’)H), 7.20-7.13 (m, 6H, 2 × p-ArH, 
4 × m-ArH), 7.11-7.08 (m, 2H, 2 × p’-ArH), 7.05-7.02 (m, 8H, 4 × m’-ArH, 4× o-ArH)), 6.84-6.82 
(m, 4H, 4 × o’-ArH), 4.78 (s, 2H, 2 × -CH-); 13C {1H} NMR (125 MHz, CDCl3) δC: 170.4 (2 × C=O), 
147.6 (C(2), C(2’)), 137.6 (i-ArCH, i’-ArCH), 134.3 (C(8a), C(8a’)), 130.1 (C(4a), C(4a’)), 129.9 
(C(4), C(4’), 129.9 (C(5), C(5’)), 129.5 (C(6), C(6’)), 128.6 (2 × m-Ar, 2 × o-ArCH), 128.4 (2 × m-
ArCH), 128.2 (2 × o’-ArCH), 127.9 (C(8), C(8’)), 127.3 (p-ArCH), 127.1 (p’-ArCH), 122.1 (C(3), 
C(3’)), 122.0 (C(1), C(1)’), 56.7 (2 × -CH-); HRMS (NSI+) C48H32Br2O4 [M+NH4]+ found 848.1011, 




Following general procedure B: 7,7'-dimethoxy-[1,1'-binaphthalene]-2,2'-diol (69.3 mg, 0.2 
mmol) and DMAP (2.4 mg, 0.02 mmol) were added into CH2Cl2 (4 mL, 0.05 M) at room 
temperature, giving a clear solution. Diphenylacetic anhydride (121.8 mg, 0.3 mmol) and 
iPr2NEt (27.9 mg, 35 µL, 0.2 mmol) were added to the previous solution. The resulted clear 
solution was left stirring for 18 hours at room temperature. The solution was diluted with 




The organic layer was dried over MgSO4, filtered and concentrated in vacuo, to give pale 
brown oil, which was purified by column chromatography (Isolera 4, EtOAc in petrol, 0% -> 
20% over 35 CV) to give 7,7'-dimethoxy-[1,1'-binaphthalene]-2,2'-diyl bis(2,2-
diphenylacetate) (20.6 mg, 14%) as white solids; Rf = 0.375 (20% EtOAc in petroleum ether); 
mp 152-154 °C; νmax (ATR): 2980 (C-H), 1746 (C=O), 1506 (C=C), 1224 (C-O), 1150 (C-O); 1H 
NMR (500 MHz, CDCl3) δH:  7.81 (d, J 8.8, 2H, C(4)H, C(4’)H), 7.76 (d, J 8.9, 2H, C(5)H, C(5’)H), 
7.20-7.14 (m, 6H, 2 × p-ArH, 4 × o-ArH), 7.12 (d, J 8.9, 2H, C(3)H, C(3’)H), 7.11-7.05 (m, 4H, 2 
× p’-ArH, C(6)H, C(6’)H), 7.04-7.00 (m, 8H, 4 × m-ArH, 4 × m’-ArH), ), 6.69 (d, J 7.3, 4H, 4 × o’-
ArH), 6.50 (d, J 2.6, 2H, C(8)H, C(8’)H), 4.74 (s, 2H, 2 × -CH-), 3.42 (s, 6H, 2 × -OCH3); 13C {1H} 
NMR (125 MHz, CDCl3) δC: 171.0 (2 × C=O), 158.4 (C(7), C(7’)),  147.4 (C(2), C(2’)), 137.9 (i-
ArCH), 137.8 (i’-ArCH), 134.7 (C(8a), C(8a’)), 129.6 (C(5), C(5’)), 129.3 (C(4), C(4’), 128.7 (2 × 
o-ArCH), 128.6 (2 × m-ArCH), 128.4 (2 × m’-ArCH), 128.3 (2 × o’-ArCH), 127.3 (p-ArCH), 127.2 
(C(4a), C(4a’)), 127.0 (p’-ArCH), 122.4 (C(1), C(1)’), 119.1 (C(3), C(3’)), 118.8 (C(6), C(6’)), 
104.5 (C(8), C(8’)), 56.7 (2 × -CH-), 55.2 (2 × -OCH3); HRMS (NSI+) C50H38O6 [M+NH4]+ found 




Following general procedure B: 5,5',6,6',7,7',8,8'-Octahydro-1,1'-bi-2-naphthol (58.9 mg, 0.2 
mmol) and DMAP (2.4 mg, 0.02 mmol) were added into CH2Cl2 (4 mL, 0.05 M) at room 
temperature, giving a clear solution. Diphenylacetic anhydride (121.8 mg, 0.3 mmol) and 
iPr2NEt (27.9 mg, 35 µL, 0.2 mmol) were added to the previous solution. The resulted clear 
solution was left stirring for 18 hours at room temperature. The solution was diluted with 
EtOAc (10 mL), washed with HCl (1 M. 2 × 10 mL), NaHCO3 (sat., 2 × 10 mL) and brine (10 mL). 
The organic layer was dried over MgSO4, filtered and concentrated in vacuo, to give pale 
brown oil, which was purified by column chromatography (Isolera 4, Et2O in petrol, 0% -> 
10% over 20 CV) to give 5,5',6,6',7,7',8,8'-octahydro-[1,1'-binaphthalene]-2,2'-diyl bis(2,2-
diphenylacetate) (59.3 mg, 43%) as a cloudy gum; Rf = 0.4 (10% Et2O in petroleum ether); 
νmax (ATR): 2930 (C-H), 1753 (C=O), 1472 (C=C), 1115 (C-O); 1H NMR (500 MHz, CDCl3) δH:  
7.22-7.19 (m, 6H, 2 × p-ArH, 4 × o/m-ArH), 7.18-7.12 (m, 10H, 2 × p-ArH, 4 × o-ArH, 4 × m-
ArH), 7.02 (d, J 8.3, 2H, C(4)H, C(4’)H), 7.00-6.96 (m, 4H, 4 × o/m-ArH), 6.83 (d, J 8.3, 2H, 




2.18-2.12 (m, 2H, C(8)H2), 2.08-2.02 (m, 2H, C(8’)H2), 1.65-1.23 (m, 8H, C(6)H2, C(6’)H2, C(7)H2, 
C(7’)H2); 13C {1H} NMR (125 MHz, CDCl3) δC: 171.0 (2 × C=O), 146.1 (C(2), C(2’)), 138.6 (i-
ArCH), 138.2 (i’-ArCH), 137.6 (C(8a), C(8a’)), 135.2 (C(4a), C(4a’), 129.4 (C(4), C(4’), 128.8 (2 × 
o/m-ArCH), 128.7 (2 × o/m-ArCH), 128.6 (2  × o’/m’-ArCH), 128.4 (2× o’/m’-ArCH), 128.2 (C(1), 
C(1)’), 127.1 (p-ArCH), 127.0 (p’-ArCH), 119.3 (C(3), C(3’), 56.9 (2 × -CH-), 29.6 (C(5), C(5’)), 
27.0 (C(8), C(8’)), 22.8 (C(7), C(7’)), 22.7 (C(6), C(6’)); HRMS (NSI+) C48H42O4 [M+H]+ found 





Following general procedure B: 3,3'-Dibromo-5,5',6,6',7,7',8,8'-octahydro-[1,1'-
binaphthalene]-2,2'-diol (90.4 mg, 0.2 mmol)  and DMAP (2.4 mg, 0.02 mmol) were added 
into CH2Cl2 (4 mL, 0.05 M) at room temperature, giving a clear solution. Diphenylacetic 
anhydride (121.8 mg, 0.3 mmol) and iPr2NEt (27.9 mg, 35 µL, 0.2 mmol) were added to the 
previous solution. The resulted clear solution was left stirring for 18 hours at room 
temperature. The concentrated in vacuo and the residue was purified by column 
chromatography (Isolera 4, EtOAc in petrol, 0% -> 8% over 35 CV) to give 3,3'-dibromo-
5,5',6,6',7,7',8,8'-octahydro-[1,1'-binaphthalene]-2,2'-diyl bis(2,2-diphenylacetate) (36.2 mg, 
22%) as colorless gum. Rf = 0.44 (20% EtOAc in petroleum ether); νmax (ATR): 2934 (C-H), 
1763 (C=O), 1450 (C=C), 1107 (C-O); 1H NMR (500 MHz, CDCl3) δH:  7.34-6.91 (m, 22H, ArH), 
4.99 (s, 2H, 2 × -CH-), 1.65-1.52 (m, 16H, 8 × -CH2); 13C {1H} NMR (125 MHz, CDCl3) δC: 137.2, 
133.4, 128.7, 128.6, 128.4, 127.2, 29.3, 22.4; HRMS (ASAP+) C48H20Br2O4 [M+H]+ found 




Following general procedure B: 5,5',6,6'-tetramethyl-[1,1'-biphenyl]-2,2'-diol (48.5 mg, 0.2 




temperature, giving a clear solution. 2,2-diphenylacetic anhydride (121.8 mg, 0.3 mmol) and 
iPr2NEt (27.9 mg, 35 µL, 0.2 mmol) were added to the previous solution. The resulted clear 
solution was left stirring for 18 hours at room temperature. The solution was concentrated 
in vacuo to give a crude oil, which was purified by column chromatography (Isolera 4, EtOAc 
in petrol, 0% -> 10% over 40 CV) to give 5,5',6,6'-tetramethyl-[1,1'-biphenyl]-2,2'-diyl bis(2,2-
diphenylacetate) (31.5 mg, 24%) as white solids. Rf = 0.49 (20% EtOAc in petroleum ether); 
mp 113-114 °C; νmax (ATR): 3028 (C-H), 1755 (C=O), 1454 (C=C), 1117 (C-O); 1H NMR (500 
MHz, CDCl3) δH:  7.22-7.20 (m, 6H, 2 × p’-ArH, 4 × m’-ArH), 7.17-7.08 (m, 10H, 2 × p-ArH, 4 × 
m-ArH, 4 × o-ArH), 7.08 (d, J 8.2, 2H, C(4)H, C(4’)H), 6.92-6.90 (m, 4H, 4 × o’-ArH), 6.79 (d, J 
8.2, 2H, C(3)H, C(3’)H), 4.85 (s, 2H, 2 × -CH-), 2.17 (s, 6H, C(5)-CH3, C(5’)-CH3), 1.74 (s, 6H, 
C(6)-CH3, C(6’)-CH3); 13C {1H} NMR (125 MHz, CDCl3) δC: 171.1 (× C=O), 146.7 (C(2), C(2’)), 
138.5 (2 × i-ArCH), 138.1 (2 × i’-ArCH), 137.4 (C(6), C(6’)), 134.6 (C(5), C(5’)) 129.7 (C(4), C(4’), 
129.1 (C(1), C(1)), 128.8 (4 × m-ArCH), 128.6 (4 × m’-ArCH), 128.6 (4 × o-ArCH), 128.4 (4 × o’-
ArCH), 127.2 (2 × p-ArCH), 127.0 (2 × p’-ArCH), 119.1 (C(3), C(3’)), 56.7 (2 × -CH-), 20.4 (2 × -
CH3), 16.4 (2 × -CH3); HRMS (NSI+) C44H38O4 [M+NH4]+ found 648.3100, requires 648.3108 
(−1.3 ppm) 
 
5,5'-Dichloro-4,4',6,6'-tetramethyl-[1,1'-biphenyl]-2,2'-diyl bis(2,2-diphenylacetate)  
 
Following general procedure B: 5,5'-dichloro-4,4',6,6'-tetramethyl-[1,1'-biphenyl]-2,2'-diol 
(62.2 mg, 0.2 mmol) and DMAP (2.4 mg, 0.02 mmol) were added into CH2Cl2 (4 mL, 0.05 M) 
at room temperature, giving a clear solution. 2,2-diphenylacetic anhydride (121.8 mg, 0.3 
mmol) and iPr2NEt (27.9 mg, 35 µL, 0.2 mmol) were added to the previous solution. The 
resulted clear solution was left stirring for 18 hours at room temperature. The solution was 
concentrated in vacuo to give a crude oil, which was purified by column chromatography 
(Isolera 4, EtOAc in petrol, 0% -> 10% over 35 CV) to give 5,5'-dichloro-4,4',6,6'-tetramethyl-
[1,1'-biphenyl]-2,2'-diyl bis(2,2-diphenylacetate) (17.3 mg, 12.4%) as white solids. Rf = 0.69 
(20% EtOAc in petroleum ether); mp 207-208 °C; νmax (ATR): 3030 (C-H), 1757 (C=O), 1454 
(C=C), 1119 (C-O); 1H NMR (500 MHz, CDCl3) δH:  7.24-7.21 (m, 6H, 2 × p-ArH, 4 × m-ArH), 
7.20-7.15 (m, 10H, 2 × p’-ArH, 4 × m’-ArH, 4 × o-ArH), 6.98-6.96 (m, 4H, 4 × o’-ArH), 6.73 (s, 




C(6’)-CH3); 13C {1H} NMR (125 MHz, CDCl3) δC: 170.7 (2 × C=O), 146.4 (C(2), C(2’)), 137.9 (2 × i-
ArCH), 137.9 (2 × i’-ArCH), 137.0 (C(6), C(6’), C(4), C(4’)), 132.6 (C(5), C(5’)), 128.7 (4 × 
m/m’/o-ArCH), 128.7 (4 × m/m’/o-ArCH), 128.5 (4 × o-ArCH), 128.4 (4 × m/m’/o-ArCH), 127.5 
(C(1), C(1)), 127.4 (2 × p-ArCH), 127.2 (2 × p’-ArCH), 121.9 (C(3), C(3’)), 56.6 (2 × -CH-), 21.2 (2 
× -CH3), 17.8 (2 × -CH3); HRMS (NSI+) C44H36Cl2O4 [M+NH4]+ found 716.2324, requires 
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